+1 #(S1 (S (NP (NP (NN Suppression)) (PP (IN of) (NP (NP (NN rat) (NN thromboxane) (NN synthase) (NN gene)) (NN transcription))) (PP (IN by) (NP (NP (NN _PROT1_) (JJ _PROT1_) (NN _PROT1_) (NN _PROT1_)) (PP (IN in) (NP (NNS macrophages))))) (PP (IN via) (NP (NP (DT an) (NN interaction)) (PP (IN with) (NP (NN _PROT2_))))))))
-1 #(S1 (S (NP (NN Deletion) (NN analysis)) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (DT the) (NN element)) (ADJP (JJ responsible) (PP (IN for) (NP (DT the) (NN PPARgamma) (NN effect))))) (VP (VBZ is) (ADJP (JJ located) (PP (IN in) (NP (NP (DT a) (NN region)) (VP (VBG containing) (NP (NP (DT the) (JJ nuclear) (NN factor) (NN E2) (-LRB- -LRB-) (NN _PROT1_) (-RRB- -RRB-) (NN _PROT2_) (NN site)) (PRN (-LRB- -LRB-) (NP (NN -98/-88)) (-RRB- -RRB-))))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN indicated) (S (VP (TO to) (VP (VB be) (NP (NP (DT the) (JJ major) (NN promoter)) (PP (IN of) (NP (DT the) (NN TXS) (NN gene)))))))))))))))))
-1 #(S1 (S (PP (IN By) (NP (NP (JJ electrophoretic) (NN mobility) (NN shift) (NN assay)) (VP (VBG using) (NP (NP (DT the) (NN _PROT1_AND_PROT2_) (NN site)) (CC and) (NP (NP (JJ nuclear) (NNS extracts)) (PP (IN from) (NP (NNS macrophages)))))))) (, ,) (NP (PRP we)) (VP (VBD observed) (NP (NP (DT a) (JJ specific) (JJ protein-DNA) (NN complex) (NN formation)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN inhibited) (PP (IN by) (NP (NP (DT a) (JJ specific) (NN antibody)) (PP (IN against) (NP (DT the) (NN transcription) (NN factor) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (JJ _PROT_) (NN _PROT_) (CD _PROT_)) (-RRB- -RRB-)))))))))))))))
-1 #(S1 (S (PP (IN By) (NP (NP (JJ electrophoretic) (NN mobility) (NN shift) (NN assay)) (VP (VBG using) (NP (NP (DT the) (NN _PROT1_) (NN site)) (CC and) (NP (NP (JJ nuclear) (NNS extracts)) (PP (IN from) (NP (NNS macrophages)))))))) (, ,) (NP (PRP we)) (VP (VBD observed) (NP (NP (DT a) (JJ specific) (JJ protein-DNA) (NN complex) (NN formation)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN inhibited) (PP (IN by) (NP (NP (DT a) (JJ specific) (NN antibody)) (PP (IN against) (NP (DT the) (NN transcription) (NN factor) (NP (NP (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (JJ _PROT_) (NN _PROT_) (CD _PROT_)) (-RRB- -RRB-)))))))))))))))
-1 #(S1 (S (PP (IN By) (NP (NP (JJ electrophoretic) (NN mobility) (NN shift) (NN assay)) (VP (VBG using) (NP (NP (DT the) (NN _PROT1_) (NN site)) (CC and) (NP (NP (JJ nuclear) (NNS extracts)) (PP (IN from) (NP (NNS macrophages)))))))) (, ,) (NP (PRP we)) (VP (VBD observed) (NP (NP (DT a) (JJ specific) (JJ protein-DNA) (NN complex) (NN formation)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN inhibited) (PP (IN by) (NP (NP (DT a) (JJ specific) (NN antibody)) (PP (IN against) (NP (DT the) (NN transcription) (NN factor) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (JJ _PROT2_) (NN _PROT2_) (CD _PROT2_)) (-RRB- -RRB-)))))))))))))))
-1 #(S1 (S (PP (IN By) (NP (NP (JJ electrophoretic) (NN mobility) (NN shift) (NN assay)) (VP (VBG using) (NP (NP (DT the) (NN _PROT1_) (NN site)) (CC and) (NP (NP (JJ nuclear) (NNS extracts)) (PP (IN from) (NP (NNS macrophages)))))))) (, ,) (NP (PRP we)) (VP (VBD observed) (NP (NP (DT a) (JJ specific) (JJ protein-DNA) (NN complex) (NN formation)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN inhibited) (PP (IN by) (NP (NP (DT a) (JJ specific) (NN antibody)) (PP (IN against) (NP (DT the) (NN transcription) (NN factor) (NP (NP (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (JJ _PROT_) (NN _PROT_) (CD _PROT_)) (-RRB- -RRB-)))))))))))))))
-1 #(S1 (S (PP (IN By) (NP (NP (JJ electrophoretic) (NN mobility) (NN shift) (NN assay)) (VP (VBG using) (NP (NP (DT the) (NN _PROT1_) (NN site)) (CC and) (NP (NP (JJ nuclear) (NNS extracts)) (PP (IN from) (NP (NNS macrophages)))))))) (, ,) (NP (PRP we)) (VP (VBD observed) (NP (NP (DT a) (JJ specific) (JJ protein-DNA) (NN complex) (NN formation)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN inhibited) (PP (IN by) (NP (NP (DT a) (JJ specific) (NN antibody)) (PP (IN against) (NP (DT the) (NN transcription) (NN factor) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (JJ _PROT2_) (NN _PROT2_) (CD _PROT2_)) (-RRB- -RRB-)))))))))))))))
-1 #(S1 (S (PP (IN By) (NP (NP (JJ electrophoretic) (NN mobility) (NN shift) (NN assay)) (VP (VBG using) (NP (NP (DT the) (NN _PROT_) (NN site)) (CC and) (NP (NP (JJ nuclear) (NNS extracts)) (PP (IN from) (NP (NNS macrophages)))))))) (, ,) (NP (PRP we)) (VP (VBD observed) (NP (NP (DT a) (JJ specific) (JJ protein-DNA) (NN complex) (NN formation)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN inhibited) (PP (IN by) (NP (NP (DT a) (JJ specific) (NN antibody)) (PP (IN against) (NP (DT the) (NN transcription) (NN factor) (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (JJ _PROT2_) (NN _PROT2_) (CD _PROT2_)) (-RRB- -RRB-)))))))))))))))
-1 #(S1 (S (ADVP (RB Finally)) (, ,) (NP (NP (DT a) (JJ direct) (NN interaction)) (PP (IN between) (NP (NP (NN PPARgamma)) (CC and) (NP (NN _PROT1_))))) (VP (VBD was) (VP (VBN confirmed) (PP (IN by) (NP (NP (NN _PROT2_) (NN _PROT2_)) (JJ pull-down) (NN assay)))))))
-1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VP (VBD cloned)) (CC and) (VP (VBD characterized) (NP (NP (DT a) (NN mouse) (NN orthologue)) (PP (IN of) (NP (JJ human) (NN _PROT1_) (NN protein)))) (PP (IN as) (NP (DT an) (JJ atypical) (NN _PROT2_))) (PRN (-LRB- -LRB-) (NP (VBN named) (NN _PROT_) (NN _PROT_)) (-RRB- -RRB-))))))
-1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VP (VBD cloned)) (CC and) (VP (VBD characterized) (NP (NP (DT a) (NN mouse) (NN orthologue)) (PP (IN of) (NP (JJ human) (NN _PROT1_) (NN protein)))) (PP (IN as) (NP (DT an) (JJ atypical) (NN _PROT_))) (PRN (-LRB- -LRB-) (NP (VBN named) (NN _PROT2_) (NN _PROT2_)) (-RRB- -RRB-))))))
-1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VP (VBD cloned)) (CC and) (VP (VBD characterized) (NP (NP (DT a) (NN mouse) (NN orthologue)) (PP (IN of) (NP (JJ human) (NN _PROT_) (NN protein)))) (PP (IN as) (NP (DT an) (JJ atypical) (NN _PROT1_))) (PRN (-LRB- -LRB-) (NP (VBN named) (NN _PROT2_) (NN _PROT2_)) (-RRB- -RRB-))))))
-1 #(S1 (S (NP (NP (JJ Subcellular) (NN fractionation)) (CC and) (NP (JJ antibody-uptake) (NNS experiments))) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN _PROT1_) (CD _PROT1_)) (VP (VP (VBZ is) (ADVP (RB indeed)) (NP (DT a) (JJ type-I) (NN membrane) (NN protein))) (, ,) (CC but) (, ,) (PP (IN unlike) (NP (JJ other) (NN _PROT2_) (NNS isoforms))) (, ,) (VP (VBZ lacks) (NP (DT an) (JJ N-terminal) (JJ extracellular) (NN domain)))))))))
+1 #(S1 (S (NP (NP (JJ Direct) (NN interaction)) (PP (IN between) (NP (NP (NP (DT the) (JJ cytoplasmic) (NN tail)) (PP (IN of) (NP (NN _PROT1_) (CD _PROT1_)))) (CC and) (NP (NP (DT the) (NN Src) (NN homology) (CD 3) (NN domain)) (PP (IN of) (NP (NN _PROT2_))))))) (VP (VBZ activates) (NP (NP (NN _PROT_) (NN _PROT_)) (PP (IN in) (NP (NN C2C12) (NNS cells)))))))
+1 #(S1 (S (NP (NP (JJ Direct) (NN interaction)) (PP (IN between) (NP (NP (NP (DT the) (JJ cytoplasmic) (NN tail)) (PP (IN of) (NP (NN _PROT1_) (CD _PROT1_)))) (CC and) (NP (NP (DT the) (NN Src) (NN homology) (CD 3) (NN domain)) (PP (IN of) (NP (NN _PROT_))))))) (VP (VBZ activates) (NP (NP (NN _PROT2_) (NN _PROT2_)) (PP (IN in) (NP (NN C2C12) (NNS cells)))))))
+1 #(S1 (S (NP (NP (JJ Direct) (NN interaction)) (PP (IN between) (NP (NP (NP (DT the) (JJ cytoplasmic) (NN tail)) (PP (IN of) (NP (NN _PROT_) (CD _PROT_)))) (CC and) (NP (NP (DT the) (NN Src) (NN homology) (CD 3) (NN domain)) (PP (IN of) (NP (NN _PROT1_))))))) (VP (VBZ activates) (NP (NP (NN _PROT2_) (NN _PROT2_)) (PP (IN in) (NP (NN C2C12) (NNS cells)))))))
+1 #(S1 (S (NP (DT This)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NN transmembrane) (NN _PROT1_) (CD _PROT1_)) (, ,) (PP (IN by) (S (VP (VBG providing) (NP (NP (NN docking) (NNS sites)) (PP (IN for) (NP (NP (DT the) (NN Src) (NN homology) (CD 3) (NN domain)) (PP (IN of) (NP (NN _PROT2_))))))))) (, ,) (VP (VBZ activates) (NP (NN PI) (NN 3-kinase)) (PP (IN by) (S (VP (VBG mediating) (NP (NP (PRP$ its) (NN recruitment)) (PP (TO to) (NP (DT the) (NN membrane)))))))))))))
+1 #(S1 (S (NP (NP (NN Modification)) (PP (IN of) (NP (ADJP (FW de) (FW novo)) (NN DNA) (NN methyltransferase) (NN 3a) (-LRB- -LRB-) (NN _PROT1_) (-RRB- -RRB-))) (PP (IN by) (NP (NN _PROT2_)))) (VP (VBZ modulates) (NP (NP (NP (PRP$ its) (NN interaction)) (PP (IN with) (NP (NP (NN histone) (NNS deacetylases)) (PRN (-LRB- -LRB-) (NP (NNS HDACs)) (-RRB- -RRB-))))) (CC and) (NP (PRP$ its) (NN capacity) (S (VP (TO to) (VP (VB repress) (NP (NN transcription))))))))))
+1 #(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ interacts) (PP (IN with) (NP (NP (NP (JJ multiple) (NNS components)) (PP (IN of) (NP (DT the) (NN sumoylation) (NN machinery)))) (, ,) (RB namely) (NP (NP (DT the) (NN E2) (NN sumo) (NN conjugating) (NN enzyme) (NN _PROT2_)) (CC and) (NP (NP (DT the) (NN E3) (NN sumo) (NNS ligases)) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (, ,) (SBAR (WHNP (NP (DT all)) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (VBP are) (VP (VBN involved) (PP (IN in) (S (VP (VBG conjugating) (NP (NP (DT the) (NP (JJ small) (JJ ubiquitin-like) (NN modifier)) (NN polypeptide)) (, ,) (NP (NN _PROT_)) (, ,)) (PP (TO to) (NP (PRP$ its) (NN target) (NNS proteins))))))))))))))))))
+1 #(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ interacts) (PP (IN with) (NP (NP (NP (JJ multiple) (NNS components)) (PP (IN of) (NP (DT the) (NN sumoylation) (NN machinery)))) (, ,) (RB namely) (NP (NP (DT the) (NN E2) (NN sumo) (NN conjugating) (NN enzyme) (NN _PROT_)) (CC and) (NP (NP (DT the) (NN E3) (NN sumo) (NNS ligases)) (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))))) (, ,) (SBAR (WHNP (NP (DT all)) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (VBP are) (VP (VBN involved) (PP (IN in) (S (VP (VBG conjugating) (NP (NP (DT the) (NP (JJ small) (JJ ubiquitin-like) (NN modifier)) (NN polypeptide)) (, ,) (NP (NN _PROT_)) (, ,)) (PP (TO to) (NP (PRP$ its) (NN target) (NNS proteins))))))))))))))))))
+1 #(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ interacts) (PP (IN with) (NP (NP (NP (JJ multiple) (NNS components)) (PP (IN of) (NP (DT the) (NN sumoylation) (NN machinery)))) (, ,) (RB namely) (NP (NP (DT the) (NN E2) (NN sumo) (NN conjugating) (NN enzyme) (NN _PROT_)) (CC and) (NP (NP (DT the) (NN E3) (NN sumo) (NNS ligases)) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))))) (, ,) (SBAR (WHNP (NP (DT all)) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (VBP are) (VP (VBN involved) (PP (IN in) (S (VP (VBG conjugating) (NP (NP (DT the) (NP (JJ small) (JJ ubiquitin-like) (NN modifier)) (NN polypeptide)) (, ,) (NP (NN _PROT_)) (, ,)) (PP (TO to) (NP (PRP$ its) (NN target) (NNS proteins))))))))))))))))))
-1 #(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ interacts) (PP (IN with) (NP (NP (NP (JJ multiple) (NNS components)) (PP (IN of) (NP (DT the) (NN sumoylation) (NN machinery)))) (, ,) (RB namely) (NP (NP (DT the) (NN E2) (NN sumo) (NN conjugating) (NN enzyme) (NN _PROT_)) (CC and) (NP (NP (DT the) (NN E3) (NN sumo) (NNS ligases)) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (, ,) (SBAR (WHNP (NP (DT all)) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (VBP are) (VP (VBN involved) (PP (IN in) (S (VP (VBG conjugating) (NP (NP (DT the) (NP (JJ small) (JJ ubiquitin-like) (NN modifier)) (NN polypeptide)) (, ,) (NP (NN _PROT2_)) (, ,)) (PP (TO to) (NP (PRP$ its) (NN target) (NNS proteins))))))))))))))))))
-1 #(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ interacts) (PP (IN with) (NP (NP (NP (JJ multiple) (NNS components)) (PP (IN of) (NP (DT the) (NN sumoylation) (NN machinery)))) (, ,) (RB namely) (NP (NP (DT the) (NN E2) (NN sumo) (NN conjugating) (NN enzyme) (NN _PROT1_)) (CC and) (NP (NP (DT the) (NN E3) (NN sumo) (NNS ligases)) (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))))) (, ,) (SBAR (WHNP (NP (DT all)) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (VBP are) (VP (VBN involved) (PP (IN in) (S (VP (VBG conjugating) (NP (NP (DT the) (NP (JJ small) (JJ ubiquitin-like) (NN modifier)) (NN polypeptide)) (, ,) (NP (NN _PROT_)) (, ,)) (PP (TO to) (NP (PRP$ its) (NN target) (NNS proteins))))))))))))))))))
-1 #(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ interacts) (PP (IN with) (NP (NP (NP (JJ multiple) (NNS components)) (PP (IN of) (NP (DT the) (NN sumoylation) (NN machinery)))) (, ,) (RB namely) (NP (NP (DT the) (NN E2) (NN sumo) (NN conjugating) (NN enzyme) (NN _PROT1_)) (CC and) (NP (NP (DT the) (NN E3) (NN sumo) (NNS ligases)) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))))) (, ,) (SBAR (WHNP (NP (DT all)) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (VBP are) (VP (VBN involved) (PP (IN in) (S (VP (VBG conjugating) (NP (NP (DT the) (NP (JJ small) (JJ ubiquitin-like) (NN modifier)) (NN polypeptide)) (, ,) (NP (NN _PROT_)) (, ,)) (PP (TO to) (NP (PRP$ its) (NN target) (NNS proteins))))))))))))))))))
+1 #(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ interacts) (PP (IN with) (NP (NP (NP (JJ multiple) (NNS components)) (PP (IN of) (NP (DT the) (NN sumoylation) (NN machinery)))) (, ,) (RB namely) (NP (NP (DT the) (NN E2) (NN sumo) (NN conjugating) (NN enzyme) (NN _PROT1_)) (CC and) (NP (NP (DT the) (NN E3) (NN sumo) (NNS ligases)) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (, ,) (SBAR (WHNP (NP (DT all)) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (VBP are) (VP (VBN involved) (PP (IN in) (S (VP (VBG conjugating) (NP (NP (DT the) (NP (JJ small) (JJ ubiquitin-like) (NN modifier)) (NN polypeptide)) (, ,) (NP (NN _PROT2_)) (, ,)) (PP (TO to) (NP (PRP$ its) (NN target) (NNS proteins))))))))))))))))))
-1 #(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ interacts) (PP (IN with) (NP (NP (NP (JJ multiple) (NNS components)) (PP (IN of) (NP (DT the) (NN sumoylation) (NN machinery)))) (, ,) (RB namely) (NP (NP (DT the) (NN E2) (NN sumo) (NN conjugating) (NN enzyme) (NN _PROT_)) (CC and) (NP (NP (DT the) (NN E3) (NN sumo) (NNS ligases)) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))))) (, ,) (SBAR (WHNP (NP (DT all)) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (VBP are) (VP (VBN involved) (PP (IN in) (S (VP (VBG conjugating) (NP (NP (DT the) (NP (JJ small) (JJ ubiquitin-like) (NN modifier)) (NN polypeptide)) (, ,) (NP (NN _PROT_)) (, ,)) (PP (TO to) (NP (PRP$ its) (NN target) (NNS proteins))))))))))))))))))
+1 #(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ interacts) (PP (IN with) (NP (NP (NP (JJ multiple) (NNS components)) (PP (IN of) (NP (DT the) (NN sumoylation) (NN machinery)))) (, ,) (RB namely) (NP (NP (DT the) (NN E2) (NN sumo) (NN conjugating) (NN enzyme) (NN _PROT_)) (CC and) (NP (NP (DT the) (NN E3) (NN sumo) (NNS ligases)) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))))) (, ,) (SBAR (WHNP (NP (DT all)) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (VBP are) (VP (VBN involved) (PP (IN in) (S (VP (VBG conjugating) (NP (NP (DT the) (NP (JJ small) (JJ ubiquitin-like) (NN modifier)) (NN polypeptide)) (, ,) (NP (NN _PROT2_)) (, ,)) (PP (TO to) (NP (PRP$ its) (NN target) (NNS proteins))))))))))))))))))
+1 #(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ interacts) (PP (IN with) (NP (NP (NP (JJ multiple) (NNS components)) (PP (IN of) (NP (DT the) (NN sumoylation) (NN machinery)))) (, ,) (RB namely) (NP (NP (DT the) (NN E2) (NN sumo) (NN conjugating) (NN enzyme) (NN _PROT_)) (CC and) (NP (NP (DT the) (NN E3) (NN sumo) (NNS ligases)) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))))) (, ,) (SBAR (WHNP (NP (DT all)) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (VBP are) (VP (VBN involved) (PP (IN in) (S (VP (VBG conjugating) (NP (NP (DT the) (NP (JJ small) (JJ ubiquitin-like) (NN modifier)) (NN polypeptide)) (, ,) (NP (NN _PROT2_)) (, ,)) (PP (TO to) (NP (PRP$ its) (NN target) (NNS proteins))))))))))))))))))
+1 #(S1 (S (S (NP (NN _PROT1_)) (VP (VBZ is) (VP (VBN modified) (PP (IN by) (NP (NN _PROT2_))) (ADVP (ADVP (FW in) (FW vivo)) (CC and) (ADVP (FW in) (FW vitro)))))) (CC and) (S (NP (NP (DT the) (NN region)) (PP (IN of) (NP (NN _PROT_))) (ADJP (JJ responsible) (PP (IN for) (NP (NN interaction))))) (VP (VBZ maps) (PP (TO to) (NP (DT the) (JJ N-terminal) (JJ regulatory) (NN domain)))))))
-1 #(S1 (S (S (NP (NN _PROT1_)) (VP (VBZ is) (VP (VBN modified) (PP (IN by) (NP (NN _PROT_))) (ADVP (ADVP (FW in) (FW vivo)) (CC and) (ADVP (FW in) (FW vitro)))))) (CC and) (S (NP (NP (DT the) (NN region)) (PP (IN of) (NP (NN _PROT2_))) (ADJP (JJ responsible) (PP (IN for) (NP (NN interaction))))) (VP (VBZ maps) (PP (TO to) (NP (DT the) (JJ N-terminal) (JJ regulatory) (NN domain)))))))
-1 #(S1 (S (S (NP (NN _PROT_)) (VP (VBZ is) (VP (VBN modified) (PP (IN by) (NP (NN _PROT1_))) (ADVP (ADVP (FW in) (FW vivo)) (CC and) (ADVP (FW in) (FW vitro)))))) (CC and) (S (NP (NP (DT the) (NN region)) (PP (IN of) (NP (NN _PROT2_))) (ADJP (JJ responsible) (PP (IN for) (NP (NN interaction))))) (VP (VBZ maps) (PP (TO to) (NP (DT the) (JJ N-terminal) (JJ regulatory) (NN domain)))))))
+1 #(S1 (S (ADVP (RB Functionally)) (, ,) (NP (NP (NN sumoylation)) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBZ disrupts) (NP (PRP$ its) (NN ability) (S (VP (TO to) (VP (VB interact) (PP (PP (IN with) (NP (NP (NN histone) (NNS deacetylases)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))) (, ,) (CC but) (PP (RB not) (IN with) (NP (NP (DT another) (NN interaction) (NN partner)) (, ,) (NP (NN _PROT_))))))))))))
-1 #(S1 (S (ADVP (RB Functionally)) (, ,) (NP (NP (NN sumoylation)) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBZ disrupts) (NP (PRP$ its) (NN ability) (S (VP (TO to) (VP (VB interact) (PP (PP (IN with) (NP (NP (NN histone) (NNS deacetylases)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (, ,) (CC but) (PP (RB not) (IN with) (NP (NP (DT another) (NN interaction) (NN partner)) (, ,) (NP (NN _PROT2_))))))))))))
-1 #(S1 (S (ADVP (RB Functionally)) (, ,) (NP (NP (NN sumoylation)) (PP (IN of) (NP (NN _PROT_)))) (VP (VBZ disrupts) (NP (PRP$ its) (NN ability) (S (VP (TO to) (VP (VB interact) (PP (PP (IN with) (NP (NP (NN histone) (NNS deacetylases)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-)))) (, ,) (CC but) (PP (RB not) (IN with) (NP (NP (DT another) (NN interaction) (NN partner)) (, ,) (NP (NN _PROT2_))))))))))))
+1 #(S1 (S (NP (NN _PROT1_)) (VP (VBZ associates) (PP (IN with) (NP (NP (NN _PROT2_) (NN _PROT2_) (NN _PROT2_) (CD _PROT2_)) (, ,) (NP (NN Syk)) (, ,) (CC and) (NP (NN phospholipase) (NN C-gamma))))) (LST (-LRB- -LRB-) (LS 1) (-RRB- -RRB-)) (PP (IN upon) (NP (NN B) (NN cell) (NN activation)))))
+1 #(S1 (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (VBN tyrosyl-phosphorylated) (NN _PROT1_)) (VP (MD may) (VP (VB be) (NP (DT a) (NN substrate)) (SBAR (IN for) (S (NP (NN _PROT2_)) (VP (VBZ regulates) (NP (NP (NN tyrosyl) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT_))))))))))))))
-1 #(S1 (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (VBN tyrosyl-phosphorylated) (NN _PROT1_)) (VP (MD may) (VP (VB be) (NP (DT a) (NN substrate)) (SBAR (IN for) (S (NP (NN _PROT_)) (VP (VBZ regulates) (NP (NP (NN tyrosyl) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT2_))))))))))))))
+1 #(S1 (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (VBN tyrosyl-phosphorylated) (NN _PROT_)) (VP (MD may) (VP (VB be) (NP (DT a) (NN substrate)) (SBAR (IN for) (S (NP (NN _PROT1_)) (VP (VBZ regulates) (NP (NP (NN tyrosyl) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT2_))))))))))))))
+1 #(S1 (S (NP (NP (DT The) (NN association)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN with) (NP (NN _PROT2_)))) (VP (VBD was) (VP (VBN mediated) (PP (IN by) (NP (NP (DT the) (JJ NH2-terminal) (NN Src) (NN homology) (CD 2) (-LRB- -LRB-) (NN SH2) (-RRB- -RRB-) (NN domain)) (PP (IN of) (NP (NN _PROT_)))))))))
-1 #(S1 (S (NP (NP (DT The) (NN association)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN with) (NP (NN _PROT_)))) (VP (VBD was) (VP (VBN mediated) (PP (IN by) (NP (NP (DT the) (JJ NH2-terminal) (NN Src) (NN homology) (CD 2) (-LRB- -LRB-) (NN SH2) (-RRB- -RRB-) (NN domain)) (PP (IN of) (NP (NN _PROT2_)))))))))
+1 #(S1 (S (NP (NP (DT The) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT1_)))) (VP (VBD was) (VP (VBN mediated) (PP (IN by) (NP (NP (DT the) (JJ NH2-terminal) (NN Src) (NN homology) (CD 2) (-LRB- -LRB-) (NN SH2) (-RRB- -RRB-) (NN domain)) (PP (IN of) (NP (NN _PROT2_)))))))))
+1 #(S1 (S (NP (NP (NNS Complexes)) (PP (IN of) (NP (DT either) (NN _PROT1_AND_PROT2_)))) (LST (-LRB- -LRB-) (LS 1) (-RRB- -RRB-)) (VP (MD could) (VP (VB be) (VP (VBN isolated) (PP (IN from) (NP (NP (NN B) (NNS cells)) (VP (VBN stimulated) (PP (IN by) (NP (NP (NP (NN BCR)) (NN engagement)) (CC or) (NP (NP (DT a) (NN mixture)) (PP (IN of) (NP (NP (NN hydrogen) (NN peroxidase)) (CC and) (NP (NN sodium) (NN orthovanadate)))))))))) (, ,) (ADVP (RB respectively)))))))
-1 #(S1 (S (NP (NP (JJ Transient) (NN expression)) (PP (IN of) (NP (NP (NN _PROT1_)) (CC and) (NP (NP (NP (DT a) (JJ null) (NN mutant)) (PP (IN of) (NP (NN _PROT2_)))) (PRN (-LRB- -LRB-) (NP (NN PTP-1CM)) (-RRB- -RRB-))))) (PP (IN in) (NP (NN COS) (NNS cells)))) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (NN tyrosyl) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT_)))))) (CC and) (NP (NP (PRP$ its) (NN interaction)) (PP (IN with) (NP (NN PTP-1CM)))))))))
-1 #(S1 (S (NP (NP (JJ Transient) (NN expression)) (PP (IN of) (NP (NP (NN _PROT1_)) (CC and) (NP (NP (NP (DT a) (JJ null) (NN mutant)) (PP (IN of) (NP (NN _PROT_)))) (PRN (-LRB- -LRB-) (NP (NN PTP-1CM)) (-RRB- -RRB-))))) (PP (IN in) (NP (NN COS) (NNS cells)))) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (NN tyrosyl) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT2_)))))) (CC and) (NP (NP (PRP$ its) (NN interaction)) (PP (IN with) (NP (NN PTP-1CM)))))))))
+1 #(S1 (S (NP (NP (JJ Transient) (NN expression)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NP (NP (DT a) (JJ null) (NN mutant)) (PP (IN of) (NP (NN _PROT1_)))) (PRN (-LRB- -LRB-) (NP (NN PTP-1CM)) (-RRB- -RRB-))))) (PP (IN in) (NP (NN COS) (NNS cells)))) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (NN tyrosyl) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT2_)))))) (CC and) (NP (NP (PRP$ its) (NN interaction)) (PP (IN with) (NP (NN PTP-1CM)))))))))
-1 #(S1 (S (PP (IN By) (NP (NN contrast))) (, ,) (NP (NN _PROT1_)) (VP (VP (VBD was) (RB not) (ADJP (NN tyrosyl) (JJ phosphorylated))) (CC or) (VP (VBD associated) (PP (IN with) (NP (NN PTP-1CM))) (PP (IN in) (DT the) (NN presence) (IN of) (NP (JJ wild-type) (NN _PROT2_)))))))
+1 #(S1 (S (NP (NN _PROT1_)) (VP (VP (VBZ binds) (PP (TO to) (NP (NP (DT the) (JJ C-terminal) (NN SH2) (NN domain)) (PP (IN of) (NP (NN _PROT2_) (NN _PROT2_)))))) (CC and) (VP (VBZ inhibits) (NP (PRP$ its) (JJ enzymatic) (NN activity))))))
+1 #(S1 (S (PP (IN In) (NP (DT this) (NN report))) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (NP (NP (DT the) (JJ stable) (NN association)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN with) (NP (NN _PROT2_)))) (PP (IN in) (NP (NP (DT a) (JJ clathrin-coated) (NN vesicle) (NN complex)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (CONJP (RB not) (RB only)) (VP (VBZ binds) (PP (TO to) (NP (NP (DT the) (JJ carboxyl-terminal) (NN SH2) (NN domain)) (PP (IN of) (NP (NN _PROT_)))))) (, ,) (CONJP (CC but) (RB also)) (VP (VBZ inhibits) (NP (PRP$ its) (JJ enzymatic) (NN activity)) (PP (IN in) (NP (DT a) (JJ dose-dependent) (NN manner))))))))))))
-1 #(S1 (S (PP (IN In) (NP (DT this) (NN report))) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (NP (NP (DT the) (JJ stable) (NN association)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN with) (NP (NN _PROT_)))) (PP (IN in) (NP (NP (DT a) (JJ clathrin-coated) (NN vesicle) (NN complex)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (CONJP (RB not) (RB only)) (VP (VBZ binds) (PP (TO to) (NP (NP (DT the) (JJ carboxyl-terminal) (NN SH2) (NN domain)) (PP (IN of) (NP (NN _PROT2_)))))) (, ,) (CONJP (CC but) (RB also)) (VP (VBZ inhibits) (NP (PRP$ its) (JJ enzymatic) (NN activity)) (PP (IN in) (NP (DT a) (JJ dose-dependent) (NN manner))))))))))))
+1 #(S1 (S (PP (IN In) (NP (DT this) (NN report))) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (NP (NP (DT the) (JJ stable) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT1_)))) (PP (IN in) (NP (NP (DT a) (JJ clathrin-coated) (NN vesicle) (NN complex)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (CONJP (RB not) (RB only)) (VP (VBZ binds) (PP (TO to) (NP (NP (DT the) (JJ carboxyl-terminal) (NN SH2) (NN domain)) (PP (IN of) (NP (NN _PROT2_)))))) (, ,) (CONJP (CC but) (RB also)) (VP (VBZ inhibits) (NP (PRP$ its) (JJ enzymatic) (NN activity)) (PP (IN in) (NP (DT a) (JJ dose-dependent) (NN manner))))))))))))
+1 #(S1 (S (NP (NP (DT The) (NN protein) (NN _PROT1_) (NNS functions)) (PP (IN in) (NP (DT a) (JJ multi-subunit) (NN E3) (NN ubiquitin) (NN ligase))) (SBAR (WHNP (WDT that)) (S (VP (VBZ targets) (NP (NP (DT the) (JJ hypoxia-inducible) (NN transcription) (NN factor)) (NP (NN _PROT2_) (NN _PROT2_))) (PP (IN for) (NP (JJ proteasomal) (NN degradation))) (PP (IN during) (NP (NN normoxia)))))))))
+1 #(S1 (S (NP (PRP We)) (VP (VBP establish) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ binds) (PP (TO to) (NP (NP (NP (JJ _PROT2_) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NN component)) (PP (IN of) (NP (NP (DT the) (NN 19S) (JJ regulatory) (NN complex)) (PP (IN of) (NP (DT the) (NN proteasome))))))))))))))
+1 #(S1 (S (NP (PRP We)) (VP (VBP establish) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ binds) (PP (TO to) (NP (NP (NP (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NN component)) (PP (IN of) (NP (NP (DT the) (NN 19S) (JJ regulatory) (NN complex)) (PP (IN of) (NP (DT the) (NN proteasome))))))))))))))
-1 #(S1 (S (NP (PRP We)) (VP (VBP establish) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ binds) (PP (TO to) (NP (NP (NP (JJ _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NN component)) (PP (IN of) (NP (NP (DT the) (NN 19S) (JJ regulatory) (NN complex)) (PP (IN of) (NP (DT the) (NN proteasome))))))))))))))
+1 #(S1 (S (NP (NN _PROT1_)) (VP (VBZ associates) (PP (IN with) (NP (NP (NP (DT the) (NN beta-domain)) (PP (IN of) (NP (NN _PROT2_)))) (CC and) (NP (NP (NNS complexes)) (PP (IN with) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_) (NN _PROT_))))))) (ADVP (FW in) (FW vivo)))))
+1 #(S1 (S (NP (NN _PROT1_)) (VP (VBZ associates) (PP (IN with) (NP (NP (NP (DT the) (NN beta-domain)) (PP (IN of) (NP (NN _PROT_)))) (CC and) (NP (NP (NNS complexes)) (PP (IN with) (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_) (NN _PROT_))))))) (ADVP (FW in) (FW vivo)))))
+1 #(S1 (S (NP (NN _PROT1_)) (VP (VBZ associates) (PP (IN with) (NP (NP (NP (DT the) (NN beta-domain)) (PP (IN of) (NP (NN _PROT_)))) (CC and) (NP (NP (NNS complexes)) (PP (IN with) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_) (NN _PROT2_))))))) (ADVP (FW in) (FW vivo)))))
-1 #(S1 (S (NP (NN _PROT_)) (VP (VBZ associates) (PP (IN with) (NP (NP (NP (DT the) (NN beta-domain)) (PP (IN of) (NP (NN _PROT1_)))) (CC and) (NP (NP (NNS complexes)) (PP (IN with) (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_) (NN _PROT_))))))) (ADVP (FW in) (FW vivo)))))
-1 #(S1 (S (NP (NN _PROT_)) (VP (VBZ associates) (PP (IN with) (NP (NP (NP (DT the) (NN beta-domain)) (PP (IN of) (NP (NN _PROT1_)))) (CC and) (NP (NP (NNS complexes)) (PP (IN with) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_) (NN _PROT2_))))))) (ADVP (FW in) (FW vivo)))))
-1 #(S1 (S (NP (NN _PROT_)) (VP (VBZ associates) (PP (IN with) (NP (NP (NP (DT the) (NN beta-domain)) (PP (IN of) (NP (NN _PROT_)))) (CC and) (NP (NP (NNS complexes)) (PP (IN with) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_) (NN _PROT2_))))))) (ADVP (FW in) (FW vivo)))))
+1 #(S1 (S (NP (NP (NN Overexpression)) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBZ promotes) (NP (NP (NN degradation)) (PP (IN of) (NP (NN _PROT2_) (NN _PROT2_)))) (PP (IN in) (NP (NP (DT a) (JJ pVHL-dependent) (NN manner)) (SBAR (WHNP (WDT that)) (S (VP (VBZ requires) (NP (NP (DT the) (NN ATPase) (NN domain)) (PP (IN of) (NP (NN _PROT_))))))))))))
-1 #(S1 (S (NP (NP (NN Overexpression)) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBZ promotes) (NP (NP (NN degradation)) (PP (IN of) (NP (NN _PROT_) (NN _PROT_)))) (PP (IN in) (NP (NP (DT a) (JJ pVHL-dependent) (NN manner)) (SBAR (WHNP (WDT that)) (S (VP (VBZ requires) (NP (NP (DT the) (NN ATPase) (NN domain)) (PP (IN of) (NP (NN _PROT2_))))))))))))
+1 #(S1 (S (NP (NP (NN Overexpression)) (PP (IN of) (NP (NN _PROT_)))) (VP (VBZ promotes) (NP (NP (NN degradation)) (PP (IN of) (NP (NN _PROT1_) (NN _PROT1_)))) (PP (IN in) (NP (NP (DT a) (JJ pVHL-dependent) (NN manner)) (SBAR (WHNP (WDT that)) (S (VP (VBZ requires) (NP (NP (DT the) (NN ATPase) (NN domain)) (PP (IN of) (NP (NN _PROT2_))))))))))))
+1 #(S1 (S (NP (NP (NN Blockade)) (PP (IN of) (NP (NN _PROT1_) (NN expression))) (PP (IN by) (NP (NP (JJ small) (VBG interfering) (NN RNA)) (PRN (-LRB- -LRB-) (NP (NN siRNA)) (-RRB- -RRB-))))) (VP (VBZ causes) (NP (NP (JJ prolonged) (NN degradation) (NN kinetics)) (PP (IN of) (NP (NN _PROT2_) (NN _PROT2_)))))))
-1 #(S1 (S (NP (NP (JJ Several) (JJ distinct) (NNS mutations)) (PP (IN in) (NP (NP (NN exon) (CD 2)) (PP (IN of) (NP (NNS _PROT1_)))))) (VP (VBP disrupt) (NP (NP (NN binding)) (PP (IN of) (NP (NN _PROT2_))) (PP (TO to) (NP (NN _PROT_)))))))
+1 #(S1 (S (NP (NP (JJ Several) (JJ distinct) (NNS mutations)) (PP (IN in) (NP (NP (NN exon) (CD 2)) (PP (IN of) (NP (NNS _PROT1_)))))) (VP (VBP disrupt) (NP (NP (NN binding)) (PP (IN of) (NP (NN _PROT_))) (PP (TO to) (NP (NN _PROT2_)))))))
+1 #(S1 (S (NP (NP (JJ Several) (JJ distinct) (NNS mutations)) (PP (IN in) (NP (NP (NN exon) (CD 2)) (PP (IN of) (NP (NNS _PROT_)))))) (VP (VBP disrupt) (NP (NP (NN binding)) (PP (IN of) (NP (NN _PROT1_))) (PP (TO to) (NP (NN _PROT2_)))))))
+1 #(S1 (S (NP (NP (DT A) (JJ _PROT1_) (NN mutant)) (VP (VBG containing) (NP (DT a) (NN P154L) (NN substitution)))) (VP (VP (VBZ coimmunoprecipitates) (PP (IN with) (NP (NP (NN _PROT2_) (NN _PROT2_)) (, ,) (CONJP (CC but) (RB not)) (NP (NN _PROT_)) (, ,)))) (CC and) (VP (VBZ does) (RB not) (VP (VB promote) (NP (NP (NN degradation)) (PP (IN of) (NP (NN _PROT_) (NN _PROT_)))))))))
-1 #(S1 (S (NP (NP (DT A) (JJ _PROT1_) (NN mutant)) (VP (VBG containing) (NP (DT a) (NN P154L) (NN substitution)))) (VP (VP (VBZ coimmunoprecipitates) (PP (IN with) (NP (NP (NN _PROT_) (NN _PROT_)) (, ,) (CONJP (CC but) (RB not)) (NP (NN _PROT2_)) (, ,)))) (CC and) (VP (VBZ does) (RB not) (VP (VB promote) (NP (NP (NN degradation)) (PP (IN of) (NP (NN _PROT_) (NN _PROT_)))))))))
-1 #(S1 (S (NP (NP (DT A) (JJ _PROT1_) (NN mutant)) (VP (VBG containing) (NP (DT a) (NN P154L) (NN substitution)))) (VP (VP (VBZ coimmunoprecipitates) (PP (IN with) (NP (NP (NN _PROT_) (NN _PROT_)) (, ,) (CONJP (CC but) (RB not)) (NP (NN _PROT_)) (, ,)))) (CC and) (VP (VBZ does) (RB not) (VP (VB promote) (NP (NP (NN degradation)) (PP (IN of) (NP (NN _PROT2_) (NN _PROT2_)))))))))
-1 #(S1 (S (NP (NP (DT A) (JJ _PROT_) (NN mutant)) (VP (VBG containing) (NP (DT a) (NN P154L) (NN substitution)))) (VP (VP (VBZ coimmunoprecipitates) (PP (IN with) (NP (NP (NN _PROT1_) (NN _PROT1_)) (, ,) (CONJP (CC but) (RB not)) (NP (NN _PROT2_)) (, ,)))) (CC and) (VP (VBZ does) (RB not) (VP (VB promote) (NP (NP (NN degradation)) (PP (IN of) (NP (NN _PROT_) (NN _PROT_)))))))))
-1 #(S1 (S (NP (NP (DT A) (JJ _PROT_) (NN mutant)) (VP (VBG containing) (NP (DT a) (NN P154L) (NN substitution)))) (VP (VP (VBZ coimmunoprecipitates) (PP (IN with) (NP (NP (NN _PROT1_) (NN _PROT1_)) (, ,) (CONJP (CC but) (RB not)) (NP (NN _PROT_)) (, ,)))) (CC and) (VP (VBZ does) (RB not) (VP (VB promote) (NP (NP (NN degradation)) (PP (IN of) (NP (NN _PROT2_) (NN _PROT2_)))))))))
-1 #(S1 (S (NP (NP (DT A) (JJ _PROT_) (NN mutant)) (VP (VBG containing) (NP (DT a) (NN P154L) (NN substitution)))) (VP (VP (VBZ coimmunoprecipitates) (PP (IN with) (NP (NP (NN _PROT_) (NN _PROT_)) (, ,) (CONJP (CC but) (RB not)) (NP (NN _PROT1_)) (, ,)))) (CC and) (VP (VBZ does) (RB not) (VP (VB promote) (NP (NP (NN degradation)) (PP (IN of) (NP (NN _PROT2_) (NN _PROT2_)))))))))
+1 #(S1 (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN _PROT1_))) (S (VP (TO to) (VP (VB degrade) (NP (NN _PROT2_) (NN _PROT2_)))))) (VP (VP (VBZ depends) (PP (IN in) (NP (NN part))) (PP (IN on) (NP (NP (PRP$ its) (NN interaction)) (PP (IN with) (NP (NN _PROT_)))))) (CC and) (VP (VBZ suggests) (NP (NP (DT a) (JJ new) (NN mechanism)) (PP (IN for) (NP (NP (NN _PROT_) (NN _PROT_) (NN stabilization)) (PP (IN in) (NP (DT some) (JJ _PROT_) (NNS tumors))))))))))
+1 #(S1 (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN _PROT1_))) (S (VP (TO to) (VP (VB degrade) (NP (NN _PROT_) (NN _PROT_)))))) (VP (VP (VBZ depends) (PP (IN in) (NP (NN part))) (PP (IN on) (NP (NP (PRP$ its) (NN interaction)) (PP (IN with) (NP (NN _PROT2_)))))) (CC and) (VP (VBZ suggests) (NP (NP (DT a) (JJ new) (NN mechanism)) (PP (IN for) (NP (NP (NN _PROT_) (NN _PROT_) (NN stabilization)) (PP (IN in) (NP (DT some) (JJ _PROT_) (NNS tumors))))))))))
-1 #(S1 (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN _PROT1_))) (S (VP (TO to) (VP (VB degrade) (NP (NN _PROT_) (NN _PROT_)))))) (VP (VP (VBZ depends) (PP (IN in) (NP (NN part))) (PP (IN on) (NP (NP (PRP$ its) (NN interaction)) (PP (IN with) (NP (NN _PROT_)))))) (CC and) (VP (VBZ suggests) (NP (NP (DT a) (JJ new) (NN mechanism)) (PP (IN for) (NP (NP (NN _PROT2_) (NN _PROT2_) (NN stabilization)) (PP (IN in) (NP (DT some) (JJ _PROT_) (NNS tumors))))))))))
-1 #(S1 (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN _PROT1_))) (S (VP (TO to) (VP (VB degrade) (NP (NN _PROT_) (NN _PROT_)))))) (VP (VP (VBZ depends) (PP (IN in) (NP (NN part))) (PP (IN on) (NP (NP (PRP$ its) (NN interaction)) (PP (IN with) (NP (NN _PROT_)))))) (CC and) (VP (VBZ suggests) (NP (NP (DT a) (JJ new) (NN mechanism)) (PP (IN for) (NP (NP (NN _PROT_) (NN _PROT_) (NN stabilization)) (PP (IN in) (NP (DT some) (JJ _PROT2_) (NNS tumors))))))))))
-1 #(S1 (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN _PROT_))) (S (VP (TO to) (VP (VB degrade) (NP (NN _PROT1_) (NN _PROT1_)))))) (VP (VP (VBZ depends) (PP (IN in) (NP (NN part))) (PP (IN on) (NP (NP (PRP$ its) (NN interaction)) (PP (IN with) (NP (NN _PROT2_)))))) (CC and) (VP (VBZ suggests) (NP (NP (DT a) (JJ new) (NN mechanism)) (PP (IN for) (NP (NP (NN _PROT_) (NN _PROT_) (NN stabilization)) (PP (IN in) (NP (DT some) (JJ _PROT_) (NNS tumors))))))))))
-1 #(S1 (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN _PROT_))) (S (VP (TO to) (VP (VB degrade) (NP (NN _PROT1_) (NN _PROT1_)))))) (VP (VP (VBZ depends) (PP (IN in) (NP (NN part))) (PP (IN on) (NP (NP (PRP$ its) (NN interaction)) (PP (IN with) (NP (NN _PROT_)))))) (CC and) (VP (VBZ suggests) (NP (NP (DT a) (JJ new) (NN mechanism)) (PP (IN for) (NP (NP (NN _PROT2_) (NN _PROT2_) (NN stabilization)) (PP (IN in) (NP (DT some) (JJ _PROT_) (NNS tumors))))))))))
-1 #(S1 (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN _PROT_))) (S (VP (TO to) (VP (VB degrade) (NP (NN _PROT1_) (NN _PROT1_)))))) (VP (VP (VBZ depends) (PP (IN in) (NP (NN part))) (PP (IN on) (NP (NP (PRP$ its) (NN interaction)) (PP (IN with) (NP (NN _PROT_)))))) (CC and) (VP (VBZ suggests) (NP (NP (DT a) (JJ new) (NN mechanism)) (PP (IN for) (NP (NP (NN _PROT_) (NN _PROT_) (NN stabilization)) (PP (IN in) (NP (DT some) (JJ _PROT2_) (NNS tumors))))))))))
-1 #(S1 (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN _PROT_))) (S (VP (TO to) (VP (VB degrade) (NP (NN _PROT_) (NN _PROT_)))))) (VP (VP (VBZ depends) (PP (IN in) (NP (NN part))) (PP (IN on) (NP (NP (PRP$ its) (NN interaction)) (PP (IN with) (NP (NN _PROT1_)))))) (CC and) (VP (VBZ suggests) (NP (NP (DT a) (JJ new) (NN mechanism)) (PP (IN for) (NP (NP (NN _PROT2_) (NN _PROT2_) (NN stabilization)) (PP (IN in) (NP (DT some) (JJ _PROT_) (NNS tumors))))))))))
-1 #(S1 (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN _PROT_))) (S (VP (TO to) (VP (VB degrade) (NP (NN _PROT_) (NN _PROT_)))))) (VP (VP (VBZ depends) (PP (IN in) (NP (NN part))) (PP (IN on) (NP (NP (PRP$ its) (NN interaction)) (PP (IN with) (NP (NN _PROT1_)))))) (CC and) (VP (VBZ suggests) (NP (NP (DT a) (JJ new) (NN mechanism)) (PP (IN for) (NP (NP (NN _PROT_) (NN _PROT_) (NN stabilization)) (PP (IN in) (NP (DT some) (JJ _PROT2_) (NNS tumors))))))))))
+1 #(S1 (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN _PROT_))) (S (VP (TO to) (VP (VB degrade) (NP (NN _PROT_) (NN _PROT_)))))) (VP (VP (VBZ depends) (PP (IN in) (NP (NN part))) (PP (IN on) (NP (NP (PRP$ its) (NN interaction)) (PP (IN with) (NP (NN _PROT_)))))) (CC and) (VP (VBZ suggests) (NP (NP (DT a) (JJ new) (NN mechanism)) (PP (IN for) (NP (NP (NN _PROT1_) (NN _PROT1_) (NN stabilization)) (PP (IN in) (NP (DT some) (JJ _PROT2_) (NNS tumors))))))))))
+1 #(S1 (S (NP (NP (NN Cross-linking)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN with) (NP (NP (NP (DT the) (NN use)) (PP (IN of) (NP (DT the) (NN mAb) (NN MEM-53)))) (CC and) (NP (DT a) (JJ polyclonal) (NN sheep) (JJ anti-mouse) (NN Ig))))) (VP (VP (VBD promoted) (NP (NP (NN activation)) (PP (IN of) (NP (VBG resting) (NN B) (NNS cells))) (PP (IN into) (NP (NP (DT the) (NN G1) (NN phase)) (PP (IN of) (NP (DT the) (NN cell) (NN cycle)))))) (SBAR (IN as) (S (VP (VBN judged) (PP (IN by) (NP (NP (NP (VBN increased) (NN expression)) (PP (IN of) (NP (DT the) (JJ early) (NN activation) (NN Ag) (NN _PROT2_)))) (, ,) (NP (NP (NNS increases)) (PP (IN in) (NP (JJ cellular) (NN volume)))) (, ,) (NP (NN RNA) (NN synthesis)) (, ,) (CC and) (NP (NN _PROT_) (NN protein) (NNS levels)))))))) (, ,) (CC and) (VP (VBD enhanced) (NP (NP (NN binding)) (PP (IN of) (NP (NN 7-aminoactinomycin) (NN D))))))))
+1 #(S1 (S (NP (NP (NN Cross-linking)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN with) (NP (NP (NP (DT the) (NN use)) (PP (IN of) (NP (DT the) (NN mAb) (NN MEM-53)))) (CC and) (NP (DT a) (JJ polyclonal) (NN sheep) (JJ anti-mouse) (NN Ig))))) (VP (VP (VBD promoted) (NP (NP (NN activation)) (PP (IN of) (NP (VBG resting) (NN B) (NNS cells))) (PP (IN into) (NP (NP (DT the) (NN G1) (NN phase)) (PP (IN of) (NP (DT the) (NN cell) (NN cycle)))))) (SBAR (IN as) (S (VP (VBN judged) (PP (IN by) (NP (NP (NP (VBN increased) (NN expression)) (PP (IN of) (NP (DT the) (JJ early) (NN activation) (NN Ag) (NN _PROT_)))) (, ,) (NP (NP (NNS increases)) (PP (IN in) (NP (JJ cellular) (NN volume)))) (, ,) (NP (NN RNA) (NN synthesis)) (, ,) (CC and) (NP (NN _PROT2_) (NN protein) (NNS levels)))))))) (, ,) (CC and) (VP (VBD enhanced) (NP (NP (NN binding)) (PP (IN of) (NP (NN 7-aminoactinomycin) (NN D))))))))
-1 #(S1 (S (NP (NP (NN Cross-linking)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NP (NP (DT the) (NN use)) (PP (IN of) (NP (DT the) (NN mAb) (NN MEM-53)))) (CC and) (NP (DT a) (JJ polyclonal) (NN sheep) (JJ anti-mouse) (NN Ig))))) (VP (VP (VBD promoted) (NP (NP (NN activation)) (PP (IN of) (NP (VBG resting) (NN B) (NNS cells))) (PP (IN into) (NP (NP (DT the) (NN G1) (NN phase)) (PP (IN of) (NP (DT the) (NN cell) (NN cycle)))))) (SBAR (IN as) (S (VP (VBN judged) (PP (IN by) (NP (NP (NP (VBN increased) (NN expression)) (PP (IN of) (NP (DT the) (JJ early) (NN activation) (NN Ag) (NN _PROT1_)))) (, ,) (NP (NP (NNS increases)) (PP (IN in) (NP (JJ cellular) (NN volume)))) (, ,) (NP (NN RNA) (NN synthesis)) (, ,) (CC and) (NP (NN _PROT2_) (NN protein) (NNS levels)))))))) (, ,) (CC and) (VP (VBD enhanced) (NP (NP (NN binding)) (PP (IN of) (NP (NN 7-aminoactinomycin) (NN D))))))))
-1 #(S1 (S (ADVP (RB However)) (, ,) (NP (NNS cytokines)) (, ,) (PP (IN in) (NP (JJ particular) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))))) (, ,) (VP (VBD potentiated) (NP (NP (DT the) (NN DNA) (NN synthesis)) (VP (VBN induced) (PP (IN by) (NP (NP (NN cross-linking)) (PP (IN of) (NP (NN _PROT_))))))))))
+1 #(S1 (S (ADVP (RB However)) (, ,) (NP (NNS cytokines)) (, ,) (PP (IN in) (NP (JJ particular) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))))) (, ,) (VP (VBD potentiated) (NP (NP (DT the) (NN DNA) (NN synthesis)) (VP (VBN induced) (PP (IN by) (NP (NP (NN cross-linking)) (PP (IN of) (NP (NN _PROT2_))))))))))
+1 #(S1 (S (ADVP (RB However)) (, ,) (NP (NNS cytokines)) (, ,) (PP (IN in) (NP (JJ particular) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))))) (, ,) (VP (VBD potentiated) (NP (NP (DT the) (NN DNA) (NN synthesis)) (VP (VBN induced) (PP (IN by) (NP (NP (NN cross-linking)) (PP (IN of) (NP (NN _PROT2_))))))))))
-1 #(S1 (S (NP (DT The) (NP (JJ human) (NN _PROT1_) (NN mRNA) (NN editing)) (NN protein)) (VP (VBZ is) (NP (NP (DT a) (NN _PROT2_) (NN _PROT2_)) (VP (VBG showing) (NP (JJ structural) (NN homology)) (PP (TO to) (NP (DT some) (JJ known) (UCP (ADJP (JJ mammalian)) (CC and) (NP (NN bacteriophage))) (NN deoxycytidylate) (NNS deaminases))))))))
-1 #(S1 (S (NP (DT The) (NN fact) (SBAR (IN that) (S (NP (DT the) (NP (NN _PROT1_) (NN mRNA) (NN editing)) (NN protein)) (ADVP (RB also)) (VP (VBZ exists) (PP (IN as) (NP (DT a) (NN _PROT2_))))))) (VP (VBZ has) (NP (NP (JJ important) (NNS implications)) (PP (IN for) (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (NN _PROT_) (NN mRNA) (NN editing))) (PP (IN in) (NP (NNS humans)))))))))
-1 #(S1 (S (NP (DT The) (NN fact) (SBAR (IN that) (S (NP (DT the) (NP (NN _PROT1_) (NN mRNA) (NN editing)) (NN protein)) (ADVP (RB also)) (VP (VBZ exists) (PP (IN as) (NP (DT a) (NN _PROT_))))))) (VP (VBZ has) (NP (NP (JJ important) (NNS implications)) (PP (IN for) (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (NN _PROT2_) (NN mRNA) (NN editing))) (PP (IN in) (NP (NNS humans)))))))))
-1 #(S1 (S (NP (DT The) (NN fact) (SBAR (IN that) (S (NP (DT the) (NP (NN _PROT_) (NN mRNA) (NN editing)) (NN protein)) (ADVP (RB also)) (VP (VBZ exists) (PP (IN as) (NP (DT a) (NN _PROT1_))))))) (VP (VBZ has) (NP (NP (JJ important) (NNS implications)) (PP (IN for) (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (NN _PROT2_) (NN mRNA) (NN editing))) (PP (IN in) (NP (NNS humans)))))))))
-1 #(S1 (S (NP (NP (NN _PROT1_) (NNS dimers)) (VP (VP (VBN formed) (PP (IN through) (NP (NP (NN self-association)) (PP (IN of) (NP (DT the) (JJ TATA-binding) (NN polypeptide) (-LRB- -LRB-) (NN _PROT2_) (-RRB- -RRB-) (NN subunit)))))) (CC and) (VP (MD could) (VP (VB be) (VP (VBN immunoprecipitated) (PP (IN with) (NP (NP (NNS antibodies)) (PP (TO to) (NP (NP (NN _PROT_) (-LRB- _PROT_) (CD _PROT_) (-RRB- _PROT_) (CD _PROT_)) (, ,) (NP (NP (DT the) (NN core) (NN subunit)) (PP (IN of) (NP (NN _PROT_)))))))))))))))
+1 #(S1 (S (NP (NP (NN _PROT1_) (NNS dimers)) (VP (VP (VBN formed) (PP (IN through) (NP (NP (NN self-association)) (PP (IN of) (NP (DT the) (JJ TATA-binding) (NN polypeptide) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-) (NN subunit)))))) (CC and) (VP (MD could) (VP (VB be) (VP (VBN immunoprecipitated) (PP (IN with) (NP (NP (NNS antibodies)) (PP (TO to) (NP (NP (NN _PROT2_) (-LRB- _PROT2_) (CD _PROT2_) (-RRB- _PROT2_) (CD _PROT2_)) (, ,) (NP (NP (DT the) (NN core) (NN subunit)) (PP (IN of) (NP (NN _PROT_)))))))))))))))
-1 #(S1 (S (NP (NP (NN _PROT1_) (NNS dimers)) (VP (VP (VBN formed) (PP (IN through) (NP (NP (NN self-association)) (PP (IN of) (NP (DT the) (JJ TATA-binding) (NN polypeptide) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-) (NN subunit)))))) (CC and) (VP (MD could) (VP (VB be) (VP (VBN immunoprecipitated) (PP (IN with) (NP (NP (NNS antibodies)) (PP (TO to) (NP (NP (NN _PROT_) (-LRB- _PROT_) (CD _PROT_) (-RRB- _PROT_) (CD _PROT_)) (, ,) (NP (NP (DT the) (NN core) (NN subunit)) (PP (IN of) (NP (NN _PROT2_)))))))))))))))
-1 #(S1 (S (NP (NP (NN _PROT_) (NNS dimers)) (VP (VP (VBN formed) (PP (IN through) (NP (NP (NN self-association)) (PP (IN of) (NP (DT the) (JJ TATA-binding) (NN polypeptide) (-LRB- -LRB-) (NN _PROT1_) (-RRB- -RRB-) (NN subunit)))))) (CC and) (VP (MD could) (VP (VB be) (VP (VBN immunoprecipitated) (PP (IN with) (NP (NP (NNS antibodies)) (PP (TO to) (NP (NP (NN _PROT2_) (-LRB- _PROT2_) (CD _PROT2_) (-RRB- _PROT2_) (CD _PROT2_)) (, ,) (NP (NP (DT the) (NN core) (NN subunit)) (PP (IN of) (NP (NN _PROT_)))))))))))))))
-1 #(S1 (S (NP (NP (NN _PROT_) (NNS dimers)) (VP (VP (VBN formed) (PP (IN through) (NP (NP (NN self-association)) (PP (IN of) (NP (DT the) (JJ TATA-binding) (NN polypeptide) (-LRB- -LRB-) (NN _PROT1_) (-RRB- -RRB-) (NN subunit)))))) (CC and) (VP (MD could) (VP (VB be) (VP (VBN immunoprecipitated) (PP (IN with) (NP (NP (NNS antibodies)) (PP (TO to) (NP (NP (NN _PROT_) (-LRB- _PROT_) (CD _PROT_) (-RRB- _PROT_) (CD _PROT_)) (, ,) (NP (NP (DT the) (NN core) (NN subunit)) (PP (IN of) (NP (NN _PROT2_)))))))))))))))
+1 #(S1 (S (NP (NP (NN _PROT_) (NNS dimers)) (VP (VP (VBN formed) (PP (IN through) (NP (NP (NN self-association)) (PP (IN of) (NP (DT the) (JJ TATA-binding) (NN polypeptide) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-) (NN subunit)))))) (CC and) (VP (MD could) (VP (VB be) (VP (VBN immunoprecipitated) (PP (IN with) (NP (NP (NNS antibodies)) (PP (TO to) (NP (NP (NN _PROT1_) (-LRB- _PROT1_) (CD _PROT1_) (-RRB- _PROT1_) (CD _PROT1_)) (, ,) (NP (NP (DT the) (NN core) (NN subunit)) (PP (IN of) (NP (NN _PROT2_)))))))))))))))
+1 #(S1 (S (NP (NN _PROT1_)) (VP (VBZ regulates) (NP (NN beta-2) (JJ integrin-mediated) (NN adhesion)) (PP (IN through) (NP (CC both) (NP (JJ ARF-GEF) (NN function)) (CC and) (NP (NP (NN interaction)) (PP (IN with) (NP (NN _PROT2_)))))))))
+1 #(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP provide) (NP (NP (NN evidence)) (PP (IN of) (SBAR (WHADVP (WRB how)) (S (NP (NP (NN _PROT1_)) (, ,) (NP (NP (NP (DT an) (JJ integrin-binding) (NN protein)) (CC and) (NP (NP (JJ guanine-nucleotide) (NN exchange) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN GEF)) (-RRB- -RRB-)))) (PP (IN for) (NP (NN _PROT2_) (NNS GTPases)))) (, ,)) (VP (VBZ regulates) (NP (NN cell) (NN adhesion))))))))))
+1 #(S1 (S (NP (NP (JJ Mutational) (NNS analyses)) (PP (IN of) (NP (DT the) (NN beta-2) (JJ cytoplasmic) (NN domain)))) (VP (VBD revealed) (SBAR (IN that) (S (NP (NP (DT the) (JJ adhesive) (NN function)) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBZ depends) (PP (IN on) (NP (NP (PRP$ its) (NN interaction)) (PP (IN with) (NP (NN _PROT2_))))) (, ,) (SBAR (IN unless) (S (NP (DT the) (NN integrin)) (VP (VBZ is) (VP (VBN activated) (PP (IN by) (NP (JJ exogenous) (JJ divalent) (NNS cations)))))))))))))
+1 #(S1 (S (ADVP (RB Secondly)) (, ,) (S (S (NP (NN _PROT1_)) (VP (VBZ induces) (NP (NP (NN expression)) (PP (IN of) (NP (NP (DT an) (JJ extracellular) (NN activation) (NN epitope)) (PP (IN of) (NP (NN _PROT2_)))))))) (, ,) (CC and) (S (NP (DT the) (NN exchange) (NN factor) (NN function)) (VP (VBZ is) (RB not) (ADJP (JJ essential) (PP (IN for) (NP (DT this) (NN activity)))))))))
+1 #(S1 (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (NP (JJ LFA-1-mediated) (NN cell) (NN adhesion)) (CC and) (NP (NN spreading))) (PP (IN on) (NP (JJ intercellular) (NN cell) (NN adhesion) (NN molecule) (CD 1)))) (VP (VBZ is) (ADVP (RB strongly)) (VP (VBN inhibited) (PP (IN by) (NP (NP (DT a) (NN _PROT1_) (NN mutant)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ fails) (S (VP (TO to) (VP (VB catalyze) (NP (NN _PROT2_) (NN GDP-GTP) (NN exchange)) (ADVP (FW in) (FW vitro))))))))))))))
+1 #(S1 (S (ADVP (RB Thus)) (, ,) (NP (NN _PROT1_)) (VP (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN _PROT2_))))) (, ,) (PP (ADVP (RBS most) (RB probably)) (IN through) (NP (NP (JJ direct) (NN interaction)) (PP (IN with) (NP (DT the) (NN integrin))))))) (, ,) (CC and) (VP (VBZ induces) (NP (NN cell) (NN spreading)) (PP (IN by) (NP (PRP$ its) (JJ ARF-GEF) (NN activity)))))))
-1 #(S1 (S (PP (IN By) (S (VP (VBG constructing) (NP (NN deletion) (NNS mutants))))) (, ,) (NP (PRP we)) (VP (VBD identified) (SBAR (IN that) (S (S (NP (NP (NN amino) (NN acid) (NNS residues) (CD 229-309)) (PP (IN of) (NP (NN Akt)))) (VP (VBD were) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN binding)) (PP (TO to) (NP (NN _PROT1_)))))))) (CC and) (S (NP (NP (NN amino) (NN acid) (NNS residues) (CD 327-340)) (PP (IN of) (NP (NN _PROT2_)))) (VP (VBD were) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN binding)) (PP (TO to) (NP (NN Akt)))))))))))))
-1 #(S1 (S (NP (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (: :) (NP (JJ multifunctional) (JJ endocytic) (NNS receptors)))))
+1 #(S1 (S (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (VP (VBP are) (NP (NP (CD two) (ADJP (RB structurally) (JJ different)) (JJ endocytic) (NNS receptors)) (SBAR (WHNP (WDT that)) (S (VP (VBP interact) (S (VP (TO to) (VP (VB serve) (NP (JJ such) (NNS functions))))))))))))
+1 #(S1 (S (NP (PRP We)) (VP (VBP report) (SBAR (IN that) (S (NP (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN MutS) (NN homolog) (CD 2)) (-RRB- -RRB-))) (NN protein)) (VP (VBZ interacts) (PP (IN with) (NP (DT the) (NN ATR) (PRN (-LRB- -LRB-) (ADJP (ADJP (JJ ATM-)) (CC and) (ADJP (JJ Rad3-related))) (-RRB- -RRB-)) (NN kinase))) (S (VP (TO to) (VP (VP (VP (VB form) (NP (DT a) (NN signaling) (NN module))) (CC and) (VP (VB regulate) (NP (NP (DT the) (NN phosphorylation)) (PP (IN of) (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))))))) (PRN (-LRB- -LRB-) (NP (NP (NN structure) (NN maintenance)) (PP (IN of) (NP (NN chromosome) (CD 1)))) (-RRB- -RRB-)))))))))))
+1 #(S1 (S (NP (PRP We)) (VP (VBP report) (SBAR (IN that) (S (NP (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN MutS) (NN homolog) (CD 2)) (-RRB- -RRB-))) (NN protein)) (VP (VBZ interacts) (PP (IN with) (NP (DT the) (NN ATR) (PRN (-LRB- -LRB-) (ADJP (ADJP (JJ ATM-)) (CC and) (ADJP (JJ Rad3-related))) (-RRB- -RRB-)) (NN kinase))) (S (VP (TO to) (VP (VP (VP (VB form) (NP (DT a) (NN signaling) (NN module))) (CC and) (VP (VB regulate) (NP (NP (DT the) (NN phosphorylation)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))))))) (PRN (-LRB- -LRB-) (NP (NP (NN structure) (NN maintenance)) (PP (IN of) (NP (NN chromosome) (CD 1)))) (-RRB- -RRB-)))))))))))
-1 #(S1 (S (NP (PRP We)) (VP (VBP report) (SBAR (IN that) (S (NP (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN MutS) (NN homolog) (CD 2)) (-RRB- -RRB-))) (NN protein)) (VP (VBZ interacts) (PP (IN with) (NP (DT the) (NN ATR) (PRN (-LRB- -LRB-) (ADJP (ADJP (JJ ATM-)) (CC and) (ADJP (JJ Rad3-related))) (-RRB- -RRB-)) (NN kinase))) (S (VP (TO to) (VP (VP (VP (VB form) (NP (DT a) (NN signaling) (NN module))) (CC and) (VP (VB regulate) (NP (NP (DT the) (NN phosphorylation)) (PP (IN of) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))))))) (PRN (-LRB- -LRB-) (NP (NP (NN structure) (NN maintenance)) (PP (IN of) (NP (NN chromosome) (CD 1)))) (-RRB- -RRB-)))))))))))
+1 #(S1 (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN by) (NP (NN ATR)))) (ADVP (RB also)) (VP (VBZ requires) (NP (NN checkpoint) (NNS proteins) (CD _PROT2_) (CC and) (NP (NN replication) (NN protein) (NN A)))))))))
-1 #(S1 (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN by) (NP (NN ATR)))) (VP (VBZ is) (ADJP (JJ independent) (PP (IN of) (NP (NP (CD _PROT2_)) (CC and) (NP (NN replication) (NN protein) (NN A))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (DT the) (NN signaling) (NN pathway)) (VP (VBG leading) (PP (TO to) (NP (NN _PROT_) (NN phosphorylation))))) (VP (VBZ is) (ADJP (JJ distinct) (PP (IN from) (NP (NP (DT that)) (VP (VBN mediated) (PP (IN by) (NP (DT the) (NN checkpoint) (NNS proteins)))))))))))))))
-1 #(S1 (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN by) (NP (NN ATR)))) (VP (VBZ is) (ADJP (JJ independent) (PP (IN of) (NP (NP (CD _PROT_)) (CC and) (NP (NN replication) (NN protein) (NN A))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (DT the) (NN signaling) (NN pathway)) (VP (VBG leading) (PP (TO to) (NP (NN _PROT2_) (NN phosphorylation))))) (VP (VBZ is) (ADJP (JJ distinct) (PP (IN from) (NP (NP (DT that)) (VP (VBN mediated) (PP (IN by) (NP (DT the) (NN checkpoint) (NNS proteins)))))))))))))))
-1 #(S1 (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN _PROT_))) (PP (IN by) (NP (NN ATR)))) (VP (VBZ is) (ADJP (JJ independent) (PP (IN of) (NP (NP (CD _PROT1_)) (CC and) (NP (NN replication) (NN protein) (NN A))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (DT the) (NN signaling) (NN pathway)) (VP (VBG leading) (PP (TO to) (NP (NN _PROT2_) (NN phosphorylation))))) (VP (VBZ is) (ADJP (JJ distinct) (PP (IN from) (NP (NP (DT that)) (VP (VBN mediated) (PP (IN by) (NP (DT the) (NN checkpoint) (NNS proteins)))))))))))))))
-1 #(S1 (S (PP (IN In) (NP (NN addition))) (, ,) (S (S (NP (CC both) (NP (NN _PROT1_)) (CC and) (NP (CD _PROT2_))) (VP (VBP are) (VP (VBN required) (PP (IN for) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (DT the) (NN S-phase) (NN checkpoint))) (S (VP (TO to) (VP (VB suppress) (NP (NN DNA) (NN synthesis)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NN MNNG))))))))))))) (, ,) (CC and) (S (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN _PROT_)))) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (JJ cellular) (NN survival)))))))))
-1 #(S1 (S (PP (IN In) (NP (NN addition))) (, ,) (S (S (NP (CC both) (NP (NN _PROT1_)) (CC and) (NP (CD _PROT_))) (VP (VBP are) (VP (VBN required) (PP (IN for) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (DT the) (NN S-phase) (NN checkpoint))) (S (VP (TO to) (VP (VB suppress) (NP (NN DNA) (NN synthesis)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NN MNNG))))))))))))) (, ,) (CC and) (S (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN _PROT2_)))) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (JJ cellular) (NN survival)))))))))
-1 #(S1 (S (PP (IN In) (NP (NN addition))) (, ,) (S (S (NP (CC both) (NP (NN _PROT_)) (CC and) (NP (CD _PROT1_))) (VP (VBP are) (VP (VBN required) (PP (IN for) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (DT the) (NN S-phase) (NN checkpoint))) (S (VP (TO to) (VP (VB suppress) (NP (NN DNA) (NN synthesis)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NN MNNG))))))))))))) (, ,) (CC and) (S (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN _PROT2_)))) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (JJ cellular) (NN survival)))))))))
-1 #(S1 (S (NP (NP (NN Assignment)) (PP (IN of) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (NN Etfa)))) (PP (TO to) (NP (NNS chromosomes) (QP (CD 3) (, ,) (CD 7) (, ,) (CC and) (CD 13))))) (: :) (NP (NP (DT the) (NN mouse) (NNS homologs)) (PP (IN of) (NP (NP (NNS genes)) (ADJP (JJ responsible) (PP (IN for) (NP (JJ glutaric) (NN acidemia) (NN type) (CD II)))))) (PP (IN in) (NP (JJ human))))))
-1 #(S1 (S (NP (PRP We)) (VP (VBD used) (NP (NP (NN cDNA) (NNS probes)) (PP (IN for) (NP (DT the) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (NN Etfa))) (NNS genes)))) (S (VP (TO to) (VP (VB determine) (NP (NP (NN localization)) (PP (IN of) (NP (DT these) (NN mouse) (NNS genes))) (PP (TO to) (NP (NNS chromosomes) (NP (NP (CD 3)) (, ,) (NP (CD 7)) (, ,) (CC and) (NP (CD 13))))))))))))
+1 #(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VP (VBP demonstrate) (NP (NN colocalization))) (CC and) (VP (VBP direct) (NP (NP (NN interaction)) (PP (IN between) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_)))))))))
+1 #(S1 (S (NP (NP (NN Overexpression)) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBZ results) (PP (IN in) (NP (NP (NP (DT a) (NN zinc) (JJ finger-dependent) (NN localization)) (PP (IN of) (NP (DT a) (NN _PROT2_) (NN isoform)))) (CC and) (NP (NP (NN dynactin)) (PP (TO to) (NP (NN MT) (NNS bundles)))))) (, ,) (S (VP (VBG raising) (NP (DT the) (NN possibility) (SBAR (IN that) (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))) (VP (VBP regulate) (NP (NP (NN dynein/dynactin) (NN binding)) (PP (TO to) (NP (NNS MTs)))))))))))))
-1 #(S1 (S (NP (NP (NN Overexpression)) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBZ results) (PP (IN in) (NP (NP (NP (DT a) (NN zinc) (JJ finger-dependent) (NN localization)) (PP (IN of) (NP (DT a) (NN _PROT_) (NN isoform)))) (CC and) (NP (NP (NN dynactin)) (PP (TO to) (NP (NN MT) (NNS bundles)))))) (, ,) (S (VP (VBG raising) (NP (DT the) (NN possibility) (SBAR (IN that) (S (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))) (VP (VBP regulate) (NP (NP (NN dynein/dynactin) (NN binding)) (PP (TO to) (NP (NNS MTs)))))))))))))
-1 #(S1 (S (NP (NP (NN Overexpression)) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBZ results) (PP (IN in) (NP (NP (NP (DT a) (NN zinc) (JJ finger-dependent) (NN localization)) (PP (IN of) (NP (DT a) (NN _PROT_) (NN isoform)))) (CC and) (NP (NP (NN dynactin)) (PP (TO to) (NP (NN MT) (NNS bundles)))))) (, ,) (S (VP (VBG raising) (NP (DT the) (NN possibility) (SBAR (IN that) (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))) (VP (VBP regulate) (NP (NP (NN dynein/dynactin) (NN binding)) (PP (TO to) (NP (NNS MTs)))))))))))))
-1 #(S1 (S (NP (NP (NN Overexpression)) (PP (IN of) (NP (NN _PROT_)))) (VP (VBZ results) (PP (IN in) (NP (NP (NP (DT a) (NN zinc) (JJ finger-dependent) (NN localization)) (PP (IN of) (NP (DT a) (NN _PROT1_) (NN isoform)))) (CC and) (NP (NP (NN dynactin)) (PP (TO to) (NP (NN MT) (NNS bundles)))))) (, ,) (S (VP (VBG raising) (NP (DT the) (NN possibility) (SBAR (IN that) (S (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))) (VP (VBP regulate) (NP (NP (NN dynein/dynactin) (NN binding)) (PP (TO to) (NP (NNS MTs)))))))))))))
-1 #(S1 (S (NP (NP (NN Overexpression)) (PP (IN of) (NP (NN _PROT_)))) (VP (VBZ results) (PP (IN in) (NP (NP (NP (DT a) (NN zinc) (JJ finger-dependent) (NN localization)) (PP (IN of) (NP (DT a) (NN _PROT1_) (NN isoform)))) (CC and) (NP (NP (NN dynactin)) (PP (TO to) (NP (NN MT) (NNS bundles)))))) (, ,) (S (VP (VBG raising) (NP (DT the) (NN possibility) (SBAR (IN that) (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))) (VP (VBP regulate) (NP (NP (NN dynein/dynactin) (NN binding)) (PP (TO to) (NP (NNS MTs)))))))))))))
-1 #(S1 (S (NP (NP (NN Overexpression)) (PP (IN of) (NP (NN _PROT_)))) (VP (VBZ results) (PP (IN in) (NP (NP (NP (DT a) (NN zinc) (JJ finger-dependent) (NN localization)) (PP (IN of) (NP (DT a) (NN _PROT_) (NN isoform)))) (CC and) (NP (NP (NN dynactin)) (PP (TO to) (NP (NN MT) (NNS bundles)))))) (, ,) (S (VP (VBG raising) (NP (DT the) (NN possibility) (SBAR (IN that) (S (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (VP (VBP regulate) (NP (NP (NN dynein/dynactin) (NN binding)) (PP (TO to) (NP (NNS MTs)))))))))))))
+1 #(S1 (S (NP (DT This) (NN work)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ is) (NP (NP (DT a) (JJ regulated) (NN adapter)) (PP (IN between) (NP (NP (NN _PROT2_)) (CC and) (NP (JJ cytoplasmic) (NN dynein)))) (PP (PP (IN at) (NP (NP (NNS sites)) (VP (VBN involved) (PP (IN in) (NP (NN cargo-MT) (NN loading)))))) (, ,) (CC and/or) (PP (IN in) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (NN MT) (NNS dynamics)))))))))))))
-1 #(S1 (S (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN type) (NN II) (NN isozyme)) (-RRB- -RRB-))) (VP (VBZ contains) (NP (NP (NP (DT a) (NN _PROT2_) (NN homology) (NN domain)) (PP (IN at) (NP (DT the) (NN N) (NN terminus)))) (CC and) (NP (NP (DT a) (JJ sterile) (NN alpha) (NN motif) (NN domain)) (PP (IN at) (NP (DT the) (NN C) (NN terminus))))))))
-1 #(S1 (S (NP (NP (JJ Differential) (NN binding)) (PP (IN of) (NP (NP (JJ vascular) (JJ cell-derived) (NNS proteoglycans)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_))) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (DT the) (NN beta-amyloid) (NN protein)) (PP (IN of) (NP (NN Alzheimer) (POS 's) (NN disease))))))))
-1 #(S1 (S (NP (NP (JJ Differential) (NN binding)) (PP (IN of) (NP (NP (JJ vascular) (JJ cell-derived) (NNS proteoglycans)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (NN _PROT_))) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (DT the) (NN beta-amyloid) (NN protein)) (PP (IN of) (NP (NN Alzheimer) (POS 's) (NN disease))))))))
-1 #(S1 (S (NP (NP (JJ Differential) (NN binding)) (PP (IN of) (NP (NP (JJ vascular) (JJ cell-derived) (NNS proteoglycans)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT2_))) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (DT the) (NN beta-amyloid) (NN protein)) (PP (IN of) (NP (NN Alzheimer) (POS 's) (NN disease))))))))
-1 #(S1 (S (NP (NP (JJ Differential) (NN binding)) (PP (IN of) (NP (NP (JJ vascular) (JJ cell-derived) (NNS proteoglycans)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (NN _PROT_))) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (DT the) (NN beta-amyloid) (NN protein)) (PP (IN of) (NP (NN Alzheimer) (POS 's) (NN disease))))))))
-1 #(S1 (S (NP (NP (JJ Differential) (NN binding)) (PP (IN of) (NP (NP (JJ vascular) (JJ cell-derived) (NNS proteoglycans)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT2_))) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (DT the) (NN beta-amyloid) (NN protein)) (PP (IN of) (NP (NN Alzheimer) (POS 's) (NN disease))))))))
-1 #(S1 (S (NP (NP (JJ Differential) (NN binding)) (PP (IN of) (NP (NP (JJ vascular) (JJ cell-derived) (NNS proteoglycans)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (CC and) (NP (NN _PROT2_))) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (DT the) (NN beta-amyloid) (NN protein)) (PP (IN of) (NP (NN Alzheimer) (POS 's) (NN disease))))))))
-1 #(S1 (S (NP (JJ Previous) (NNS studies)) (VP (VBP have) (VP (VBN demonstrated) (NP (NP (DT the) (NN immunolocalization)) (PP (IN of) (NP (NP (NN _PROT1_)) (, ,) (NP (DT a) (JJ specific) (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)) (, ,))) (PP (TO to) (NP (NP (DT the) (NN _PROT_) (NN protein) (PRN (-LRB- -LRB-) (NP (NN A) (NN beta)) (-RRB- -RRB-)) (JJ -containing) (NN _PROT_) (NNS deposits)) (PP (IN within) (NP (NP (DT the) (NNS walls)) (PP (IN of) (NP (NP (NN blood) (NNS vessels)) (PRN (-LRB- -LRB-) (PP (FW i.e.) (, ,) (NP (JJ congophilic) (NN angiopathy))) (-RRB- -RRB-)))))) (PP (IN in) (NP (NP (NP (NN Alzheimer) (POS 's) (NN disease)) (PRN (-LRB- -LRB-) (NP (NN AD)) (-RRB- -RRB-))) (NN brain))))))))))
+1 #(S1 (S (NP (JJ Previous) (NNS studies)) (VP (VBP have) (VP (VBN demonstrated) (NP (NP (DT the) (NN immunolocalization)) (PP (IN of) (NP (NP (NN _PROT1_)) (, ,) (NP (DT a) (JJ specific) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (, ,))) (PP (TO to) (NP (NP (DT the) (NN _PROT2_) (NN protein) (PRN (-LRB- -LRB-) (NP (NN A) (NN beta)) (-RRB- -RRB-)) (JJ -containing) (NN _PROT_) (NNS deposits)) (PP (IN within) (NP (NP (DT the) (NNS walls)) (PP (IN of) (NP (NP (NN blood) (NNS vessels)) (PRN (-LRB- -LRB-) (PP (FW i.e.) (, ,) (NP (JJ congophilic) (NN angiopathy))) (-RRB- -RRB-)))))) (PP (IN in) (NP (NP (NP (NN Alzheimer) (POS 's) (NN disease)) (PRN (-LRB- -LRB-) (NP (NN AD)) (-RRB- -RRB-))) (NN brain))))))))))
+1 #(S1 (S (NP (JJ Previous) (NNS studies)) (VP (VBP have) (VP (VBN demonstrated) (NP (NP (DT the) (NN immunolocalization)) (PP (IN of) (NP (NP (NN _PROT1_)) (, ,) (NP (DT a) (JJ specific) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (, ,))) (PP (TO to) (NP (NP (DT the) (NN _PROT_) (NN protein) (PRN (-LRB- -LRB-) (NP (NN A) (NN beta)) (-RRB- -RRB-)) (JJ -containing) (NN _PROT2_) (NNS deposits)) (PP (IN within) (NP (NP (DT the) (NNS walls)) (PP (IN of) (NP (NP (NN blood) (NNS vessels)) (PRN (-LRB- -LRB-) (PP (FW i.e.) (, ,) (NP (JJ congophilic) (NN angiopathy))) (-RRB- -RRB-)))))) (PP (IN in) (NP (NP (NP (NN Alzheimer) (POS 's) (NN disease)) (PRN (-LRB- -LRB-) (NP (NN AD)) (-RRB- -RRB-))) (NN brain))))))))))
+1 #(S1 (S (NP (JJ Previous) (NNS studies)) (VP (VBP have) (VP (VBN demonstrated) (NP (NP (DT the) (NN immunolocalization)) (PP (IN of) (NP (NP (NN _PROT_)) (, ,) (NP (DT a) (JJ specific) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (, ,))) (PP (TO to) (NP (NP (DT the) (NN _PROT2_) (NN protein) (PRN (-LRB- -LRB-) (NP (NN A) (NN beta)) (-RRB- -RRB-)) (JJ -containing) (NN _PROT_) (NNS deposits)) (PP (IN within) (NP (NP (DT the) (NNS walls)) (PP (IN of) (NP (NP (NN blood) (NNS vessels)) (PRN (-LRB- -LRB-) (PP (FW i.e.) (, ,) (NP (JJ congophilic) (NN angiopathy))) (-RRB- -RRB-)))))) (PP (IN in) (NP (NP (NP (NN Alzheimer) (POS 's) (NN disease)) (PRN (-LRB- -LRB-) (NP (NN AD)) (-RRB- -RRB-))) (NN brain))))))))))
+1 #(S1 (S (NP (JJ Previous) (NNS studies)) (VP (VBP have) (VP (VBN demonstrated) (NP (NP (DT the) (NN immunolocalization)) (PP (IN of) (NP (NP (NN _PROT_)) (, ,) (NP (DT a) (JJ specific) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (, ,))) (PP (TO to) (NP (NP (DT the) (NN _PROT_) (NN protein) (PRN (-LRB- -LRB-) (NP (NN A) (NN beta)) (-RRB- -RRB-)) (JJ -containing) (NN _PROT2_) (NNS deposits)) (PP (IN within) (NP (NP (DT the) (NNS walls)) (PP (IN of) (NP (NP (NN blood) (NNS vessels)) (PRN (-LRB- -LRB-) (PP (FW i.e.) (, ,) (NP (JJ congophilic) (NN angiopathy))) (-RRB- -RRB-)))))) (PP (IN in) (NP (NP (NP (NN Alzheimer) (POS 's) (NN disease)) (PRN (-LRB- -LRB-) (NP (NN AD)) (-RRB- -RRB-))) (NN brain))))))))))
-1 #(S1 (S (NP (JJ Previous) (NNS studies)) (VP (VBP have) (VP (VBN demonstrated) (NP (NP (DT the) (NN immunolocalization)) (PP (IN of) (NP (NP (NN _PROT_)) (, ,) (NP (DT a) (JJ specific) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (, ,))) (PP (TO to) (NP (NP (DT the) (NN _PROT1_) (NN protein) (PRN (-LRB- -LRB-) (NP (NN A) (NN beta)) (-RRB- -RRB-)) (JJ -containing) (NN _PROT2_) (NNS deposits)) (PP (IN within) (NP (NP (DT the) (NNS walls)) (PP (IN of) (NP (NP (NN blood) (NNS vessels)) (PRN (-LRB- -LRB-) (PP (FW i.e.) (, ,) (NP (JJ congophilic) (NN angiopathy))) (-RRB- -RRB-)))))) (PP (IN in) (NP (NP (NP (NN Alzheimer) (POS 's) (NN disease)) (PRN (-LRB- -LRB-) (NP (NN AD)) (-RRB- -RRB-))) (NN brain))))))))))
-1 #(S1 (S (ADVP (RB Overall)) (, ,) (NP (DT the) (NNS results)) (VP (VBP indicate) (SBAR (SBAR (IN that) (S (NP (JJ specific) (JJ vascular) (JJ cell-derived) (NNS _PROT1_)) (ADVP (RB differentially)) (VP (VBP interact) (PP (IN with) (NP (NN A) (NN beta)))))) (, ,) (CC and) (SBAR (IN that) (S (NP (NP (DT the) (NNS interactions)) (PP (IN of) (NP (JJS highest) (NN affinity)))) (VP (VBP occur) (PP (IN between) (NP (NP (NP (NN A) (NN beta)) (CC and) (NP (NN binding) (NNS sites))) (PP (IN on) (NP (CC both) (NP (DT the) (NN core) (NN protein)) (CC and) (NP (NP (NN glycosaminoglycan) (NNS chains)) (PP (IN of) (NP (NN _PROT2_)))))))))))))))
-1 #(S1 (S (PP (IN In) (NP (DT the) (JJ present) (NN investigation))) (, ,) (NP (NP (DT the) (JJ differential) (NN binding)) (PP (IN of) (NP (ADJP (RB previously) (VBN characterized)) (ADJP (NP (NP (JJ endothelial) (NN cell)) (PRN (-LRB- -LRB-) (NP (NN EC)) (-RRB- -RRB-)) (: -) (CC and) (NP (NP (JJ smooth) (NN muscle) (NN cell)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-)))) (JJ -derived)) (NNS _PROT2_))) (PP (TO to) (NP (NN A) (NN beta)))) (VP (VBD was) (VP (VBN examined) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (NP (DT the) (NN accumulation)) (PP (IN of) (NP (NN A) (NN beta))) (PP (IN in) (NP (JJ cerebrovascular) (NN _PROT_) (NNS deposits)))) (VP (MD may) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (NP (PRP$ its) (NNS interactions)) (PP (IN with) (NP (NN _PROT_)))))))))))))))))
-1 #(S1 (S (PP (IN In) (NP (DT the) (JJ present) (NN investigation))) (, ,) (NP (NP (DT the) (JJ differential) (NN binding)) (PP (IN of) (NP (ADJP (RB previously) (VBN characterized)) (ADJP (NP (NP (JJ endothelial) (NN cell)) (PRN (-LRB- -LRB-) (NP (NN EC)) (-RRB- -RRB-)) (: -) (CC and) (NP (NP (JJ smooth) (NN muscle) (NN cell)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-)))) (JJ -derived)) (NNS _PROT_))) (PP (TO to) (NP (NN A) (NN beta)))) (VP (VBD was) (VP (VBN examined) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (NP (DT the) (NN accumulation)) (PP (IN of) (NP (NN A) (NN beta))) (PP (IN in) (NP (JJ cerebrovascular) (NN _PROT2_) (NNS deposits)))) (VP (MD may) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (NP (PRP$ its) (NNS interactions)) (PP (IN with) (NP (NN _PROT_)))))))))))))))))
-1 #(S1 (S (PP (IN In) (NP (DT the) (JJ present) (NN investigation))) (, ,) (NP (NP (DT the) (JJ differential) (NN binding)) (PP (IN of) (NP (ADJP (RB previously) (VBN characterized)) (ADJP (NP (NP (JJ endothelial) (NN cell)) (PRN (-LRB- -LRB-) (NP (NN EC)) (-RRB- -RRB-)) (: -) (CC and) (NP (NP (JJ smooth) (NN muscle) (NN cell)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-)))) (JJ -derived)) (NNS _PROT_))) (PP (TO to) (NP (NN A) (NN beta)))) (VP (VBD was) (VP (VBN examined) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (NP (DT the) (NN accumulation)) (PP (IN of) (NP (NN A) (NN beta))) (PP (IN in) (NP (JJ cerebrovascular) (NN _PROT_) (NNS deposits)))) (VP (MD may) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (NP (PRP$ its) (NNS interactions)) (PP (IN with) (NP (NN _PROT2_)))))))))))))))))
-1 #(S1 (S (PP (IN In) (NP (DT the) (JJ present) (NN investigation))) (, ,) (NP (NP (DT the) (JJ differential) (NN binding)) (PP (IN of) (NP (ADJP (RB previously) (VBN characterized)) (ADJP (NP (NP (JJ endothelial) (NN cell)) (PRN (-LRB- -LRB-) (NP (NN EC)) (-RRB- -RRB-)) (: -) (CC and) (NP (NP (JJ smooth) (NN muscle) (NN cell)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (JJ -derived)) (NNS _PROT1_))) (PP (TO to) (NP (NN A) (NN beta)))) (VP (VBD was) (VP (VBN examined) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (NP (DT the) (NN accumulation)) (PP (IN of) (NP (NN A) (NN beta))) (PP (IN in) (NP (JJ cerebrovascular) (NN _PROT2_) (NNS deposits)))) (VP (MD may) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (NP (PRP$ its) (NNS interactions)) (PP (IN with) (NP (NN _PROT_)))))))))))))))))
-1 #(S1 (S (PP (IN In) (NP (DT the) (JJ present) (NN investigation))) (, ,) (NP (NP (DT the) (JJ differential) (NN binding)) (PP (IN of) (NP (ADJP (RB previously) (VBN characterized)) (ADJP (NP (NP (JJ endothelial) (NN cell)) (PRN (-LRB- -LRB-) (NP (NN EC)) (-RRB- -RRB-)) (: -) (CC and) (NP (NP (JJ smooth) (NN muscle) (NN cell)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (JJ -derived)) (NNS _PROT1_))) (PP (TO to) (NP (NN A) (NN beta)))) (VP (VBD was) (VP (VBN examined) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (NP (DT the) (NN accumulation)) (PP (IN of) (NP (NN A) (NN beta))) (PP (IN in) (NP (JJ cerebrovascular) (NN _PROT_) (NNS deposits)))) (VP (MD may) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (NP (PRP$ its) (NNS interactions)) (PP (IN with) (NP (NN _PROT2_)))))))))))))))))
-1 #(S1 (S (PP (IN In) (NP (DT the) (JJ present) (NN investigation))) (, ,) (NP (NP (DT the) (JJ differential) (NN binding)) (PP (IN of) (NP (ADJP (RB previously) (VBN characterized)) (ADJP (NP (NP (JJ endothelial) (NN cell)) (PRN (-LRB- -LRB-) (NP (NN EC)) (-RRB- -RRB-)) (: -) (CC and) (NP (NP (JJ smooth) (NN muscle) (NN cell)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (JJ -derived)) (NNS _PROT_))) (PP (TO to) (NP (NN A) (NN beta)))) (VP (VBD was) (VP (VBN examined) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (NP (DT the) (NN accumulation)) (PP (IN of) (NP (NN A) (NN beta))) (PP (IN in) (NP (JJ cerebrovascular) (NN _PROT1_) (NNS deposits)))) (VP (MD may) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (NP (PRP$ its) (NNS interactions)) (PP (IN with) (NP (NN _PROT2_)))))))))))))))))
-1 #(S1 (S (NP (NP (NN Pretreatment)) (PP (IN of) (NP (NN AA) (JJ amyloidotic) (UCP (ADJP (JJ splenic)) (CC and) (NP (NN liver))) (NN tissue) (NNS sections))) (PP (IN with) (NP (NP (JJ synthetic) (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-))))) (VP (VBD produced) (NP (JJ strong) (NN immunoreactivity)) (PP (IN with) (NP (NN A) (NN beta) (NNS antibodies))) (PP (IN at) (NP (NP (NN tissue) (NNS sites)) (VP (VBN enriched) (PP (IN in) (NP (NP (NN _PROT1_)) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (ADVP (RB partially)) (VP (VBN removed) (PP (PP (IN by) (NP (NP (NN pretreatment)) (PP (IN with) (NP (NN heparitinase))))) (, ,) (CC but) (PP (RB not) (IN by) (NP (NN chondroitin) (NN _PROT2_) (NN lyase))))))))))))))))
-1 #(S1 (S (NP (NP (LST (LS [35S) (-RRB- -RSB-)) (NP (JJ -Sulfate) (JJ labeled) (NNS proteoglycans)) (PRN (-LRB- -LRB-) (NP (NNS _PROT1_)) (-RRB- -RRB-)) (VP (VBN derived) (PP (IN from) (NP (VBN cultured) (NP (NNS ECs)) (CC and) (NP (NNS SMCs)))))) (VP (VBD bound) (PP (TO to) (NP (NP (NN affinity) (NNS columns)) (VP (VBG containing) (NP (NP (DT A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)) (CC or) (PRN (-LRB- -LRB-) (NP (NN 1-40)) (-RRB- -RRB-)))))) (, ,) (PP (IN with) (NP (NP (ADJP (RB virtually) (DT no)) (NN binding)) (PP (TO to) (NP (NP (NP (NP (DT A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 40-1)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NN reverse) (NN peptide)) (-RRB- -RRB-))) (, ,) (NP (NP (NN beta-amyloid) (NN precursor) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN 410-429)) (-RRB- -RRB-))) (, ,) (CC or) (NP (JJ bovine) (NN _PROT2_) (NN _PROT2_))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT1_))) (NNS _PROT2_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT1_))) (NNS _PROT_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT2_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT1_))) (NNS _PROT_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT1_))) (NNS _PROT_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT1_))) (NNS _PROT_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT2_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT1_))) (NNS _PROT_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT2_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
+1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT_))) (NNS _PROT1_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT2_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
+1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT_))) (NNS _PROT1_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
+1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT_))) (NNS _PROT1_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT_))) (NNS _PROT1_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT2_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT_))) (NNS _PROT1_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT2_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT_))) (NNS _PROT_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT1_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT_))) (NNS _PROT_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT1_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT_))) (NNS _PROT_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT1_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT2_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT_))) (NNS _PROT_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT1_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT2_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT_))) (NNS _PROT_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT_))) (NNS _PROT_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT2_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT_))) (NNS _PROT_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT2_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT_))) (NNS _PROT_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT2_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT_))) (NNS _PROT_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT2_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT_))) (NNS _PROT_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT1_AND_PROT2_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (ADVP (RB Herein)) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (DT a) (JJ distinct) (NN IkappaB) (NN protein) (NN _PROT1_)) (ADVP (RB also)) (VP (VBZ interacts) (PP (IN with) (NP (NN RXR))) (, ,) (SBAR (IN as) (S (VP (VBN shown) (PP (IN in) (NP (NP (DT the) (NN yeast) (JJ two-hybrid) (NNS tests)) (CC and) (NP (NP (NN _PROT2_) (NN _PROT2_)) (JJ pull-down) (NNS assays)))))))))))))
-1 #(S1 (S (PP (IN In) (NP (NP (NN contrast)) (PP (TO to) (NP (NN _PROT1_))))) (, ,) (NP (NN _PROT2_)) (VP (VBD did) (RB not) (VP (VB interact) (PP (IN with) (NP (NP (DT the) (NN AF2) (NN domain)) (PP (IN of) (NP (NN RXR)))))))))
+1 #(S1 (S (NP (NN _PROT1_)) (ADVP (RB specifically)) (VP (VBD interacted) (PP (PP (IN with) (NP (DT the) (JJ general) (NN transcription) (NNS factors) (NP (NP (NN _PROT2_)) (, ,) (NP (NN TBP)) (, ,) (CC and) (NP (NN _PROT_))))) (CC but) (PP (RB not) (IN with) (NP (NN TFIIEalpha)))) (PP (IN in) (NP (DT the) (NN _PROT_) (JJ pull-down) (NNS assays))))))
+1 #(S1 (S (NP (NN _PROT1_)) (ADVP (RB specifically)) (VP (VBD interacted) (PP (PP (IN with) (NP (DT the) (JJ general) (NN transcription) (NNS factors) (NP (NP (NN _PROT_)) (, ,) (NP (NN TBP)) (, ,) (CC and) (NP (NN _PROT2_))))) (CC but) (PP (RB not) (IN with) (NP (NN TFIIEalpha)))) (PP (IN in) (NP (DT the) (NN _PROT_) (JJ pull-down) (NNS assays))))))
-1 #(S1 (S (NP (NN _PROT1_)) (ADVP (RB specifically)) (VP (VBD interacted) (PP (PP (IN with) (NP (DT the) (JJ general) (NN transcription) (NNS factors) (NP (NP (NN _PROT_)) (, ,) (NP (NN TBP)) (, ,) (CC and) (NP (NN _PROT_))))) (CC but) (PP (RB not) (IN with) (NP (NN TFIIEalpha)))) (PP (IN in) (NP (DT the) (NN _PROT2_) (JJ pull-down) (NNS assays))))))
-1 #(S1 (S (NP (NN _PROT_)) (ADVP (RB specifically)) (VP (VBD interacted) (PP (PP (IN with) (NP (DT the) (JJ general) (NN transcription) (NNS factors) (NP (NP (NN _PROT1_)) (, ,) (NP (NN TBP)) (, ,) (CC and) (NP (NN _PROT2_))))) (CC but) (PP (RB not) (IN with) (NP (NN TFIIEalpha)))) (PP (IN in) (NP (DT the) (NN _PROT_) (JJ pull-down) (NNS assays))))))
-1 #(S1 (S (NP (NN _PROT_)) (ADVP (RB specifically)) (VP (VBD interacted) (PP (PP (IN with) (NP (DT the) (JJ general) (NN transcription) (NNS factors) (NP (NP (NN _PROT1_)) (, ,) (NP (NN TBP)) (, ,) (CC and) (NP (NN _PROT_))))) (CC but) (PP (RB not) (IN with) (NP (NN TFIIEalpha)))) (PP (IN in) (NP (DT the) (NN _PROT2_) (JJ pull-down) (NNS assays))))))
-1 #(S1 (S (NP (NN _PROT_)) (ADVP (RB specifically)) (VP (VBD interacted) (PP (PP (IN with) (NP (DT the) (JJ general) (NN transcription) (NNS factors) (NP (NP (NN _PROT_)) (, ,) (NP (NN TBP)) (, ,) (CC and) (NP (NN _PROT1_))))) (CC but) (PP (RB not) (IN with) (NP (NN TFIIEalpha)))) (PP (IN in) (NP (DT the) (NN _PROT2_) (JJ pull-down) (NNS assays))))))
-1 #(S1 (S (NP (NP (NN TBP)) (CC and) (NP (NN _PROT1_))) (, ,) (ADVP (RB however)) (, ,) (VP (VBD were) (RB not) (ADJP (JJ able) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NN _PROT2_))))))))))
-1 #(S1 (S (ADVP (RB Accordingly)) (, ,) (NP (NN _PROT1_)) (VP (VBN coactivated) (NP (NP (DT the) (JJ 9-cis-RA-induced) (NNS transactivations)) (PP (IN of) (NP (NN RXR)))) (, ,) (PP (IN in) (NN contrast) (TO to) (NP (NP (DT the) (JJ inhibitory) (NNS actions)) (PP (IN of) (NP (NN _PROT2_))))))))
-1 #(S1 (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NN coexpression)) (PP (IN of) (NP (NP (NN _PROT1_)) (CONJP (CC but) (RB not)) (NP (NN _PROT2_))))) (ADVP (RB further)) (VP (VBD stimulated) (NP (NP (DT the) (JJ Bcl3-mediated) (NN enhancement)) (PP (IN of) (NP (NP (DT the) (JJ 9-cis-RA-induced) (NNS transactivations)) (PP (IN of) (NP (NN RXR)))))))))
-1 #(S1 (S (PP (IN In) (NP (NN solution))) (, ,) (NP (NN FGFR4ed)) (VP (VBD formed) (NP (NNS complexes)) (PP (PP (IN with) (NP (NP (NP (JJ _PROT1_) (NN _PROT1_)) (PRN (-LRB- _PROT1_) (NP (NN _PROT1_)) (-RRB- _PROT1_))) (CC and) (NP (NP (JJ _PROT2_) (NN _PROT2_)) (PRN (-LRB- _PROT2_) (NP (NN _PROT2_)) (-RRB- _PROT2_))))) (, ,) (CC both) (PP (IN in) (NP (NP (DT the) (NP (NN presence)) (CC and) (NP (NN absence))) (PP (IN of) (NP (NN heparin)))))))))
+1 #(S1 (S (NP (JJ Immobilized) (NN _PROT1_)) (ADVP (RB also)) (VP (VBD bound) (NP (NN _PROT2_)) (PP (IN besides) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_)))))))
+1 #(S1 (S (NP (JJ Immobilized) (NN _PROT1_)) (ADVP (RB also)) (VP (VBD bound) (NP (NN _PROT_)) (PP (IN besides) (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_)))))))
+1 #(S1 (S (NP (JJ Immobilized) (NN _PROT1_)) (ADVP (RB also)) (VP (VBD bound) (NP (NN _PROT_)) (PP (IN besides) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_)))))))
-1 #(S1 (S (NP (JJ Immobilized) (NN _PROT_)) (ADVP (RB also)) (VP (VBD bound) (NP (NN _PROT1_)) (PP (IN besides) (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_)))))))
-1 #(S1 (S (NP (JJ Immobilized) (NN _PROT_)) (ADVP (RB also)) (VP (VBD bound) (NP (NN _PROT1_)) (PP (IN besides) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_)))))))
-1 #(S1 (S (NP (JJ Immobilized) (NN _PROT_)) (ADVP (RB also)) (VP (VBD bound) (NP (NN _PROT_)) (PP (IN besides) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_)))))))
+1 #(S1 (S (NP (NP (JJ Physical) (NN association)) (PP (IN of) (NP (NN _PROT1_) (CD _PROT1_) (NN _PROT1_))) (PP (IN with) (NP (NP (NN _PROT2_)) (, ,) (NP (NP (DT a) (JJ novel) (JJ glycosylphosphatidylinositol-anchored) (NN protein)) (PP (IN with) (NP (NN potential))) (PP (IN for) (S (VP (VBG regulating) (NP (NP (NN adhesion)) (CC and) (NP (NN migration))))))))))))
+1 #(S1 (S (S (VP (TO To) (VP (VB clarify) (NP (NP (DT the) (NNS mechanisms)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (NN _PROT1_)) (VP (VBZ functions) (PP (IN on) (NP (NNS leukocytes)))))))))) (, ,) (S (NP (PRP we)) (VP (VBD explored) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (NP (PRP$ its) (JJ physical) (NN association)) (PP (IN with) (NP (NP (NN _PROT2_) (CD _PROT2_) (NN _PROT2_)) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (JJ important) (PP (IN for) (NP (NP (NN leukocyte) (NN adherence)) (, ,) (NP (NN locomotion)) (, ,) (CC and) (NP (NN extravasation)))))))))))))))))
+1 #(S1 (S (NP (NP (NN _PROT1_) (CD _PROT1_) (NN _PROT1_)) (, ,) (VP (VBN detected) (PP (IN by) (NP (JJ anti-CD18) (NN mAb)))) (, ,)) (VP (VBD was) (VP (VBD coprecipitated) (PP (IN with) (NP (NN _PROT2_))) (PP (IN from) (NP (JJ human) (NN neutrophil) (NNS lysates))) (PP (IN by) (NP (NP (DT a) (NN mAb)) (PP (TO to) (NP (NN _PROT_)))))))))
-1 #(S1 (S (NP (NP (NN _PROT1_) (CD _PROT1_) (NN _PROT1_)) (, ,) (VP (VBN detected) (PP (IN by) (NP (JJ anti-CD18) (NN mAb)))) (, ,)) (VP (VBD was) (VP (VBD coprecipitated) (PP (IN with) (NP (NN _PROT_))) (PP (IN from) (NP (JJ human) (NN neutrophil) (NNS lysates))) (PP (IN by) (NP (NP (DT a) (NN mAb)) (PP (TO to) (NP (NN _PROT2_)))))))))
-1 #(S1 (S (NP (NP (NN _PROT_) (CD _PROT_) (NN _PROT_)) (, ,) (VP (VBN detected) (PP (IN by) (NP (JJ anti-CD18) (NN mAb)))) (, ,)) (VP (VBD was) (VP (VBD coprecipitated) (PP (IN with) (NP (NN _PROT1_))) (PP (IN from) (NP (JJ human) (NN neutrophil) (NNS lysates))) (PP (IN by) (NP (NP (DT a) (NN mAb)) (PP (TO to) (NP (NN _PROT2_)))))))))
+1 #(S1 (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NN _PROT1_)) (VP (VBD was) (VP (VBN immunoprecipitated) (PP (IN from) (NP (JJ human) (NN neutrophil) (NNS lysates))) (PP (IN by) (NP (JJ anti-human) (NN _PROT2_) (NN mAb)))))))
+1 #(S1 (S (NP (DT These) (NNS results)) (ADVP (RB clearly)) (VP (VBP show) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ is) (ADVP (RB physically)) (VP (VBN associated) (PP (IN with) (NP (NP (NN _PROT2_) (CD _PROT2_) (NN _PROT2_)) (PP (IN in) (NP (JJ human) (NNS neutrophils))))))))))))
+1 #(S1 (S (NP (NP (NP (NN _PROT1_) (NN orphan) (NN receptor)) (VP (VBZ functions) (PP (IN as) (NP (NP (JJ negative) (NN modulator)) (PP (IN for) (NP (NN _PROT2_) (NN _PROT2_))))) (PP (IN in) (NP (NN prostate) (NN cancer) (NNS cells))))) (NP (NN _PROT_)))))
-1 #(S1 (S (NP (NP (NP (NN _PROT1_) (NN orphan) (NN receptor)) (VP (VBZ functions) (PP (IN as) (NP (NP (JJ negative) (NN modulator)) (PP (IN for) (NP (NN _PROT_) (NN _PROT_))))) (PP (IN in) (NP (NN prostate) (NN cancer) (NNS cells))))) (NP (NN _PROT2_)))))
-1 #(S1 (S (NP (NP (NP (NN _PROT_) (NN orphan) (NN receptor)) (VP (VBZ functions) (PP (IN as) (NP (NP (JJ negative) (NN modulator)) (PP (IN for) (NP (NN _PROT1_) (NN _PROT1_))))) (PP (IN in) (NP (NN prostate) (NN cancer) (NNS cells))))) (NP (NN _PROT2_)))))
-1 #(S1 (S (NP (NP (NN BACKGROUND)) (: :) (S (NP (CC Both) (NP (NP (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN AR)) (-RRB- -RRB-))) (CC and) (NP (NP (NN orphan) (NN receptor) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (VP (VP (VBP belong) (PP (TO to) (NP (DT the) (NN steroid) (JJ nuclear) (NN receptor) (NN superfamily)))) (CC and) (VP (VBP are) (VP (VBN expressed) (PP (IN in) (NP (NP (NN prostate) (NN cancer) (NN tissue)) (CC and) (NP (NN cell) (NNS lines)))))))))))
-1 #(S1 (S (NP (NP (NN BACKGROUND)) (: :) (S (NP (CC Both) (NP (NP (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN AR)) (-RRB- -RRB-))) (CC and) (NP (NP (NN orphan) (NN receptor) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))) (VP (VP (VBP belong) (PP (TO to) (NP (DT the) (NN steroid) (JJ nuclear) (NN receptor) (NN superfamily)))) (CC and) (VP (VBP are) (VP (VBN expressed) (PP (IN in) (NP (NP (NN prostate) (NN cancer) (NN tissue)) (CC and) (NP (NN cell) (NNS lines)))))))))))
-1 #(S1 (S (NP (NP (NN BACKGROUND)) (: :) (S (NP (CC Both) (NP (NP (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN AR)) (-RRB- -RRB-))) (CC and) (NP (NP (NN orphan) (NN receptor) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))) (VP (VP (VBP belong) (PP (TO to) (NP (DT the) (NN steroid) (JJ nuclear) (NN receptor) (NN superfamily)))) (CC and) (VP (VBP are) (VP (VBN expressed) (PP (IN in) (NP (NP (NN prostate) (NN cancer) (NN tissue)) (CC and) (NP (NN cell) (NNS lines)))))))))))
-1 #(S1 (S (NP (NP (DT The) (NN interaction)) (PP (IN between) (NP (NP (NN AR)) (CC and) (NP (NN _PROT1_))))) (VP (VBD was) (VP (VBN assessed) (PP (IN by) (NP (NP (ADJP (NN _PROT2_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-) (JJ pull-down)) (NN assay)) (CC and) (NP (JJ mammalian) (JJ two-hybrid) (NN system) (NN assay))))))))
-1 #(S1 (S (NP (NP (DT The) (NN interaction)) (PP (IN between) (NP (NP (NN AR)) (CC and) (NP (NN _PROT1_))))) (VP (VBD was) (VP (VBN assessed) (PP (IN by) (NP (NP (ADJP (NN _PROT_) (-LRB- -LRB-) (NN _PROT2_) (-RRB- -RRB-) (JJ pull-down)) (NN assay)) (CC and) (NP (JJ mammalian) (JJ two-hybrid) (NN system) (NN assay))))))))
-1 #(S1 (S (NP (NP (DT The) (NN interaction)) (PP (IN between) (NP (NP (NN AR)) (CC and) (NP (NN _PROT_))))) (VP (VBD was) (VP (VBN assessed) (PP (IN by) (NP (NP (ADJP (NN _PROT1_) (-LRB- -LRB-) (NN _PROT2_) (-RRB- -RRB-) (JJ pull-down)) (NN assay)) (CC and) (NP (JJ mammalian) (JJ two-hybrid) (NN system) (NN assay))))))))
+1 #(S1 (S (NP (PRP We)) (VP (VBP report) (ADVP (RB here)) (SBAR (IN that) (S (NP (NP (NN PLZF)) (, ,) (CC and) (NP (NP (DT a) (ADJP (RB structurally) (JJ similar)) (JJ transcriptional) (NN repressor)) (, ,) (NP (NN _PROT1_)) (, ,))) (VP (MD can) (VP (VB interact) (PP (IN with) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NP (JJ corepressor) (NNS proteins)) (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NN SMRT))))) (, ,) (PP (VBG including) (NP (NP (DT the) (NN mSin3A) (NN protein)) (CC and) (NP (PRN (-LRB- -LRB-) (PP (IN for) (NP (NN PLZF))) (-RRB- -RRB-)) (NN _PROT2_) (NN _PROT2_)))))))))))))))
-1 #(S1 (S (NP (NP (NP (NP (NN Cloning)) (CC and) (NP (NN characterization))) (PP (IN of) (NP (NP (NP (CD two) (ADJP (RB evolutionarily) (VBN conserved)) (NNS subunits)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (-RRB- -RRB-))) (PP (IN of) (NP (JJ human) (NN _PROT_)))))) (CC and) (NP (NP (PRP$ their) (NN involvement)) (PP (IN in) (NP (NP (JJ functional) (NNS interactions)) (PP (IN with) (NP (NP (NN TFIIIB)) (CC and) (NP (NN RNA) (NN polymerase) (CD III))))))))))
-1 #(S1 (S (NP (NP (NP (NP (NN Cloning)) (CC and) (NP (NN characterization))) (PP (IN of) (NP (NP (NP (CD two) (ADJP (RB evolutionarily) (VBN conserved)) (NNS subunits)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))) (-RRB- -RRB-))) (PP (IN of) (NP (JJ human) (NN _PROT2_)))))) (CC and) (NP (NP (PRP$ their) (NN involvement)) (PP (IN in) (NP (NP (JJ functional) (NNS interactions)) (PP (IN with) (NP (NP (NN TFIIIB)) (CC and) (NP (NN RNA) (NN polymerase) (CD III))))))))))
-1 #(S1 (S (NP (NP (NP (NP (NN Cloning)) (CC and) (NP (NN characterization))) (PP (IN of) (NP (NP (NP (CD two) (ADJP (RB evolutionarily) (VBN conserved)) (NNS subunits)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))) (-RRB- -RRB-))) (PP (IN of) (NP (JJ human) (NN _PROT2_)))))) (CC and) (NP (NP (PRP$ their) (NN involvement)) (PP (IN in) (NP (NP (JJ functional) (NNS interactions)) (PP (IN with) (NP (NP (NN TFIIIB)) (CC and) (NP (NN RNA) (NN polymerase) (CD III))))))))))
-1 #(S1 (S (NP (NP (NN _PROT1_)) (CC and) (NP (NNP _PROT2_))) (VP (VBP are) (NP (NP (NN _PROT_) (NN kinase) (NNS inhibitors)) (PP (IN with) (NP (NP (DT a) (NN role)) (PP (IN in) (NP (NP (NP (NP (NN S)) (CC and) (NP (NN G2/M))) (NN cell) (NN cycle) (NNS checkpoints)) (VP (VBN induced) (PP (IN by) (NP (JJ genotoxic) (NN stress))))))))))))
+1 #(S1 (S (NP (NP (NN _PROT1_)) (CC and) (NP (NNP _PROT_))) (VP (VBP are) (NP (NP (NN _PROT2_) (NN kinase) (NNS inhibitors)) (PP (IN with) (NP (NP (DT a) (NN role)) (PP (IN in) (NP (NP (NP (NP (NN S)) (CC and) (NP (NN G2/M))) (NN cell) (NN cycle) (NNS checkpoints)) (VP (VBN induced) (PP (IN by) (NP (JJ genotoxic) (NN stress))))))))))))
+1 #(S1 (S (NP (NP (NN _PROT_)) (CC and) (NP (NNP _PROT1_))) (VP (VBP are) (NP (NP (NN _PROT2_) (NN kinase) (NNS inhibitors)) (PP (IN with) (NP (NP (DT a) (NN role)) (PP (IN in) (NP (NP (NP (NP (NN S)) (CC and) (NP (NN G2/M))) (NN cell) (NN cycle) (NNS checkpoints)) (VP (VBN induced) (PP (IN by) (NP (JJ genotoxic) (NN stress))))))))))))
-1 #(S1 (S (NP (NP (NN _PROT1_) (-LRB- -LRB-) (NN _PROT2_) (-RRB- -RRB-)) (, ,) (NP (NN _PROT_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-)) (, ,) (CC and) (NP (NNP _PROT_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-))) (VP (VBP constitute) (NP (NP (DT a) (NN family)) (PP (IN of) (NP (NP (ADJP (RB evolutionarily) (VBN conserved)) (, ,) (ADJP (ADJP (JJ small)) (, ,) (ADJP (JJ acidic))) (, ,) (NP (JJ nuclear) (NNS proteins)) (, ,)) (SBAR (WHNP (WDT which)) (S (VP (VBP have) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NP (JJ terminal) (NN differentiation)) (, ,) (NP (NN growth) (NN suppression)) (, ,) (CC and) (NP (NN apoptosis)))))))))))))))
-1 #(S1 (S (NP (NP (NN _PROT1_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-)) (, ,) (NP (NN _PROT2_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-)) (, ,) (CC and) (NP (NNP _PROT_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-))) (VP (VBP constitute) (NP (NP (DT a) (NN family)) (PP (IN of) (NP (NP (ADJP (RB evolutionarily) (VBN conserved)) (, ,) (ADJP (ADJP (JJ small)) (, ,) (ADJP (JJ acidic))) (, ,) (NP (JJ nuclear) (NNS proteins)) (, ,)) (SBAR (WHNP (WDT which)) (S (VP (VBP have) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NP (JJ terminal) (NN differentiation)) (, ,) (NP (NN growth) (NN suppression)) (, ,) (CC and) (NP (NN apoptosis)))))))))))))))
-1 #(S1 (S (NP (NP (NN _PROT1_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-)) (, ,) (NP (NN _PROT_) (-LRB- -LRB-) (NN _PROT2_) (-RRB- -RRB-)) (, ,) (CC and) (NP (NNP _PROT_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-))) (VP (VBP constitute) (NP (NP (DT a) (NN family)) (PP (IN of) (NP (NP (ADJP (RB evolutionarily) (VBN conserved)) (, ,) (ADJP (ADJP (JJ small)) (, ,) (ADJP (JJ acidic))) (, ,) (NP (JJ nuclear) (NNS proteins)) (, ,)) (SBAR (WHNP (WDT which)) (S (VP (VBP have) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NP (JJ terminal) (NN differentiation)) (, ,) (NP (NN growth) (NN suppression)) (, ,) (CC and) (NP (NN apoptosis)))))))))))))))
-1 #(S1 (S (NP (NP (NN _PROT1_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-)) (, ,) (NP (NN _PROT_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-)) (, ,) (CC and) (NP (NNP _PROT2_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-))) (VP (VBP constitute) (NP (NP (DT a) (NN family)) (PP (IN of) (NP (NP (ADJP (RB evolutionarily) (VBN conserved)) (, ,) (ADJP (ADJP (JJ small)) (, ,) (ADJP (JJ acidic))) (, ,) (NP (JJ nuclear) (NNS proteins)) (, ,)) (SBAR (WHNP (WDT which)) (S (VP (VBP have) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NP (JJ terminal) (NN differentiation)) (, ,) (NP (NN growth) (NN suppression)) (, ,) (CC and) (NP (NN apoptosis)))))))))))))))
-1 #(S1 (S (NP (NP (NN _PROT1_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-)) (, ,) (NP (NN _PROT_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-)) (, ,) (CC and) (NP (NNP _PROT_) (-LRB- -LRB-) (NN _PROT2_) (-RRB- -RRB-))) (VP (VBP constitute) (NP (NP (DT a) (NN family)) (PP (IN of) (NP (NP (ADJP (RB evolutionarily) (VBN conserved)) (, ,) (ADJP (ADJP (JJ small)) (, ,) (ADJP (JJ acidic))) (, ,) (NP (JJ nuclear) (NNS proteins)) (, ,)) (SBAR (WHNP (WDT which)) (S (VP (VBP have) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NP (JJ terminal) (NN differentiation)) (, ,) (NP (NN growth) (NN suppression)) (, ,) (CC and) (NP (NN apoptosis)))))))))))))))
-1 #(S1 (S (NP (NP (NN _PROT_) (-LRB- -LRB-) (NN _PROT1_) (-RRB- -RRB-)) (, ,) (NP (NN _PROT2_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-)) (, ,) (CC and) (NP (NNP _PROT_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-))) (VP (VBP constitute) (NP (NP (DT a) (NN family)) (PP (IN of) (NP (NP (ADJP (RB evolutionarily) (VBN conserved)) (, ,) (ADJP (ADJP (JJ small)) (, ,) (ADJP (JJ acidic))) (, ,) (NP (JJ nuclear) (NNS proteins)) (, ,)) (SBAR (WHNP (WDT which)) (S (VP (VBP have) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NP (JJ terminal) (NN differentiation)) (, ,) (NP (NN growth) (NN suppression)) (, ,) (CC and) (NP (NN apoptosis)))))))))))))))
-1 #(S1 (S (NP (NP (NN _PROT_) (-LRB- -LRB-) (NN _PROT1_) (-RRB- -RRB-)) (, ,) (NP (NN _PROT_) (-LRB- -LRB-) (NN _PROT2_) (-RRB- -RRB-)) (, ,) (CC and) (NP (NNP _PROT_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-))) (VP (VBP constitute) (NP (NP (DT a) (NN family)) (PP (IN of) (NP (NP (ADJP (RB evolutionarily) (VBN conserved)) (, ,) (ADJP (ADJP (JJ small)) (, ,) (ADJP (JJ acidic))) (, ,) (NP (JJ nuclear) (NNS proteins)) (, ,)) (SBAR (WHNP (WDT which)) (S (VP (VBP have) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NP (JJ terminal) (NN differentiation)) (, ,) (NP (NN growth) (NN suppression)) (, ,) (CC and) (NP (NN apoptosis)))))))))))))))
-1 #(S1 (S (NP (NP (NN _PROT_) (-LRB- -LRB-) (NN _PROT1_) (-RRB- -RRB-)) (, ,) (NP (NN _PROT_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-)) (, ,) (CC and) (NP (NNP _PROT2_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-))) (VP (VBP constitute) (NP (NP (DT a) (NN family)) (PP (IN of) (NP (NP (ADJP (RB evolutionarily) (VBN conserved)) (, ,) (ADJP (ADJP (JJ small)) (, ,) (ADJP (JJ acidic))) (, ,) (NP (JJ nuclear) (NNS proteins)) (, ,)) (SBAR (WHNP (WDT which)) (S (VP (VBP have) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NP (JJ terminal) (NN differentiation)) (, ,) (NP (NN growth) (NN suppression)) (, ,) (CC and) (NP (NN apoptosis)))))))))))))))
-1 #(S1 (S (NP (NP (NN _PROT_) (-LRB- -LRB-) (NN _PROT1_) (-RRB- -RRB-)) (, ,) (NP (NN _PROT_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-)) (, ,) (CC and) (NP (NNP _PROT_) (-LRB- -LRB-) (NN _PROT2_) (-RRB- -RRB-))) (VP (VBP constitute) (NP (NP (DT a) (NN family)) (PP (IN of) (NP (NP (ADJP (RB evolutionarily) (VBN conserved)) (, ,) (ADJP (ADJP (JJ small)) (, ,) (ADJP (JJ acidic))) (, ,) (NP (JJ nuclear) (NNS proteins)) (, ,)) (SBAR (WHNP (WDT which)) (S (VP (VBP have) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NP (JJ terminal) (NN differentiation)) (, ,) (NP (NN growth) (NN suppression)) (, ,) (CC and) (NP (NN apoptosis)))))))))))))))
-1 #(S1 (S (NP (NP (NN _PROT_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-)) (, ,) (NP (NN _PROT1_) (-LRB- -LRB-) (NN _PROT2_) (-RRB- -RRB-)) (, ,) (CC and) (NP (NNP _PROT_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-))) (VP (VBP constitute) (NP (NP (DT a) (NN family)) (PP (IN of) (NP (NP (ADJP (RB evolutionarily) (VBN conserved)) (, ,) (ADJP (ADJP (JJ small)) (, ,) (ADJP (JJ acidic))) (, ,) (NP (JJ nuclear) (NNS proteins)) (, ,)) (SBAR (WHNP (WDT which)) (S (VP (VBP have) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NP (JJ terminal) (NN differentiation)) (, ,) (NP (NN growth) (NN suppression)) (, ,) (CC and) (NP (NN apoptosis)))))))))))))))
-1 #(S1 (S (NP (NP (NN _PROT_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-)) (, ,) (NP (NN _PROT1_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-)) (, ,) (CC and) (NP (NNP _PROT2_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-))) (VP (VBP constitute) (NP (NP (DT a) (NN family)) (PP (IN of) (NP (NP (ADJP (RB evolutionarily) (VBN conserved)) (, ,) (ADJP (ADJP (JJ small)) (, ,) (ADJP (JJ acidic))) (, ,) (NP (JJ nuclear) (NNS proteins)) (, ,)) (SBAR (WHNP (WDT which)) (S (VP (VBP have) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NP (JJ terminal) (NN differentiation)) (, ,) (NP (NN growth) (NN suppression)) (, ,) (CC and) (NP (NN apoptosis)))))))))))))))
-1 #(S1 (S (NP (NP (NN _PROT_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-)) (, ,) (NP (NN _PROT1_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-)) (, ,) (CC and) (NP (NNP _PROT_) (-LRB- -LRB-) (NN _PROT2_) (-RRB- -RRB-))) (VP (VBP constitute) (NP (NP (DT a) (NN family)) (PP (IN of) (NP (NP (ADJP (RB evolutionarily) (VBN conserved)) (, ,) (ADJP (ADJP (JJ small)) (, ,) (ADJP (JJ acidic))) (, ,) (NP (JJ nuclear) (NNS proteins)) (, ,)) (SBAR (WHNP (WDT which)) (S (VP (VBP have) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NP (JJ terminal) (NN differentiation)) (, ,) (NP (NN growth) (NN suppression)) (, ,) (CC and) (NP (NN apoptosis)))))))))))))))
-1 #(S1 (S (NP (NP (NN _PROT_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-)) (, ,) (NP (NN _PROT_) (-LRB- -LRB-) (NN _PROT1_) (-RRB- -RRB-)) (, ,) (CC and) (NP (NNP _PROT2_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-))) (VP (VBP constitute) (NP (NP (DT a) (NN family)) (PP (IN of) (NP (NP (ADJP (RB evolutionarily) (VBN conserved)) (, ,) (ADJP (ADJP (JJ small)) (, ,) (ADJP (JJ acidic))) (, ,) (NP (JJ nuclear) (NNS proteins)) (, ,)) (SBAR (WHNP (WDT which)) (S (VP (VBP have) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NP (JJ terminal) (NN differentiation)) (, ,) (NP (NN growth) (NN suppression)) (, ,) (CC and) (NP (NN apoptosis)))))))))))))))
-1 #(S1 (S (NP (NP (NN _PROT_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-)) (, ,) (NP (NN _PROT_) (-LRB- -LRB-) (NN _PROT1_) (-RRB- -RRB-)) (, ,) (CC and) (NP (NNP _PROT_) (-LRB- -LRB-) (NN _PROT2_) (-RRB- -RRB-))) (VP (VBP constitute) (NP (NP (DT a) (NN family)) (PP (IN of) (NP (NP (ADJP (RB evolutionarily) (VBN conserved)) (, ,) (ADJP (ADJP (JJ small)) (, ,) (ADJP (JJ acidic))) (, ,) (NP (JJ nuclear) (NNS proteins)) (, ,)) (SBAR (WHNP (WDT which)) (S (VP (VBP have) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NP (JJ terminal) (NN differentiation)) (, ,) (NP (NN growth) (NN suppression)) (, ,) (CC and) (NP (NN apoptosis)))))))))))))))
-1 #(S1 (S (NP (NP (NN _PROT_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-)) (, ,) (NP (NN _PROT_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-)) (, ,) (CC and) (NP (NNP _PROT1_) (-LRB- -LRB-) (NN _PROT2_) (-RRB- -RRB-))) (VP (VBP constitute) (NP (NP (DT a) (NN family)) (PP (IN of) (NP (NP (ADJP (RB evolutionarily) (VBN conserved)) (, ,) (ADJP (ADJP (JJ small)) (, ,) (ADJP (JJ acidic))) (, ,) (NP (JJ nuclear) (NNS proteins)) (, ,)) (SBAR (WHNP (WDT which)) (S (VP (VBP have) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NP (JJ terminal) (NN differentiation)) (, ,) (NP (NN growth) (NN suppression)) (, ,) (CC and) (NP (NN apoptosis)))))))))))))))
+1 #(S1 (S (NP (JJ Recent) (NN evidence)) (VP (VBZ has) (VP (VBN implicated) (NP (NN _PROT1_)) (PP (PP (IN in) (NP (NP (NN inhibition)) (PP (IN of) (NP (NN _PROT2_) (NN kinase))))) (CC and) (PP (IN in) (NP (NN G2/M) (NN cell) (NN cycle) (NN arrest))))))))
-1 #(S1 (S (ADVP (RB Yet)) (, ,) (SBAR (IN whether) (S (NP (NP (NN _PROT1_)) (CC and/or) (NP (NNP _PROT2_))) (VP (VP (VBP function) (PP (IN as) (NP (NP (NNS inhibitors)) (PP (IN of) (NP (NN _PROT_) (NN kinase)))))) (CC and/or) (VP (VBP play) (NP (DT a) (NN role)) (PP (IN in) (NP (NN G2/M) (NN cell) (NN cycle) (NN arrest))))))) (VP (VBZ has) (RB not) (VP (VBN been) (ADVP (RB fully)) (VP (VBN established))))))
+1 #(S1 (S (ADVP (RB Yet)) (, ,) (SBAR (IN whether) (S (NP (NP (NN _PROT1_)) (CC and/or) (NP (NNP _PROT_))) (VP (VP (VBP function) (PP (IN as) (NP (NP (NNS inhibitors)) (PP (IN of) (NP (NN _PROT2_) (NN kinase)))))) (CC and/or) (VP (VBP play) (NP (DT a) (NN role)) (PP (IN in) (NP (NN G2/M) (NN cell) (NN cycle) (NN arrest))))))) (VP (VBZ has) (RB not) (VP (VBN been) (ADVP (RB fully)) (VP (VBN established))))))
+1 #(S1 (S (ADVP (RB Yet)) (, ,) (SBAR (IN whether) (S (NP (NP (NN _PROT_)) (CC and/or) (NP (NNP _PROT1_))) (VP (VP (VBP function) (PP (IN as) (NP (NP (NNS inhibitors)) (PP (IN of) (NP (NN _PROT2_) (NN kinase)))))) (CC and/or) (VP (VBP play) (NP (DT a) (NN role)) (PP (IN in) (NP (NN G2/M) (NN cell) (NN cycle) (NN arrest))))))) (VP (VBZ has) (RB not) (VP (VBN been) (ADVP (RB fully)) (VP (VBN established))))))
-1 #(S1 (S (PP (IN In) (NP (DT this) (NN work))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (NN _PROT1_)) (CC and) (NP (NNP _PROT2_))) (ADVP (RB specifically)) (VP (VBP interact) (PP (PP (IN with) (NP (DT the) (NN _PROT_) (NN complex))) (, ,) (CC but) (PP (RB not) (IN with) (NP (JJ other) (NN Cdk/Cyclin) (NNS complexes)))) (, ,) (ADVP (ADVP (FW in) (FW vitro)) (CC and) (ADVP (FW in) (FW vivo)))))))))
+1 #(S1 (S (PP (IN In) (NP (DT this) (NN work))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (NN _PROT1_)) (CC and) (NP (NNP _PROT_))) (ADVP (RB specifically)) (VP (VBP interact) (PP (PP (IN with) (NP (DT the) (NN _PROT2_) (NN complex))) (, ,) (CC but) (PP (RB not) (IN with) (NP (JJ other) (NN Cdk/Cyclin) (NNS complexes)))) (, ,) (ADVP (ADVP (FW in) (FW vitro)) (CC and) (ADVP (FW in) (FW vivo)))))))))
+1 #(S1 (S (PP (IN In) (NP (DT this) (NN work))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (NN _PROT_)) (CC and) (NP (NNP _PROT1_))) (ADVP (RB specifically)) (VP (VBP interact) (PP (PP (IN with) (NP (DT the) (NN _PROT2_) (NN complex))) (, ,) (CC but) (PP (RB not) (IN with) (NP (JJ other) (NN Cdk/Cyclin) (NNS complexes)))) (, ,) (ADVP (ADVP (FW in) (FW vitro)) (CC and) (ADVP (FW in) (FW vivo)))))))))
-1 #(S1 (S (NP (NN Data)) (ADVP (RB also)) (VP (VBZ has) (VP (VBN been) (VP (VBN obtained) (SBAR (IN that) (S (NP (NP (NN _PROT1_)) (CC and) (NP (NNP _PROT2_)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NN _PROT_)) (, ,)) (VP (VBP interact) (PP (IN with) (NP (CC both) (NP (NN _PROT_)) (CC and) (NP (NN cyclinB1)))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (DT the) (NN kinase) (NN activity)) (PP (IN of) (NP (DT the) (NN _PROT_) (NN complex)))))))))))))))))
-1 #(S1 (S (NP (NN Data)) (ADVP (RB also)) (VP (VBZ has) (VP (VBN been) (VP (VBN obtained) (SBAR (IN that) (S (NP (NP (NN _PROT1_)) (CC and) (NP (NNP _PROT_)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NN _PROT2_)) (, ,)) (VP (VBP interact) (PP (IN with) (NP (CC both) (NP (NN _PROT_)) (CC and) (NP (NN cyclinB1)))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (DT the) (NN kinase) (NN activity)) (PP (IN of) (NP (DT the) (NN _PROT_) (NN complex)))))))))))))))))
+1 #(S1 (S (NP (NN Data)) (ADVP (RB also)) (VP (VBZ has) (VP (VBN been) (VP (VBN obtained) (SBAR (IN that) (S (NP (NP (NN _PROT1_)) (CC and) (NP (NNP _PROT_)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NN _PROT_)) (, ,)) (VP (VBP interact) (PP (IN with) (NP (CC both) (NP (NN _PROT2_)) (CC and) (NP (NN cyclinB1)))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (DT the) (NN kinase) (NN activity)) (PP (IN of) (NP (DT the) (NN _PROT_) (NN complex)))))))))))))))))
+1 #(S1 (S (NP (NN Data)) (ADVP (RB also)) (VP (VBZ has) (VP (VBN been) (VP (VBN obtained) (SBAR (IN that) (S (NP (NP (NN _PROT1_)) (CC and) (NP (NNP _PROT_)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NN _PROT_)) (, ,)) (VP (VBP interact) (PP (IN with) (NP (CC both) (NP (NN _PROT_)) (CC and) (NP (NN cyclinB1)))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (DT the) (NN kinase) (NN activity)) (PP (IN of) (NP (DT the) (NN _PROT2_) (NN complex)))))))))))))))))
-1 #(S1 (S (NP (NN Data)) (ADVP (RB also)) (VP (VBZ has) (VP (VBN been) (VP (VBN obtained) (SBAR (IN that) (S (NP (NP (NN _PROT_)) (CC and) (NP (NNP _PROT1_)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NN _PROT2_)) (, ,)) (VP (VBP interact) (PP (IN with) (NP (CC both) (NP (NN _PROT_)) (CC and) (NP (NN cyclinB1)))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (DT the) (NN kinase) (NN activity)) (PP (IN of) (NP (DT the) (NN _PROT_) (NN complex)))))))))))))))))
+1 #(S1 (S (NP (NN Data)) (ADVP (RB also)) (VP (VBZ has) (VP (VBN been) (VP (VBN obtained) (SBAR (IN that) (S (NP (NP (NN _PROT_)) (CC and) (NP (NNP _PROT1_)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NN _PROT_)) (, ,)) (VP (VBP interact) (PP (IN with) (NP (CC both) (NP (NN _PROT2_)) (CC and) (NP (NN cyclinB1)))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (DT the) (NN kinase) (NN activity)) (PP (IN of) (NP (DT the) (NN _PROT_) (NN complex)))))))))))))))))
+1 #(S1 (S (NP (NN Data)) (ADVP (RB also)) (VP (VBZ has) (VP (VBN been) (VP (VBN obtained) (SBAR (IN that) (S (NP (NP (NN _PROT_)) (CC and) (NP (NNP _PROT1_)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NN _PROT_)) (, ,)) (VP (VBP interact) (PP (IN with) (NP (CC both) (NP (NN _PROT_)) (CC and) (NP (NN cyclinB1)))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (DT the) (NN kinase) (NN activity)) (PP (IN of) (NP (DT the) (NN _PROT2_) (NN complex)))))))))))))))))
+1 #(S1 (S (NP (NN Data)) (ADVP (RB also)) (VP (VBZ has) (VP (VBN been) (VP (VBN obtained) (SBAR (IN that) (S (NP (NP (NN _PROT_)) (CC and) (NP (NNP _PROT_)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NN _PROT1_)) (, ,)) (VP (VBP interact) (PP (IN with) (NP (CC both) (NP (NN _PROT2_)) (CC and) (NP (NN cyclinB1)))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (DT the) (NN kinase) (NN activity)) (PP (IN of) (NP (DT the) (NN _PROT_) (NN complex)))))))))))))))))
+1 #(S1 (S (NP (NN Data)) (ADVP (RB also)) (VP (VBZ has) (VP (VBN been) (VP (VBN obtained) (SBAR (IN that) (S (NP (NP (NN _PROT_)) (CC and) (NP (NNP _PROT_)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NN _PROT1_)) (, ,)) (VP (VBP interact) (PP (IN with) (NP (CC both) (NP (NN _PROT_)) (CC and) (NP (NN cyclinB1)))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (DT the) (NN kinase) (NN activity)) (PP (IN of) (NP (DT the) (NN _PROT2_) (NN complex)))))))))))))))))
-1 #(S1 (S (NP (NN Data)) (ADVP (RB also)) (VP (VBZ has) (VP (VBN been) (VP (VBN obtained) (SBAR (IN that) (S (NP (NP (NN _PROT_)) (CC and) (NP (NNP _PROT_)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NN _PROT_)) (, ,)) (VP (VBP interact) (PP (IN with) (NP (CC both) (NP (NN _PROT1_)) (CC and) (NP (NN cyclinB1)))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (DT the) (NN kinase) (NN activity)) (PP (IN of) (NP (DT the) (NN _PROT2_) (NN complex)))))))))))))))))
+1 #(S1 (S (S (NP (NP (NN Inhibition)) (PP (IN of) (NP (NN _PROT1_) (NN kinase) (NN activity))) (PP (IN by) (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))))) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB involve) (NP (NP (NN disruption)) (PP (IN of) (NP (DT the) (NN complex)))))))))) (, ,) (IN whereas) (S (NP (NNP _PROT_)) (VP (VBD did) (RB not) (VP (VB disrupt) (NP (DT the) (NN complex)))))))
+1 #(S1 (S (S (NP (NP (NN Inhibition)) (PP (IN of) (NP (NN _PROT1_) (NN kinase) (NN activity))) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))))) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB involve) (NP (NP (NN disruption)) (PP (IN of) (NP (DT the) (NN complex)))))))))) (, ,) (IN whereas) (S (NP (NNP _PROT_)) (VP (VBD did) (RB not) (VP (VB disrupt) (NP (DT the) (NN complex)))))))
-1 #(S1 (S (S (NP (NP (NN Inhibition)) (PP (IN of) (NP (NN _PROT1_) (NN kinase) (NN activity))) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB involve) (NP (NP (NN disruption)) (PP (IN of) (NP (DT the) (NN complex)))))))))) (, ,) (IN whereas) (S (NP (NNP _PROT2_)) (VP (VBD did) (RB not) (VP (VB disrupt) (NP (DT the) (NN complex)))))))
-1 #(S1 (S (S (NP (NP (NN Inhibition)) (PP (IN of) (NP (NN _PROT_) (NN kinase) (NN activity))) (PP (IN by) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))))) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB involve) (NP (NP (NN disruption)) (PP (IN of) (NP (DT the) (NN complex)))))))))) (, ,) (IN whereas) (S (NP (NNP _PROT_)) (VP (VBD did) (RB not) (VP (VB disrupt) (NP (DT the) (NN complex)))))))
-1 #(S1 (S (S (NP (NP (NN Inhibition)) (PP (IN of) (NP (NN _PROT_) (NN kinase) (NN activity))) (PP (IN by) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))))) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB involve) (NP (NP (NN disruption)) (PP (IN of) (NP (DT the) (NN complex)))))))))) (, ,) (IN whereas) (S (NP (NNP _PROT2_)) (VP (VBD did) (RB not) (VP (VB disrupt) (NP (DT the) (NN complex)))))))
-1 #(S1 (S (S (NP (NP (NN Inhibition)) (PP (IN of) (NP (NN _PROT_) (NN kinase) (NN activity))) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))))) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB involve) (NP (NP (NN disruption)) (PP (IN of) (NP (DT the) (NN complex)))))))))) (, ,) (IN whereas) (S (NP (NNP _PROT2_)) (VP (VBD did) (RB not) (VP (VB disrupt) (NP (DT the) (NN complex)))))))
+1 #(S1 (S (NP (DT The) (NN tyrosine) (NN kinase) (NN _PROT1_)) (VP (VP (VBZ is) (ADVP (RB physically)) (VP (VBN associated) (PP (IN with) (NP (DT the) (NP (NP (NN Type) (CD I) (NN interferon)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (NN receptor) (NN complex))))) (CC and) (VP (VBZ is) (ADVP (RB rapidly)) (VP (VBN activated) (PP (IN during) (NP (NN _PROT_) (NN _PROT_) (NN stimulation))))))))
+1 #(S1 (S (NP (DT The) (NN tyrosine) (NN kinase) (NN _PROT1_)) (VP (VP (VBZ is) (ADVP (RB physically)) (VP (VBN associated) (PP (IN with) (NP (DT the) (NP (NP (NN Type) (CD I) (NN interferon)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (NN receptor) (NN complex))))) (CC and) (VP (VBZ is) (ADVP (RB rapidly)) (VP (VBN activated) (PP (IN during) (NP (NN _PROT2_) (NN _PROT2_) (NN stimulation))))))))
-1 #(S1 (S (NP (DT The) (NN tyrosine) (NN kinase) (NN _PROT_)) (VP (VP (VBZ is) (ADVP (RB physically)) (VP (VBN associated) (PP (IN with) (NP (DT the) (NP (NP (NN Type) (CD I) (NN interferon)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))) (NN receptor) (NN complex))))) (CC and) (VP (VBZ is) (ADVP (RB rapidly)) (VP (VBN activated) (PP (IN during) (NP (NN _PROT2_) (NN _PROT2_) (NN stimulation))))))))
+1 #(S1 (S (NP (NP (NN _PROT1_) (NN interaction)) (PP (IN with) (NP (NN _PROT2_) (NN phosphatase) (NNS ties) (JJ mitogenic) (NN signal) (NN transduction))) (PP (TO to) (NP (NN cell) (NN cycle) (NN activation))))))
+1 #(S1 (S (NP (PRP We)) (VP (VBP show) (ADVP (RB here)) (SBAR (IN that) (S (NP (NN _PROT1_) (NN phosphatase)) (VP (VBZ associates) (PP (IN with) (NP (NN _PROT2_))) (PP (PP (IN in) (NP (JJ somatic) (JJ mammalian) (NNS cells))) (CC and) (PP (IN in) (NP (JJ meiotic) (NN frog) (NNS oocytes))))))))))
+1 #(S1 (S (NP (NP (NN Identification)) (PP (IN of) (NP (NP (NNS residues)) (PP (IN in) (NP (DT the) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_))))) (SBAR (WHNP (WDT that)) (S (VP (NN contact) (NP (DT the) (NN MCP-1) (NN receptor) (, ,) (NN _PROT2_))))))))
-1 #(S1 (S (NP (NP (DT The) (NN receptor) (NN binding) (NN site)) (PP (IN of) (NP (NN _PROT1_)))) (ADVP (RB also)) (VP (VBZ is) (ADJP (RB significantly) (JJ different) (PP (IN from) (NP (NP (DT the) (VBG binding) (NNS sites)) (PP (IN of) (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))))))) (, ,) (S (VP (VBG providing) (NP (NP (NN insight)) (PP (IN into) (NP (NP (DT the) (NN issue)) (PP (IN of) (NP (NN receptor) (NN specificity)))))))))))
-1 #(S1 (S (NP (NP (DT The) (NN receptor) (NN binding) (NN site)) (PP (IN of) (NP (NN _PROT1_)))) (ADVP (RB also)) (VP (VBZ is) (ADJP (RB significantly) (JJ different) (PP (IN from) (NP (NP (DT the) (VBG binding) (NNS sites)) (PP (IN of) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))))))) (, ,) (S (VP (VBG providing) (NP (NP (NN insight)) (PP (IN into) (NP (NP (DT the) (NN issue)) (PP (IN of) (NP (NN receptor) (NN specificity)))))))))))
-1 #(S1 (S (NP (NP (DT The) (NN receptor) (NN binding) (NN site)) (PP (IN of) (NP (NN _PROT_)))) (ADVP (RB also)) (VP (VBZ is) (ADJP (RB significantly) (JJ different) (PP (IN from) (NP (NP (DT the) (VBG binding) (NNS sites)) (PP (IN of) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))))))) (, ,) (S (VP (VBG providing) (NP (NP (NN insight)) (PP (IN into) (NP (NP (DT the) (NN issue)) (PP (IN of) (NP (NN receptor) (NN specificity)))))))))))
+1 #(S1 (S (NP (PRP It)) (VP (VBD was) (ADVP (RB previously)) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (NN N-terminus)) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBZ is) (ADJP (JJ critical) (PP (IN for) (S (VP (VBG binding) (NP (NN _PROT2_)))))))))))))
+1 #(S1 (S (S (VP (TO To) (VP (VB identify) (NP (NP (DT the) (NNS regions)) (PP (IN of) (NP (NP (NP (NN _PROT1_)) (SBAR (WHNP (WDT that)) (S (VP (NN contact) (NP (PRP$ its) (NN receptor)))))) (, ,) (NP (NN _PROT2_)))))))) (, ,) (S (NP (PRP we)) (VP (VBD substituted) (NP (NP (DT all) (JJ surface-exposed) (NNS residues)) (PP (IN with) (NP (NN alanine))))))))
+1 #(S1 (S (NP (NN _PROT1_)) (VP (VBZ activates) (NP (NP (NN _PROT2_) (NN _PROT2_)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ inhibits) (NP (NP (NN apoptosis)) (PP (IN in) (NP (JJ human) (NN prostate) (NN cancer) (NN cell) (NNS lines)))))))))))
-1 #(S1 (S (NP (NP (NNS RESULTS)) (: :) (S (NP (NP (NN Tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NN p85)))) (VP (VBZ is) (VP (VBN upregulated) (PP (IN by) (NP (NN _PROT1_))) (PP (IN in) (NP (CC both) (NP (NN LNCaP)) (CC and) (NP (NN _PROT2_))))))))))
+1 #(S1 (S (NP (NN _PROT1_)) (VP (VBZ promotes) (NP (NP (NN coprecipitation)) (PP (IN of) (NP (NN p85))) (PP (IN with) (NP (NP (NN _PROT2_)) (, ,) (NP (NP (DT the) (JJ signal-transducing) (NN component)) (PP (IN of) (NP (DT the) (NN _PROT_) (NN _PROT_))))))))))
-1 #(S1 (S (NP (NN _PROT1_)) (VP (VBZ promotes) (NP (NP (NN coprecipitation)) (PP (IN of) (NP (NN p85))) (PP (IN with) (NP (NP (NN _PROT_)) (, ,) (NP (NP (DT the) (JJ signal-transducing) (NN component)) (PP (IN of) (NP (DT the) (NN _PROT2_) (NN _PROT2_))))))))))
-1 #(S1 (S (NP (NN _PROT_)) (VP (VBZ promotes) (NP (NP (NN coprecipitation)) (PP (IN of) (NP (NN p85))) (PP (IN with) (NP (NP (NN _PROT1_)) (, ,) (NP (NP (DT the) (JJ signal-transducing) (NN component)) (PP (IN of) (NP (DT the) (NN _PROT2_) (NN _PROT2_))))))))))
-1 #(S1 (S (NP (NN _PROT1_AND_PROT2_)) (VP (VBZ interacts) (PP (IN with) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (CC and) (NP (NN SRrp130)))) (PP (IN in) (NP (NN corneal) (JJ epithelial) (NNS cells))))))
+1 #(S1 (S (NP (NN _PROT1_)) (VP (VBZ interacts) (PP (IN with) (NP (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (CC and) (NP (NN SRrp130)))) (PP (IN in) (NP (NN corneal) (JJ epithelial) (NNS cells))))))
+1 #(S1 (S (NP (NN _PROT1_)) (VP (VBZ interacts) (PP (IN with) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (CC and) (NP (NN SRrp130)))) (PP (IN in) (NP (NN corneal) (JJ epithelial) (NNS cells))))))
+1 #(S1 (S (NP (NN _PROT1_)) (VP (VBZ interacts) (PP (IN with) (NP (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (CC and) (NP (NN SRrp130)))) (PP (IN in) (NP (NN corneal) (JJ epithelial) (NNS cells))))))
+1 #(S1 (S (NP (NN _PROT1_)) (VP (VBZ interacts) (PP (IN with) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (CC and) (NP (NN SRrp130)))) (PP (IN in) (NP (NN corneal) (JJ epithelial) (NNS cells))))))
-1 #(S1 (S (NP (NN _PROT_)) (VP (VBZ interacts) (PP (IN with) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT2_)) (CC and) (NP (NN SRrp130)))) (PP (IN in) (NP (NN corneal) (JJ epithelial) (NNS cells))))))
-1 #(S1 (S (S (NP (CD Three) (JJ SR-rich) (NNS proteins)) (VP (VBD were) (VP (VBN identified) (SBAR (WHNP (WDT that)) (S (VP (VBP interact) (PP (IN with) (NP (NP (DT the) (NN C-terminus)) (PP (IN of) (NP (NNP Pnn))))))))))) (: :) (NP (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (, ,) (NP (NP (JJ known) (NNS components)) (PP (IN of) (NP (NN spliceosome) (NN machinery)))) (, ,) (CC and) (NP (NP (DT a) (JJ novel) (JJ 130-kDa) (JJ nuclear) (NN protein)) (, ,) (NP (NN SRrp130))))))
+1 #(S1 (S (NP (JJ Subsequent) (NN amino) (NN acid) (NN sequencing)) (VP (VBD revealed) (NP (NP (JJ many) (NNS peptides)) (VP (VBG involving) (NP (NP (NP (NN _PROT1_)) (VP (VBN cross-linked) (PP (CC either) (PP (TO to) (NP (PRP itself))) (CC or) (PP (TO to) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ other) (JJ known) (NN CE) (NN protein) (NNS components))) (, ,) (VP (VBG including) (NP (NN _PROT2_) (NN _PROT2_)))))))) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN keratins)) (, ,) (NP (NP (NNS members)) (PP (IN of) (NP (NP (DT the) (JJ small) (JJ proline-rich) (NN superfamily)) (, ,) (NP (NN _PROT_))))) (, ,) (CC and) (NP (NP (JJ unknown) (NNS proteins)) (ADJP (JJ related) (PP (TO to) (NP (DT the) (NN _PROT_) (NN family)))))))))))
+1 #(S1 (S (NP (JJ Subsequent) (NN amino) (NN acid) (NN sequencing)) (VP (VBD revealed) (NP (NP (JJ many) (NNS peptides)) (VP (VBG involving) (NP (NP (NP (NN _PROT1_)) (VP (VBN cross-linked) (PP (CC either) (PP (TO to) (NP (PRP itself))) (CC or) (PP (TO to) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ other) (JJ known) (NN CE) (NN protein) (NNS components))) (, ,) (VP (VBG including) (NP (NN _PROT_) (NN _PROT_)))))))) (, ,) (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN keratins)) (, ,) (NP (NP (NNS members)) (PP (IN of) (NP (NP (DT the) (JJ small) (JJ proline-rich) (NN superfamily)) (, ,) (NP (NN _PROT_))))) (, ,) (CC and) (NP (NP (JJ unknown) (NNS proteins)) (ADJP (JJ related) (PP (TO to) (NP (DT the) (NN _PROT_) (NN family)))))))))))
+1 #(S1 (S (NP (JJ Subsequent) (NN amino) (NN acid) (NN sequencing)) (VP (VBD revealed) (NP (NP (JJ many) (NNS peptides)) (VP (VBG involving) (NP (NP (NP (NN _PROT1_)) (VP (VBN cross-linked) (PP (CC either) (PP (TO to) (NP (PRP itself))) (CC or) (PP (TO to) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ other) (JJ known) (NN CE) (NN protein) (NNS components))) (, ,) (VP (VBG including) (NP (NN _PROT_) (NN _PROT_)))))))) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (NP (NN keratins)) (, ,) (NP (NP (NNS members)) (PP (IN of) (NP (NP (DT the) (JJ small) (JJ proline-rich) (NN superfamily)) (, ,) (NP (NN _PROT_))))) (, ,) (CC and) (NP (NP (JJ unknown) (NNS proteins)) (ADJP (JJ related) (PP (TO to) (NP (DT the) (NN _PROT_) (NN family)))))))))))
+1 #(S1 (S (NP (JJ Subsequent) (NN amino) (NN acid) (NN sequencing)) (VP (VBD revealed) (NP (NP (JJ many) (NNS peptides)) (VP (VBG involving) (NP (NP (NP (NN _PROT1_)) (VP (VBN cross-linked) (PP (CC either) (PP (TO to) (NP (PRP itself))) (CC or) (PP (TO to) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ other) (JJ known) (NN CE) (NN protein) (NNS components))) (, ,) (VP (VBG including) (NP (NN _PROT_) (NN _PROT_)))))))) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN keratins)) (, ,) (NP (NP (NNS members)) (PP (IN of) (NP (NP (DT the) (JJ small) (JJ proline-rich) (NN superfamily)) (, ,) (NP (NN _PROT2_))))) (, ,) (CC and) (NP (NP (JJ unknown) (NNS proteins)) (ADJP (JJ related) (PP (TO to) (NP (DT the) (NN _PROT_) (NN family)))))))))))
+1 #(S1 (S (NP (JJ Subsequent) (NN amino) (NN acid) (NN sequencing)) (VP (VBD revealed) (NP (NP (JJ many) (NNS peptides)) (VP (VBG involving) (NP (NP (NP (NN _PROT1_)) (VP (VBN cross-linked) (PP (CC either) (PP (TO to) (NP (PRP itself))) (CC or) (PP (TO to) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ other) (JJ known) (NN CE) (NN protein) (NNS components))) (, ,) (VP (VBG including) (NP (NN _PROT_) (NN _PROT_)))))))) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN keratins)) (, ,) (NP (NP (NNS members)) (PP (IN of) (NP (NP (DT the) (JJ small) (JJ proline-rich) (NN superfamily)) (, ,) (NP (NN _PROT_))))) (, ,) (CC and) (NP (NP (JJ unknown) (NNS proteins)) (ADJP (JJ related) (PP (TO to) (NP (DT the) (NN _PROT2_) (NN family)))))))))))
-1 #(S1 (S (NP (JJ Subsequent) (NN amino) (NN acid) (NN sequencing)) (VP (VBD revealed) (NP (NP (JJ many) (NNS peptides)) (VP (VBG involving) (NP (NP (NP (NN _PROT_)) (VP (VBN cross-linked) (PP (CC either) (PP (TO to) (NP (PRP itself))) (CC or) (PP (TO to) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ other) (JJ known) (NN CE) (NN protein) (NNS components))) (, ,) (VP (VBG including) (NP (NN _PROT1_) (NN _PROT1_)))))))) (, ,) (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN keratins)) (, ,) (NP (NP (NNS members)) (PP (IN of) (NP (NP (DT the) (JJ small) (JJ proline-rich) (NN superfamily)) (, ,) (NP (NN _PROT_))))) (, ,) (CC and) (NP (NP (JJ unknown) (NNS proteins)) (ADJP (JJ related) (PP (TO to) (NP (DT the) (NN _PROT_) (NN family)))))))))))
-1 #(S1 (S (NP (JJ Subsequent) (NN amino) (NN acid) (NN sequencing)) (VP (VBD revealed) (NP (NP (JJ many) (NNS peptides)) (VP (VBG involving) (NP (NP (NP (NN _PROT_)) (VP (VBN cross-linked) (PP (CC either) (PP (TO to) (NP (PRP itself))) (CC or) (PP (TO to) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ other) (JJ known) (NN CE) (NN protein) (NNS components))) (, ,) (VP (VBG including) (NP (NN _PROT1_) (NN _PROT1_)))))))) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (NP (NN keratins)) (, ,) (NP (NP (NNS members)) (PP (IN of) (NP (NP (DT the) (JJ small) (JJ proline-rich) (NN superfamily)) (, ,) (NP (NN _PROT_))))) (, ,) (CC and) (NP (NP (JJ unknown) (NNS proteins)) (ADJP (JJ related) (PP (TO to) (NP (DT the) (NN _PROT_) (NN family)))))))))))
-1 #(S1 (S (NP (JJ Subsequent) (NN amino) (NN acid) (NN sequencing)) (VP (VBD revealed) (NP (NP (JJ many) (NNS peptides)) (VP (VBG involving) (NP (NP (NP (NN _PROT_)) (VP (VBN cross-linked) (PP (CC either) (PP (TO to) (NP (PRP itself))) (CC or) (PP (TO to) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ other) (JJ known) (NN CE) (NN protein) (NNS components))) (, ,) (VP (VBG including) (NP (NN _PROT1_) (NN _PROT1_)))))))) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN keratins)) (, ,) (NP (NP (NNS members)) (PP (IN of) (NP (NP (DT the) (JJ small) (JJ proline-rich) (NN superfamily)) (, ,) (NP (NN _PROT2_))))) (, ,) (CC and) (NP (NP (JJ unknown) (NNS proteins)) (ADJP (JJ related) (PP (TO to) (NP (DT the) (NN _PROT_) (NN family)))))))))))
-1 #(S1 (S (NP (JJ Subsequent) (NN amino) (NN acid) (NN sequencing)) (VP (VBD revealed) (NP (NP (JJ many) (NNS peptides)) (VP (VBG involving) (NP (NP (NP (NN _PROT_)) (VP (VBN cross-linked) (PP (CC either) (PP (TO to) (NP (PRP itself))) (CC or) (PP (TO to) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ other) (JJ known) (NN CE) (NN protein) (NNS components))) (, ,) (VP (VBG including) (NP (NN _PROT1_) (NN _PROT1_)))))))) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN keratins)) (, ,) (NP (NP (NNS members)) (PP (IN of) (NP (NP (DT the) (JJ small) (JJ proline-rich) (NN superfamily)) (, ,) (NP (NN _PROT_))))) (, ,) (CC and) (NP (NP (JJ unknown) (NNS proteins)) (ADJP (JJ related) (PP (TO to) (NP (DT the) (NN _PROT2_) (NN family)))))))))))
-1 #(S1 (S (NP (JJ Subsequent) (NN amino) (NN acid) (NN sequencing)) (VP (VBD revealed) (NP (NP (JJ many) (NNS peptides)) (VP (VBG involving) (NP (NP (NP (NN _PROT_)) (VP (VBN cross-linked) (PP (CC either) (PP (TO to) (NP (PRP itself))) (CC or) (PP (TO to) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ other) (JJ known) (NN CE) (NN protein) (NNS components))) (, ,) (VP (VBG including) (NP (NN _PROT_) (NN _PROT_)))))))) (, ,) (NP (NN _PROT1_)) (, ,) (NP (NN _PROT2_)) (, ,) (NP (NN keratins)) (, ,) (NP (NP (NNS members)) (PP (IN of) (NP (NP (DT the) (JJ small) (JJ proline-rich) (NN superfamily)) (, ,) (NP (NN _PROT_))))) (, ,) (CC and) (NP (NP (JJ unknown) (NNS proteins)) (ADJP (JJ related) (PP (TO to) (NP (DT the) (NN _PROT_) (NN family)))))))))))
-1 #(S1 (S (NP (JJ Subsequent) (NN amino) (NN acid) (NN sequencing)) (VP (VBD revealed) (NP (NP (JJ many) (NNS peptides)) (VP (VBG involving) (NP (NP (NP (NN _PROT_)) (VP (VBN cross-linked) (PP (CC either) (PP (TO to) (NP (PRP itself))) (CC or) (PP (TO to) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ other) (JJ known) (NN CE) (NN protein) (NNS components))) (, ,) (VP (VBG including) (NP (NN _PROT_) (NN _PROT_)))))))) (, ,) (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN keratins)) (, ,) (NP (NP (NNS members)) (PP (IN of) (NP (NP (DT the) (JJ small) (JJ proline-rich) (NN superfamily)) (, ,) (NP (NN _PROT2_))))) (, ,) (CC and) (NP (NP (JJ unknown) (NNS proteins)) (ADJP (JJ related) (PP (TO to) (NP (DT the) (NN _PROT_) (NN family)))))))))))
-1 #(S1 (S (NP (JJ Subsequent) (NN amino) (NN acid) (NN sequencing)) (VP (VBD revealed) (NP (NP (JJ many) (NNS peptides)) (VP (VBG involving) (NP (NP (NP (NN _PROT_)) (VP (VBN cross-linked) (PP (CC either) (PP (TO to) (NP (PRP itself))) (CC or) (PP (TO to) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ other) (JJ known) (NN CE) (NN protein) (NNS components))) (, ,) (VP (VBG including) (NP (NN _PROT_) (NN _PROT_)))))))) (, ,) (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN keratins)) (, ,) (NP (NP (NNS members)) (PP (IN of) (NP (NP (DT the) (JJ small) (JJ proline-rich) (NN superfamily)) (, ,) (NP (NN _PROT_))))) (, ,) (CC and) (NP (NP (JJ unknown) (NNS proteins)) (ADJP (JJ related) (PP (TO to) (NP (DT the) (NN _PROT2_) (NN family)))))))))))
-1 #(S1 (S (NP (JJ Subsequent) (NN amino) (NN acid) (NN sequencing)) (VP (VBD revealed) (NP (NP (JJ many) (NNS peptides)) (VP (VBG involving) (NP (NP (NP (NN _PROT_)) (VP (VBN cross-linked) (PP (CC either) (PP (TO to) (NP (PRP itself))) (CC or) (PP (TO to) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ other) (JJ known) (NN CE) (NN protein) (NNS components))) (, ,) (VP (VBG including) (NP (NN _PROT_) (NN _PROT_)))))))) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (NP (NN keratins)) (, ,) (NP (NP (NNS members)) (PP (IN of) (NP (NP (DT the) (JJ small) (JJ proline-rich) (NN superfamily)) (, ,) (NP (NN _PROT2_))))) (, ,) (CC and) (NP (NP (JJ unknown) (NNS proteins)) (ADJP (JJ related) (PP (TO to) (NP (DT the) (NN _PROT_) (NN family)))))))))))
-1 #(S1 (S (NP (JJ Subsequent) (NN amino) (NN acid) (NN sequencing)) (VP (VBD revealed) (NP (NP (JJ many) (NNS peptides)) (VP (VBG involving) (NP (NP (NP (NN _PROT_)) (VP (VBN cross-linked) (PP (CC either) (PP (TO to) (NP (PRP itself))) (CC or) (PP (TO to) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ other) (JJ known) (NN CE) (NN protein) (NNS components))) (, ,) (VP (VBG including) (NP (NN _PROT_) (NN _PROT_)))))))) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (NP (NN keratins)) (, ,) (NP (NP (NNS members)) (PP (IN of) (NP (NP (DT the) (JJ small) (JJ proline-rich) (NN superfamily)) (, ,) (NP (NN _PROT_))))) (, ,) (CC and) (NP (NP (JJ unknown) (NNS proteins)) (ADJP (JJ related) (PP (TO to) (NP (DT the) (NN _PROT2_) (NN family)))))))))))
-1 #(S1 (S (NP (JJ Subsequent) (NN amino) (NN acid) (NN sequencing)) (VP (VBD revealed) (NP (NP (JJ many) (NNS peptides)) (VP (VBG involving) (NP (NP (NP (NN _PROT_)) (VP (VBN cross-linked) (PP (CC either) (PP (TO to) (NP (PRP itself))) (CC or) (PP (TO to) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ other) (JJ known) (NN CE) (NN protein) (NNS components))) (, ,) (VP (VBG including) (NP (NN _PROT_) (NN _PROT_)))))))) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN keratins)) (, ,) (NP (NP (NNS members)) (PP (IN of) (NP (NP (DT the) (JJ small) (JJ proline-rich) (NN superfamily)) (, ,) (NP (NN _PROT1_))))) (, ,) (CC and) (NP (NP (JJ unknown) (NNS proteins)) (ADJP (JJ related) (PP (TO to) (NP (DT the) (NN _PROT2_) (NN family)))))))))))
-1 #(S1 (S (NP (NP (NP (JJ Specific) (NNS glutamines)) (CC or) (NP (NNS lysines))) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBD were) (VP (VBN used) (S (VP (TO to) (VP (VBP cross-link) (NP (NP (DT the) (JJ different) (NNS proteins)) (, ,) (PP (JJ such) (IN as) (NP (NNS glutamines) (CD 495) (CC and) (CD 496)))) (PP (TO to) (NP (NP (NN _PROT2_)) (, ,) (NP (NP (NN glutamine) (NN 288)) (PP (TO to) (NP (NN keratins)))) (, ,) (CC and) (NP (NP (NP (NNS lysines) (QP (CD 468) (, ,) (CD 485) (, ,) (CC and) (CD 508))) (CC and) (NP (NNS glutamines) (QP (CD 465) (CC and) (CD 489)))) (PP (IN for) (NP (NN interchain) (NN _PROT_) (NN cross-links)))))))))))))
-1 #(S1 (S (NP (NP (NP (JJ Specific) (NNS glutamines)) (CC or) (NP (NNS lysines))) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBD were) (VP (VBN used) (S (VP (TO to) (VP (VBP cross-link) (NP (NP (DT the) (JJ different) (NNS proteins)) (, ,) (PP (JJ such) (IN as) (NP (NNS glutamines) (CD 495) (CC and) (CD 496)))) (PP (TO to) (NP (NP (NN _PROT_)) (, ,) (NP (NP (NN glutamine) (NN 288)) (PP (TO to) (NP (NN keratins)))) (, ,) (CC and) (NP (NP (NP (NNS lysines) (QP (CD 468) (, ,) (CD 485) (, ,) (CC and) (CD 508))) (CC and) (NP (NNS glutamines) (QP (CD 465) (CC and) (CD 489)))) (PP (IN for) (NP (NN interchain) (NN _PROT2_) (NN cross-links)))))))))))))
-1 #(S1 (S (NP (NP (NP (JJ Specific) (NNS glutamines)) (CC or) (NP (NNS lysines))) (PP (IN of) (NP (NN _PROT_)))) (VP (VBD were) (VP (VBN used) (S (VP (TO to) (VP (VBP cross-link) (NP (NP (DT the) (JJ different) (NNS proteins)) (, ,) (PP (JJ such) (IN as) (NP (NNS glutamines) (CD 495) (CC and) (CD 496)))) (PP (TO to) (NP (NP (NN _PROT1_)) (, ,) (NP (NP (NN glutamine) (NN 288)) (PP (TO to) (NP (NN keratins)))) (, ,) (CC and) (NP (NP (NP (NNS lysines) (QP (CD 468) (, ,) (CD 485) (, ,) (CC and) (CD 508))) (CC and) (NP (NNS glutamines) (QP (CD 465) (CC and) (CD 489)))) (PP (IN for) (NP (NN interchain) (NN _PROT2_) (NN cross-links)))))))))))))
-1 #(S1 (S (NP (DT The) (NN transmembrane) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_) (NN _PROT2_)) (VP (VBZ interacts) (PP (IN with) (NP (NP (NN _PROT_)) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_)))))))
+1 #(S1 (S (NP (DT The) (NN transmembrane) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_) (NN _PROT_)) (VP (VBZ interacts) (PP (IN with) (NP (NP (NN _PROT2_)) (PRN (-LRB- _PROT2_) (NP (NN _PROT2_)) (-RRB- _PROT2_)))))))
+1 #(S1 (S (NP (DT The) (NN transmembrane) (NN _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT1_)) (VP (VBZ interacts) (PP (IN with) (NP (NP (NN _PROT2_)) (PRN (-LRB- _PROT2_) (NP (NN _PROT2_)) (-RRB- _PROT2_)))))))
-1 #(S1 (S (NP (NP (DT The) (JJ _PROT1_) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_) (NN _PROT2_)) (, ,) (VP (ADVP (RB also)) (VBN known) (PP (IN as) (NP (NN _PROT_)))) (, ,)) (VP (VBZ is) (VP (VBN expressed) (ADVP (RB predominantly)) (PP (PP (IN in) (NP (JJ epithelial) (NNS cells))) (, ,) (PP (IN in) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NN tumor) (NN cell) (NNS lines))))) (, ,) (CC and) (PP (IN in) (NP (NNS lymphocytes))))))))
-1 #(S1 (S (NP (NP (DT The) (JJ _PROT1_) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_) (NN _PROT_)) (, ,) (VP (ADVP (RB also)) (VBN known) (PP (IN as) (NP (NN _PROT2_)))) (, ,)) (VP (VBZ is) (VP (VBN expressed) (ADVP (RB predominantly)) (PP (PP (IN in) (NP (JJ epithelial) (NNS cells))) (, ,) (PP (IN in) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NN tumor) (NN cell) (NNS lines))))) (, ,) (CC and) (PP (IN in) (NP (NNS lymphocytes))))))))
-1 #(S1 (S (NP (NP (DT The) (JJ _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT1_)) (, ,) (VP (ADVP (RB also)) (VBN known) (PP (IN as) (NP (NN _PROT2_)))) (, ,)) (VP (VBZ is) (VP (VBN expressed) (ADVP (RB predominantly)) (PP (PP (IN in) (NP (JJ epithelial) (NNS cells))) (, ,) (PP (IN in) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NN tumor) (NN cell) (NNS lines))))) (, ,) (CC and) (PP (IN in) (NP (NNS lymphocytes))))))))
+1 #(S1 (S (NP (NN _PROT1_)) (ADVP (RB also)) (VP (VBD interacted) (PP (IN with) (NP (NP (JJ other) (NNS members)) (PP (IN of) (NP (DT the) (NN catenin) (NN gene) (NN family))) (PP (VBG including) (NP (NP (NN _PROT2_)) (CC and) (NP (NN gamma-catenin)))))))))
-1 #(S1 (S (NP (NP (DT The) (NN interaction)) (PP (IN with) (NP (NP (NN _PROT1_)) (PRN (-LRB- _PROT1_) (NP (NN _PROT1_)) (-RRB- _PROT1_))))) (VP (VBZ is) (ADJP (JJ likely) (S (VP (TO to) (VP (VB be) (ADJP (JJ direct)))))) (, ,) (SBAR (IN as) (S (NP (DT the) (NN interaction)) (VP (VBZ occurs) (PP (IN in) (NP (NP (NN K562) (NNS cells)) (VP (VBG lacking) (NP (NP (JJ functional) (JJ adherens) (NNS junctions)) (CC and) (NP (NN _PROT2_) (NN expression))))))))))))
-1 #(S1 (S (NP (NP (JJ Catalytic) (NNS domains)) (PP (IN of) (NP (DT the) (NN tyrosine) (NNS phosphatases) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (NN PTPbeta)))))) (VP (VBD did) (RB not) (VP (VB interact) (PP (IN with) (NP (NP (NNS proteins)) (PP (IN of) (NP (NP (DT the) (NN catenin) (NN family)) (PP (TO to) (NP (JJ detectable) (NNS levels)))))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (DT these) (NNS proteins)))) (VP (VBZ is) (VP (JJ specific))))))))))
-1 #(S1 (S (NP (NP (JJ Catalytic) (NNS domains)) (PP (IN of) (NP (DT the) (NN tyrosine) (NNS phosphatases) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN PTPbeta)))))) (VP (VBD did) (RB not) (VP (VB interact) (PP (IN with) (NP (NP (NNS proteins)) (PP (IN of) (NP (NP (DT the) (NN catenin) (NN family)) (PP (TO to) (NP (JJ detectable) (NNS levels)))))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (NN _PROT2_))) (PP (IN with) (NP (DT these) (NNS proteins)))) (VP (VBZ is) (VP (JJ specific))))))))))
-1 #(S1 (S (NP (NP (JJ Catalytic) (NNS domains)) (PP (IN of) (NP (DT the) (NN tyrosine) (NNS phosphatases) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (CC and) (NP (NN PTPbeta)))))) (VP (VBD did) (RB not) (VP (VB interact) (PP (IN with) (NP (NP (NNS proteins)) (PP (IN of) (NP (NP (DT the) (NN catenin) (NN family)) (PP (TO to) (NP (JJ detectable) (NNS levels)))))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (NN _PROT2_))) (PP (IN with) (NP (DT these) (NNS proteins)))) (VP (VBZ is) (VP (JJ specific))))))))))
-1 #(S1 (S (NP (NP (NN _PROT1_AND_PROT2_) (PRN (-LRB- -LRB-) (NP (`` ') (NN _PROT_) ('' ')) (-RRB- -RRB-)) (JJ -binding) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN CBP)) (-RRB- -RRB-))) (VP (VBZ modulates) (NP (NP (NN co-operation)) (PP (IN between) (NP (NP (NP (JJ myocyte) (NN enhancer) (NN factor) (NN 2A)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NN thyroid) (NN hormone) (JJ receptor-retinoid) (NN X) (NN receptor))))))))
-1 #(S1 (S (NP (NP (NN _PROT1_) (PRN (-LRB- -LRB-) (NP (`` ') (NN _PROT2_) ('' ')) (-RRB- -RRB-)) (JJ -binding) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN CBP)) (-RRB- -RRB-))) (VP (VBZ modulates) (NP (NP (NN co-operation)) (PP (IN between) (NP (NP (NP (JJ myocyte) (NN enhancer) (NN factor) (NN 2A)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NN thyroid) (NN hormone) (JJ receptor-retinoid) (NN X) (NN receptor))))))))
+1 #(S1 (S (NP (NP (NN _PROT1_) (PRN (-LRB- -LRB-) (NP (`` ') (NN _PROT_) ('' ')) (-RRB- -RRB-)) (JJ -binding) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN CBP)) (-RRB- -RRB-))) (VP (VBZ modulates) (NP (NP (NN co-operation)) (PP (IN between) (NP (NP (NP (JJ myocyte) (NN enhancer) (NN factor) (NN 2A)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (CC and) (NP (NN thyroid) (NN hormone) (JJ receptor-retinoid) (NN X) (NN receptor))))))))
-1 #(S1 (S (NP (NP (NN _PROT1_) (PRN (-LRB- -LRB-) (NP (`` ') (NN _PROT2_) ('' ')) (-RRB- -RRB-)) (JJ -binding) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN CBP)) (-RRB- -RRB-))) (VP (VBZ modulates) (NP (NP (NN co-operation)) (PP (IN between) (NP (NP (NP (JJ myocyte) (NN enhancer) (NN factor) (NN 2A)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NN thyroid) (NN hormone) (JJ receptor-retinoid) (NN X) (NN receptor))))))))
+1 #(S1 (S (NP (NP (NN _PROT1_) (PRN (-LRB- -LRB-) (NP (`` ') (NN _PROT_) ('' ')) (-RRB- -RRB-)) (JJ -binding) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN CBP)) (-RRB- -RRB-))) (VP (VBZ modulates) (NP (NP (NN co-operation)) (PP (IN between) (NP (NP (NP (JJ myocyte) (NN enhancer) (NN factor) (NN 2A)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (CC and) (NP (NN thyroid) (NN hormone) (JJ receptor-retinoid) (NN X) (NN receptor))))))))
+1 #(S1 (S (NP (NP (NN _PROT_) (PRN (-LRB- -LRB-) (NP (`` ') (NN _PROT1_) ('' ')) (-RRB- -RRB-)) (JJ -binding) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN CBP)) (-RRB- -RRB-))) (VP (VBZ modulates) (NP (NP (NN co-operation)) (PP (IN between) (NP (NP (NP (JJ myocyte) (NN enhancer) (NN factor) (NN 2A)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (CC and) (NP (NN thyroid) (NN hormone) (JJ receptor-retinoid) (NN X) (NN receptor))))))))
-1 #(S1 (S (NP (NP (NP (NN _PROT1_AND_PROT2_) (PRN (-LRB- -LRB-) (NP (`` ') (NN _PROT_) ('' ')) (-RRB- -RRB-)) (JJ -binding) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN CBP)) (-RRB- -RRB-))) (VP (VBG interacting) (PP (IN with) (NP (NN transcription) (NNS factors))))) (VP (VBZ is) (ADJP (JJ able) (S (VP (TO to) (VP (VB increase) (NP (NP (PRP$ their) (NN activity)) (PP (IN on) (NP (NN target) (NN gene) (NNS promoters)))))))))))
-1 #(S1 (S (NP (NP (NP (NN _PROT1_) (PRN (-LRB- -LRB-) (NP (`` ') (NN _PROT2_) ('' ')) (-RRB- -RRB-)) (JJ -binding) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN CBP)) (-RRB- -RRB-))) (VP (VBG interacting) (PP (IN with) (NP (NN transcription) (NNS factors))))) (VP (VBZ is) (ADJP (JJ able) (S (VP (TO to) (VP (VB increase) (NP (NP (PRP$ their) (NN activity)) (PP (IN on) (NP (NN target) (NN gene) (NNS promoters)))))))))))
-1 #(S1 (S (NP (NP (NP (NN _PROT1_) (PRN (-LRB- -LRB-) (NP (`` ') (NN _PROT2_) ('' ')) (-RRB- -RRB-)) (JJ -binding) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN CBP)) (-RRB- -RRB-))) (VP (VBG interacting) (PP (IN with) (NP (NN transcription) (NNS factors))))) (VP (VBZ is) (ADJP (JJ able) (S (VP (TO to) (VP (VB increase) (NP (NP (PRP$ their) (NN activity)) (PP (IN on) (NP (NN target) (NN gene) (NNS promoters)))))))))))
+1 #(S1 (S (NP (PRP$ Our) (NNS findings)) (VP (VBD showed) (SBAR (IN that) (S (S (NP (NP (DT the) (JJ same) (JJ C-terminal) (NN portion)) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBZ binds) (NP (NP (DT the) (JJ N-terminal) (NNS domains)) (PP (IN of) (NP (CC both) (NP (NN TR)) (CC and) (NP (NN _PROT2_))))))) (, ,) (CC and) (S (NP (PRP$ our) (ADJP (FW in) (FW vivo)) (NNS studies)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (NN TR)) (, ,) (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))) (VP (VBP form) (NP (DT a) (JJ ternary) (NN complex))))))))))))
-1 #(S1 (S (NP (PRP$ Our) (NNS findings)) (VP (VBD showed) (SBAR (IN that) (S (S (NP (NP (DT the) (JJ same) (JJ C-terminal) (NN portion)) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBZ binds) (NP (NP (DT the) (JJ N-terminal) (NNS domains)) (PP (IN of) (NP (CC both) (NP (NN TR)) (CC and) (NP (NN _PROT_))))))) (, ,) (CC and) (S (NP (PRP$ our) (ADJP (FW in) (FW vivo)) (NNS studies)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (NN TR)) (, ,) (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))) (VP (VBP form) (NP (DT a) (JJ ternary) (NN complex))))))))))))
-1 #(S1 (S (NP (PRP$ Our) (NNS findings)) (VP (VBD showed) (SBAR (IN that) (S (S (NP (NP (DT the) (JJ same) (JJ C-terminal) (NN portion)) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBZ binds) (NP (NP (DT the) (JJ N-terminal) (NNS domains)) (PP (IN of) (NP (CC both) (NP (NN TR)) (CC and) (NP (NN _PROT_))))))) (, ,) (CC and) (S (NP (PRP$ our) (ADJP (FW in) (FW vivo)) (NNS studies)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (NN TR)) (, ,) (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))) (VP (VBP form) (NP (DT a) (JJ ternary) (NN complex))))))))))))
-1 #(S1 (S (NP (PRP$ Our) (NNS findings)) (VP (VBD showed) (SBAR (IN that) (S (S (NP (NP (DT the) (JJ same) (JJ C-terminal) (NN portion)) (PP (IN of) (NP (NN _PROT_)))) (VP (VBZ binds) (NP (NP (DT the) (JJ N-terminal) (NNS domains)) (PP (IN of) (NP (CC both) (NP (NN TR)) (CC and) (NP (NN _PROT1_))))))) (, ,) (CC and) (S (NP (PRP$ our) (ADJP (FW in) (FW vivo)) (NNS studies)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (NN TR)) (, ,) (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))) (VP (VBP form) (NP (DT a) (JJ ternary) (NN complex))))))))))))
-1 #(S1 (S (NP (PRP$ Our) (NNS findings)) (VP (VBD showed) (SBAR (IN that) (S (S (NP (NP (DT the) (JJ same) (JJ C-terminal) (NN portion)) (PP (IN of) (NP (NN _PROT_)))) (VP (VBZ binds) (NP (NP (DT the) (JJ N-terminal) (NNS domains)) (PP (IN of) (NP (CC both) (NP (NN TR)) (CC and) (NP (NN _PROT1_))))))) (, ,) (CC and) (S (NP (PRP$ our) (ADJP (FW in) (FW vivo)) (NNS studies)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (NN TR)) (, ,) (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))) (VP (VBP form) (NP (DT a) (JJ ternary) (NN complex))))))))))))
+1 #(S1 (S (NP (PRP$ Our) (NNS findings)) (VP (VBD showed) (SBAR (IN that) (S (S (NP (NP (DT the) (JJ same) (JJ C-terminal) (NN portion)) (PP (IN of) (NP (NN _PROT_)))) (VP (VBZ binds) (NP (NP (DT the) (JJ N-terminal) (NNS domains)) (PP (IN of) (NP (CC both) (NP (NN TR)) (CC and) (NP (NN _PROT_))))))) (, ,) (CC and) (S (NP (PRP$ our) (ADJP (FW in) (FW vivo)) (NNS studies)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (NN TR)) (, ,) (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (VP (VBP form) (NP (DT a) (JJ ternary) (NN complex))))))))))))
+1 #(S1 (S (NP (DT The) (JJ human) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (NNS proteins)) (VP (VBP form) (NP (NP (DT a) (JJ ternary) (NN complex)) (PP (IN with) (NP (NN hMpp10))) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB only)) (VP (VBZ interacts) (PP (IN with) (NP (NP (DT the) (NN U3) (NN _PROT_)) (PP (IN in) (NP (NN 60-80S) (NN ribonucleoprotein) (NNS complexes))))))))))))
+1 #(S1 (S (NP (DT The) (JJ human) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))) (NNS proteins)) (VP (VBP form) (NP (NP (DT a) (JJ ternary) (NN complex)) (PP (IN with) (NP (NN hMpp10))) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB only)) (VP (VBZ interacts) (PP (IN with) (NP (NP (DT the) (NN U3) (NN _PROT2_)) (PP (IN in) (NP (NN 60-80S) (NN ribonucleoprotein) (NNS complexes))))))))))))
+1 #(S1 (S (NP (DT The) (JJ human) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))) (NNS proteins)) (VP (VBP form) (NP (NP (DT a) (JJ ternary) (NN complex)) (PP (IN with) (NP (NN hMpp10))) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB only)) (VP (VBZ interacts) (PP (IN with) (NP (NP (DT the) (NN U3) (NN _PROT2_)) (PP (IN in) (NP (NN 60-80S) (NN ribonucleoprotein) (NNS complexes))))))))))))
-1 #(S1 (S (NP (PRP We)) (VP (VBP have) (VP (VBN cloned) (NP (NP (NNS cDNAs)) (VP (VBG encoding) (NP (NP (DT the) (JJ human) (CC and) (NN mouse) (NNS homologs)) (PP (IN of) (NP (DT the) (NN yeast) (NN U3) (JJ snoRNP-associated) (NNS proteins) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))))))))))))
-1 #(S1 (S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (NN complementation) (NNS experiments)))) (VP (VBP show) (SBAR (IN that) (S (, ,) (PP (IN in) (NN contrast) (TO to) (NP (NN mouse) (NN _PROT1_))) (, ,) (NP (NN mouse) (NN _PROT2_)) (VP (MD can) (ADVP (RB partially)) (VP (VB alleviate) (NP (NP (DT the) (NN growth) (NN defect)) (PP (IN of) (NP (DT the) (JJ corresponding) (NN yeast) (NN null) (NN strain)))))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN _PROT_))) (PP (IN in) (NP (NN pre-rRNA) (NN processing)))) (VP (VBZ is) (ADVP (RB evolutionarily)) (VP (VBN conserved))))))))))
-1 #(S1 (S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (NN complementation) (NNS experiments)))) (VP (VBP show) (SBAR (IN that) (S (, ,) (PP (IN in) (NN contrast) (TO to) (NP (NN mouse) (NN _PROT1_))) (, ,) (NP (NN mouse) (NN _PROT_)) (VP (MD can) (ADVP (RB partially)) (VP (VB alleviate) (NP (NP (DT the) (NN growth) (NN defect)) (PP (IN of) (NP (DT the) (JJ corresponding) (NN yeast) (NN null) (NN strain)))))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN _PROT2_))) (PP (IN in) (NP (NN pre-rRNA) (NN processing)))) (VP (VBZ is) (ADVP (RB evolutionarily)) (VP (VBN conserved))))))))))
-1 #(S1 (S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (NN complementation) (NNS experiments)))) (VP (VBP show) (SBAR (IN that) (S (, ,) (PP (IN in) (NN contrast) (TO to) (NP (NN mouse) (NN _PROT_))) (, ,) (NP (NN mouse) (NN _PROT1_)) (VP (MD can) (ADVP (RB partially)) (VP (VB alleviate) (NP (NP (DT the) (NN growth) (NN defect)) (PP (IN of) (NP (DT the) (JJ corresponding) (NN yeast) (NN null) (NN strain)))))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN _PROT2_))) (PP (IN in) (NP (NN pre-rRNA) (NN processing)))) (VP (VBZ is) (ADVP (RB evolutionarily)) (VP (VBN conserved))))))))))
-1 #(S1 (S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (NP (NN density) (NN gradient) (NN centrifugation)) (NNS experiments)))) (VP (VBP show) (SBAR (IN that) (S (, ,) (PP (IN in) (NN contrast) (TO to) (NP (NN hU3-55K))) (, ,) (NP (DT the) (JJ human) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (NNS proteins)) (ADVP (RB predominantly)) (VP (VBP interact) (PP (IN with) (NP (NP (DT the) (NN U3) (NN _PROT_)) (PP (IN in) (NP (NN 60-80S) (NN ribonucleoprotein) (NNS complexes)))))))))))
+1 #(S1 (S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (NP (NN density) (NN gradient) (NN centrifugation)) (NNS experiments)))) (VP (VBP show) (SBAR (IN that) (S (, ,) (PP (IN in) (NN contrast) (TO to) (NP (NN hU3-55K))) (, ,) (NP (DT the) (JJ human) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))) (NNS proteins)) (ADVP (RB predominantly)) (VP (VBP interact) (PP (IN with) (NP (NP (DT the) (NN U3) (NN _PROT2_)) (PP (IN in) (NP (NN 60-80S) (NN ribonucleoprotein) (NNS complexes)))))))))))
+1 #(S1 (S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (NP (NN density) (NN gradient) (NN centrifugation)) (NNS experiments)))) (VP (VBP show) (SBAR (IN that) (S (, ,) (PP (IN in) (NN contrast) (TO to) (NP (NN hU3-55K))) (, ,) (NP (DT the) (JJ human) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))) (NNS proteins)) (ADVP (RB predominantly)) (VP (VBP interact) (PP (IN with) (NP (NP (DT the) (NN U3) (NN _PROT2_)) (PP (IN in) (NP (NN 60-80S) (NN ribonucleoprotein) (NNS complexes)))))))))))
+1 #(S1 (S (NP (NP (JJ Transient) (NN expression)) (PP (IN of) (NP (DT the) (JJ full-length) (NN _PROT1_))) (PP (IN without) (NP (NNS RSRS))) (PP (IN in) (NP (NN U1240MG) (NN glioblastoma) (NNS cells)))) (VP (VBD resulted) (PP (IN in) (NP (NP (NN repression)) (PP (IN of) (NP (JJ _PROT2_) (NN promoter) (NN activity))))))))
+1 #(S1 (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (JJ relative) (NN abundance)) (PP (IN of) (NP (NP (DT the) (CD two) (NN splice) (NNS variants)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN in) (NP (NN brain)))))) (VP (MD could) (VP (VB be) (NP (NP (DT an) (JJ important) (NN determinant)) (PP (IN for) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN _PROT2_)))))))))))))
-1 #(S1 (S (NP (PRP We)) (VP (VBD tested) (NP (DT this) (NN point)) (PP (IN by) (S (VP (VBG cotransfecting) (NP (NN CHO) (NNS cells)) (PP (IN with) (NP (NP (DT the) (NNS genes)) (VP (VBG encoding) (NP (NP (NP (NN F) (NN beta) (NN alpha)) (CC and) (NP (DT the) (NN _PROT1_) (NN _PROT1_) (NN subunit))) (CC or) (NP (DT the) (NP (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)) (CC and) (NP (NN _PROT_) (NN _PROT_)) (NP (NN monomer)))))))))))))
-1 #(S1 (S (NP (PRP We)) (VP (VBD tested) (NP (DT this) (NN point)) (PP (IN by) (S (VP (VBG cotransfecting) (NP (NN CHO) (NNS cells)) (PP (IN with) (NP (NP (DT the) (NNS genes)) (VP (VBG encoding) (NP (NP (NP (NN F) (NN beta) (NN alpha)) (CC and) (NP (DT the) (NN _PROT1_) (NN _PROT1_) (NN subunit))) (CC or) (NP (DT the) (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (CC and) (NP (NN _PROT2_) (NN _PROT2_)) (NP (NN monomer)))))))))))))
-1 #(S1 (S (NP (PRP We)) (VP (VBD tested) (NP (DT this) (NN point)) (PP (IN by) (S (VP (VBG cotransfecting) (NP (NN CHO) (NNS cells)) (PP (IN with) (NP (NP (DT the) (NNS genes)) (VP (VBG encoding) (NP (NP (NP (NN F) (NN beta) (NN alpha)) (CC and) (NP (DT the) (NN _PROT_) (NN _PROT_) (NN subunit))) (CC or) (NP (DT the) (NP (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (CC and) (NP (NN _PROT2_) (NN _PROT2_)) (NP (NN monomer)))))))))))))
-1 #(S1 (S (NP (NP (DT The) (NN formation)) (PP (IN of) (NP (DT a) (JJ functional) (JJ single) (NN chain/subunit) (NN complex)))) (VP (VBD was) (RB not) (ADJP (JJ restricted) (PP (TO to) (NP (DT the) (NN FSH) (JJ single) (NN _PROT1_) (NN _PROT1_) (NN subunit)))) (SBAR (IN since) (S (NP (NN CG) (JJ single) (NN chain)) (VP (VP (VBZ interacts) (PP (IN with) (NP (DT the) (JJ monomeric) (NN _PROT2_) (NN _PROT2_) (NN subunit)))) (CC and) (VP (VBZ exhibits) (NP (NN FSH) (NN activity)))))))))
-1 #(S1 (S (NP (DT This)) (VP (VBZ is) (ADJP (JJ relevant) (PP (IN for) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NP (NN LH)) (CC and) (NP (NN FSH))))))) (, ,) (SBAR (IN because) (S (S (NP (DT both)) (VP (VBP are) (VP (VBN synthesized) (PP (IN in) (NP (NP (DT the) (JJ same) (NN cell)) (-LRB- -LRB-) (PP (FW i.e.) (, ,) (NP (JJ pituitary) (NN gonadotrophs))) (-RRB- -RRB-)))))) (CC and) (S (NP (NP (JJ several)) (PP (IN of) (NP (NP (DT the) (NN alpha) (NN subunit) (NNS sequences)) (VP (VBN required) (PP (IN for) (NP (NP (NN association)) (PP (IN with) (NP (CC either) (DT the) (NP (NP (NN _PROT1_) (NN _PROT1_)) (CC or) (NP (NN _PROT2_) (NN _PROT2_))) (NNS subunits))))))))) (VP (VBP are) (JJ different))))))))
-1 #(S1 (S (ADVP (RB Previously)) (, ,) (NP (PRP we)) (VP (VBD showed) (SBAR (IN that) (S (NP (DT the) (NP (NP (NN _PROT1_) (NN _PROT1_)) (CC or) (NP (NN _PROT2_) (NN _PROT2_))) (NN subunit) (NNS genes)) (VP (MD can) (VP (VB be) (VP (ADVP (RB genetically)) (VBN fused) (PP (TO to) (NP (DT the) (NN alpha) (NN gene))) (S (VP (TO to) (VP (VB produce) (NP (NP (ADJP (RB biologically) (JJ active)) (JJ single) (NNS chains)) (, ,) (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (CC and) (NP (NN F) (NN beta) (NN alpha)))) (, ,) (ADVP (RB respectively)))))))))))))
-1 #(S1 (S (ADVP (RB Previously)) (, ,) (NP (PRP we)) (VP (VBD showed) (SBAR (IN that) (S (NP (DT the) (NP (NP (NN _PROT1_) (NN _PROT1_)) (CC or) (NP (NN _PROT_) (NN _PROT_))) (NN subunit) (NNS genes)) (VP (MD can) (VP (VB be) (VP (ADVP (RB genetically)) (VBN fused) (PP (TO to) (NP (DT the) (NN alpha) (NN gene))) (S (VP (TO to) (VP (VB produce) (NP (NP (ADJP (RB biologically) (JJ active)) (JJ single) (NNS chains)) (, ,) (NP (NP (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)) (CC and) (NP (NN F) (NN beta) (NN alpha)))) (, ,) (ADVP (RB respectively)))))))))))))
-1 #(S1 (S (ADVP (RB Previously)) (, ,) (NP (PRP we)) (VP (VBD showed) (SBAR (IN that) (S (NP (DT the) (NP (NP (NN _PROT_) (NN _PROT_)) (CC or) (NP (NN _PROT1_) (NN _PROT1_))) (NN subunit) (NNS genes)) (VP (MD can) (VP (VB be) (VP (ADVP (RB genetically)) (VBN fused) (PP (TO to) (NP (DT the) (NN alpha) (NN gene))) (S (VP (TO to) (VP (VB produce) (NP (NP (ADJP (RB biologically) (JJ active)) (JJ single) (NNS chains)) (, ,) (NP (NP (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)) (CC and) (NP (NN F) (NN beta) (NN alpha)))) (, ,) (ADVP (RB respectively)))))))))))))
+1 #(S1 (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (PRP we)) (VP (VBD observed) (NP (NP (NN evidence)) (PP (IN of) (NP (NP (NN cross-talk)) (PP (IN between) (NP (NP (DT the) (JJ cannabinoid) (NN receptor) (NN _PROT1_)) (CC and) (NP (NP (DT the) (NN _PROT2_) (CD _PROT2_) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))))))) (S (VP (VBG using) (NP (DT a) (JJ heterologous) (NN system)))))))
+1 #(S1 (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (PRP we)) (VP (VBD observed) (NP (NP (NN evidence)) (PP (IN of) (NP (NP (NN cross-talk)) (PP (IN between) (NP (NP (DT the) (JJ cannabinoid) (NN receptor) (NN _PROT1_)) (CC and) (NP (NP (DT the) (NN _PROT_) (CD _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))))))) (S (VP (VBG using) (NP (DT a) (JJ heterologous) (NN system)))))))
-1 #(S1 (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (PRP we)) (VP (VBD observed) (NP (NP (NN evidence)) (PP (IN of) (NP (NP (NN cross-talk)) (PP (IN between) (NP (NP (DT the) (JJ cannabinoid) (NN receptor) (NN _PROT_)) (CC and) (NP (NP (DT the) (NN _PROT1_) (CD _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))))))) (S (VP (VBG using) (NP (DT a) (JJ heterologous) (NN system)))))))
-1 #(S1 (S (PP (IN In) (NN contrast) (TO to) (NP (NN _PROT1_))) (, ,) (NP (NP (DT the) (NN potency)) (PP (IN of) (NP (NP (JJ direct) (NN activation)) (PP (IN of) (NP (NN _PROT2_)))))) (VP (VBD was) (RB not) (VP (VBN affected) (PP (IN by) (NP (NP (NN co-expression)) (PP (IN with) (NP (NN _PROT_)))))))))
-1 #(S1 (S (PP (IN In) (NN contrast) (TO to) (NP (NN _PROT1_))) (, ,) (NP (NP (DT the) (NN potency)) (PP (IN of) (NP (NP (JJ direct) (NN activation)) (PP (IN of) (NP (NN _PROT_)))))) (VP (VBD was) (RB not) (VP (VBN affected) (PP (IN by) (NP (NP (NN co-expression)) (PP (IN with) (NP (NN _PROT2_)))))))))
-1 #(S1 (S (PP (IN In) (NN contrast) (TO to) (NP (NN _PROT_))) (, ,) (NP (NP (DT the) (NN potency)) (PP (IN of) (NP (NP (JJ direct) (NN activation)) (PP (IN of) (NP (NN _PROT1_)))))) (VP (VBD was) (RB not) (VP (VBN affected) (PP (IN by) (NP (NP (NN co-expression)) (PP (IN with) (NP (NN _PROT2_)))))))))
-1 #(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NN electron) (NN microscopy) (NNS experiments)) (VP (VBD revealed) (SBAR (IN that) (S (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (VP (VBP are) (ADJP (RB closely) (JJ apposed)) (PP (IN at) (NP (DT the) (NN plasma) (NN membrane) (NN level)))))))) (: ;) (S (NP (PRP they)) (VP (VBP are) (ADJP (JJ close) (S (ADVP (RB enough)) (VP (TO to) (VP (VB form) (NP (NNS hetero-oligomers))))))))))
-1 #(S1 (S (NP (NP (NN _PROT1_)) (, ,) (NP (NP (DT a) (NN Rho) (NN family) (NN _PROT2_) (NN _PROT2_)) (SBAR (WHNP (WDT that)) (S (VP (VBZ interacts) (PP (IN with) (NP (NN signaling) (NNS adapters) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))))))))))
+1 #(S1 (S (NP (NP (NN _PROT1_)) (, ,) (NP (NP (DT a) (NN Rho) (NN family) (NN _PROT_) (NN _PROT_)) (SBAR (WHNP (WDT that)) (S (VP (VBZ interacts) (PP (IN with) (NP (NN signaling) (NNS adapters) (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))))))))))))
+1 #(S1 (S (NP (NP (NN _PROT1_)) (, ,) (NP (NP (DT a) (NN Rho) (NN family) (NN _PROT_) (NN _PROT_)) (SBAR (WHNP (WDT that)) (S (VP (VBZ interacts) (PP (IN with) (NP (NN signaling) (NNS adapters) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))))))))))))
+1 #(S1 (S (NP (NP (NN _PROT_)) (, ,) (NP (NP (DT a) (NN Rho) (NN family) (NN _PROT1_) (NN _PROT1_)) (SBAR (WHNP (WDT that)) (S (VP (VBZ interacts) (PP (IN with) (NP (NN signaling) (NNS adapters) (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))))))))))))
+1 #(S1 (S (NP (NP (NN _PROT_)) (, ,) (NP (NP (DT a) (NN Rho) (NN family) (NN _PROT1_) (NN _PROT1_)) (SBAR (WHNP (WDT that)) (S (VP (VBZ interacts) (PP (IN with) (NP (NN signaling) (NNS adapters) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))))))))))))
-1 #(S1 (S (NP (NP (NN _PROT_)) (, ,) (NP (NP (DT a) (NN Rho) (NN family) (NN _PROT_) (NN _PROT_)) (SBAR (WHNP (WDT that)) (S (VP (VBZ interacts) (PP (IN with) (NP (NN signaling) (NNS adapters) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))))))))))))
-1 #(S1 (S (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (VP (VP (VBP are) (NP (NP (JJ scaffolding) (NNS proteins)) (VP (VBG acting) (ADVP (RB downstream) (PP (IN of) (NP (NN cell) (NN surface) (NNS receptors))))))) (CC and) (VP (VBP interact) (PP (IN with) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NP (JJ cytoplasmic) (NN signaling) (NNS proteins)) (PP (JJ such) (IN as) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_) (NN _PROT_)) (, ,) (NP (NN Shc)) (, ,) (CC and) (NP (NN Crk))))))))))))
+1 #(S1 (S (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))) (VP (VP (VBP are) (NP (NP (JJ scaffolding) (NNS proteins)) (VP (VBG acting) (ADVP (RB downstream) (PP (IN of) (NP (NN cell) (NN surface) (NNS receptors))))))) (CC and) (VP (VBP interact) (PP (IN with) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NP (JJ cytoplasmic) (NN signaling) (NNS proteins)) (PP (JJ such) (IN as) (NP (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_) (NN _PROT_)) (, ,) (NP (NN Shc)) (, ,) (CC and) (NP (NN Crk))))))))))))
+1 #(S1 (S (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))) (VP (VP (VBP are) (NP (NP (JJ scaffolding) (NNS proteins)) (VP (VBG acting) (ADVP (RB downstream) (PP (IN of) (NP (NN cell) (NN surface) (NNS receptors))))))) (CC and) (VP (VBP interact) (PP (IN with) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NP (JJ cytoplasmic) (NN signaling) (NNS proteins)) (PP (JJ such) (IN as) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_) (NN _PROT_)) (, ,) (NP (NN Shc)) (, ,) (CC and) (NP (NN Crk))))))))))))
+1 #(S1 (S (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))) (VP (VP (VBP are) (NP (NP (JJ scaffolding) (NNS proteins)) (VP (VBG acting) (ADVP (RB downstream) (PP (IN of) (NP (NN cell) (NN surface) (NNS receptors))))))) (CC and) (VP (VBP interact) (PP (IN with) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NP (JJ cytoplasmic) (NN signaling) (NNS proteins)) (PP (JJ such) (IN as) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_) (NN _PROT2_)) (, ,) (NP (NN Shc)) (, ,) (CC and) (NP (NN Crk))))))))))))
+1 #(S1 (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))) (VP (VP (VBP are) (NP (NP (JJ scaffolding) (NNS proteins)) (VP (VBG acting) (ADVP (RB downstream) (PP (IN of) (NP (NN cell) (NN surface) (NNS receptors))))))) (CC and) (VP (VBP interact) (PP (IN with) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NP (JJ cytoplasmic) (NN signaling) (NNS proteins)) (PP (JJ such) (IN as) (NP (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_) (NN _PROT_)) (, ,) (NP (NN Shc)) (, ,) (CC and) (NP (NN Crk))))))))))))
+1 #(S1 (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))) (VP (VP (VBP are) (NP (NP (JJ scaffolding) (NNS proteins)) (VP (VBG acting) (ADVP (RB downstream) (PP (IN of) (NP (NN cell) (NN surface) (NNS receptors))))))) (CC and) (VP (VBP interact) (PP (IN with) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NP (JJ cytoplasmic) (NN signaling) (NNS proteins)) (PP (JJ such) (IN as) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_) (NN _PROT_)) (, ,) (NP (NN Shc)) (, ,) (CC and) (NP (NN Crk))))))))))))
+1 #(S1 (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))) (VP (VP (VBP are) (NP (NP (JJ scaffolding) (NNS proteins)) (VP (VBG acting) (ADVP (RB downstream) (PP (IN of) (NP (NN cell) (NN surface) (NNS receptors))))))) (CC and) (VP (VBP interact) (PP (IN with) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NP (JJ cytoplasmic) (NN signaling) (NNS proteins)) (PP (JJ such) (IN as) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_) (NN _PROT2_)) (, ,) (NP (NN Shc)) (, ,) (CC and) (NP (NN Crk))))))))))))
-1 #(S1 (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))) (VP (VP (VBP are) (NP (NP (JJ scaffolding) (NNS proteins)) (VP (VBG acting) (ADVP (RB downstream) (PP (IN of) (NP (NN cell) (NN surface) (NNS receptors))))))) (CC and) (VP (VBP interact) (PP (IN with) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NP (JJ cytoplasmic) (NN signaling) (NNS proteins)) (PP (JJ such) (IN as) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_) (NN _PROT_)) (, ,) (NP (NN Shc)) (, ,) (CC and) (NP (NN Crk))))))))))))
-1 #(S1 (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))) (VP (VP (VBP are) (NP (NP (JJ scaffolding) (NNS proteins)) (VP (VBG acting) (ADVP (RB downstream) (PP (IN of) (NP (NN cell) (NN surface) (NNS receptors))))))) (CC and) (VP (VBP interact) (PP (IN with) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NP (JJ cytoplasmic) (NN signaling) (NNS proteins)) (PP (JJ such) (IN as) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_) (NN _PROT2_)) (, ,) (NP (NN Shc)) (, ,) (CC and) (NP (NN Crk))))))))))))
-1 #(S1 (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))) (VP (VP (VBP are) (NP (NP (JJ scaffolding) (NNS proteins)) (VP (VBG acting) (ADVP (RB downstream) (PP (IN of) (NP (NN cell) (NN surface) (NNS receptors))))))) (CC and) (VP (VBP interact) (PP (IN with) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NP (JJ cytoplasmic) (NN signaling) (NNS proteins)) (PP (JJ such) (IN as) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (NP (NN _PROT2_) (NN _PROT2_)) (, ,) (NP (NN Shc)) (, ,) (CC and) (NP (NN Crk))))))))))))
+1 #(S1 (S (PP (IN In) (NP (NN addition))) (, ,) (S (S (NP (NN _PROT1_)) (VP (VBZ contains) (NP (JJ several) (JJ classic) (JJ proline-rich) (NNS motifs)))) (, ,) (CC and) (S (NP (PRP it)) (VP (VBZ interacts) (PP (IN with) (NP (NP (DT the) (JJ first) (NN SH3) (NN domain)) (PP (IN of) (NP (NP (NN Crk)) (CC and) (NP (JJ full-length) (NN _PROT2_)))))) (ADVP (FW in) (FW vitro)))))))
-1 #(S1 (S (NP (PRP We)) (VP (VBP propose) (SBAR (IN that) (S (NP (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (PP (IN in) (NP (NP (NN cooperation)) (PP (IN with) (NP (JJ other) (NN adapter) (NNS molecules)))))) (VP (MD might) (VP (VB regulate) (NP (NP (DT the) (JJ cellular) (NN localization)) (PP (IN of) (NP (NN _PROT_))) (PP (IN under) (NP (JJ specific) (NNS stimuli)))))))) (, ,) (S (VP (VBG acting) (S (VP (TO to) (VP (VB regulate) (ADVP (RB precisely)) (NP (NP (NP (NN Rac)) (CC and) (NP (NN _PROT_))) (NNS activities))))))))))
+1 #(S1 (S (NP (PRP We)) (VP (VBP propose) (SBAR (IN that) (S (NP (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))) (PP (IN in) (NP (NP (NN cooperation)) (PP (IN with) (NP (JJ other) (NN adapter) (NNS molecules)))))) (VP (MD might) (VP (VB regulate) (NP (NP (DT the) (JJ cellular) (NN localization)) (PP (IN of) (NP (NN _PROT2_))) (PP (IN under) (NP (JJ specific) (NNS stimuli)))))))) (, ,) (S (VP (VBG acting) (S (VP (TO to) (VP (VB regulate) (ADVP (RB precisely)) (NP (NP (NP (NN Rac)) (CC and) (NP (NN _PROT_))) (NNS activities))))))))))
+1 #(S1 (S (NP (PRP We)) (VP (VBP propose) (SBAR (IN that) (S (NP (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))) (PP (IN in) (NP (NP (NN cooperation)) (PP (IN with) (NP (JJ other) (NN adapter) (NNS molecules)))))) (VP (MD might) (VP (VB regulate) (NP (NP (DT the) (JJ cellular) (NN localization)) (PP (IN of) (NP (NN _PROT_))) (PP (IN under) (NP (JJ specific) (NNS stimuli)))))))) (, ,) (S (VP (VBG acting) (S (VP (TO to) (VP (VB regulate) (ADVP (RB precisely)) (NP (NP (NP (NN Rac)) (CC and) (NP (NN _PROT2_))) (NNS activities))))))))))
+1 #(S1 (S (NP (PRP We)) (VP (VBP propose) (SBAR (IN that) (S (NP (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))) (PP (IN in) (NP (NP (NN cooperation)) (PP (IN with) (NP (JJ other) (NN adapter) (NNS molecules)))))) (VP (MD might) (VP (VB regulate) (NP (NP (DT the) (JJ cellular) (NN localization)) (PP (IN of) (NP (NN _PROT2_))) (PP (IN under) (NP (JJ specific) (NNS stimuli)))))))) (, ,) (S (VP (VBG acting) (S (VP (TO to) (VP (VB regulate) (ADVP (RB precisely)) (NP (NP (NP (NN Rac)) (CC and) (NP (NN _PROT_))) (NNS activities))))))))))
+1 #(S1 (S (NP (PRP We)) (VP (VBP propose) (SBAR (IN that) (S (NP (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))) (PP (IN in) (NP (NP (NN cooperation)) (PP (IN with) (NP (JJ other) (NN adapter) (NNS molecules)))))) (VP (MD might) (VP (VB regulate) (NP (NP (DT the) (JJ cellular) (NN localization)) (PP (IN of) (NP (NN _PROT_))) (PP (IN under) (NP (JJ specific) (NNS stimuli)))))))) (, ,) (S (VP (VBG acting) (S (VP (TO to) (VP (VB regulate) (ADVP (RB precisely)) (NP (NP (NP (NN Rac)) (CC and) (NP (NN _PROT2_))) (NNS activities))))))))))
-1 #(S1 (S (NP (PRP We)) (VP (VBP propose) (SBAR (IN that) (S (NP (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))) (PP (IN in) (NP (NP (NN cooperation)) (PP (IN with) (NP (JJ other) (NN adapter) (NNS molecules)))))) (VP (MD might) (VP (VB regulate) (NP (NP (DT the) (JJ cellular) (NN localization)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN under) (NP (JJ specific) (NNS stimuli)))))))) (, ,) (S (VP (VBG acting) (S (VP (TO to) (VP (VB regulate) (ADVP (RB precisely)) (NP (NP (NP (NN Rac)) (CC and) (NP (NN _PROT2_))) (NNS activities))))))))))
-1 #(S1 (S (NP (DT This) (NN work)) (VP (VBD led) (PP (TO to) (NP (NP (NN identification)) (PP (IN of) (NP (NP (NP (DT a) (JJ novel) (JJ _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (PP (IN for) (NP (NN Rho) (NN family) (NNS GTPases))))))))))
-1 #(S1 (S (NP (DT The) (NN GAP) (NN domain)) (VP (VP (VBZ shows) (NP (NP (JJ high) (NN similarity)) (PP (TO to) (NP (DT the) (ADJP (RB recently) (VBN cloned)) (NN _PROT1_))))) (CC and) (VP (VBZ displays) (NP (NP (NN activity)) (PP (IN toward) (NP (NP (NN RhoA)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (NN _PROT_))))) (ADVP (FW in) (FW vitro))))))
-1 #(S1 (S (NP (DT The) (NN GAP) (NN domain)) (VP (VP (VBZ shows) (NP (NP (JJ high) (NN similarity)) (PP (TO to) (NP (DT the) (ADJP (RB recently) (VBN cloned)) (NN _PROT1_))))) (CC and) (VP (VBZ displays) (NP (NP (NN activity)) (PP (IN toward) (NP (NP (NN RhoA)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT2_))))) (ADVP (FW in) (FW vitro))))))
-1 #(S1 (S (NP (DT The) (NN GAP) (NN domain)) (VP (VP (VBZ shows) (NP (NP (JJ high) (NN similarity)) (PP (TO to) (NP (DT the) (ADJP (RB recently) (VBN cloned)) (NN _PROT_))))) (CC and) (VP (VBZ displays) (NP (NP (NN activity)) (PP (IN toward) (NP (NP (NN RhoA)) (, ,) (NP (NN _PROT1_)) (, ,) (CC and) (NP (NN _PROT2_))))) (ADVP (FW in) (FW vitro))))))
+1 #(S1 (S (NP (DT The) (NN protein)) (VP (VBD was) (VP (VBN named) (NP (NN _PROT1_)) (PP (IN for) (NP (NP (PRP$ its) (NN ability) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NN _PROT2_) (NNS proteins))))))) (CC and) (NP (NP (PRP$ its) (NN activity)) (PP (IN toward) (NP (NP (NN Rac)) (CC and) (NP (NN _PROT_)))))))))))
+1 #(S1 (S (NP (DT The) (NN protein)) (VP (VBD was) (VP (VBN named) (NP (NN _PROT1_)) (PP (IN for) (NP (NP (PRP$ its) (NN ability) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NN _PROT_) (NNS proteins))))))) (CC and) (NP (NP (PRP$ its) (NN activity)) (PP (IN toward) (NP (NP (NN Rac)) (CC and) (NP (NN _PROT2_)))))))))))
-1 #(S1 (S (NP (DT The) (NN protein)) (VP (VBD was) (VP (VBN named) (NP (NN _PROT_)) (PP (IN for) (NP (NP (PRP$ its) (NN ability) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NN _PROT1_) (NNS proteins))))))) (CC and) (NP (NP (PRP$ its) (NN activity)) (PP (IN toward) (NP (NP (NN Rac)) (CC and) (NP (NN _PROT2_)))))))))))
+1 #(S1 (S (NP (NP (NN Expression)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN in) (NP (NN 293T) (NNS cells)))) (VP (VBD led) (PP (TO to) (NP (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (JJ active) (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))) (NNS levels)))) (CONJP (CC but) (RB not)) (NP (NN RhoA)))))))
+1 #(S1 (S (NP (NP (NN Expression)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN in) (NP (NN 293T) (NNS cells)))) (VP (VBD led) (PP (TO to) (NP (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (JJ active) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))) (NNS levels)))) (CONJP (CC but) (RB not)) (NP (NN RhoA)))))))
-1 #(S1 (S (NP (NP (NN Expression)) (PP (IN of) (NP (NN _PROT_))) (PP (IN in) (NP (NN 293T) (NNS cells)))) (VP (VBD led) (PP (TO to) (NP (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (JJ active) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (NNS levels)))) (CONJP (CC but) (RB not)) (NP (NN RhoA)))))))
+1 #(S1 (S (NP (NP (JJ Specific) (NN interaction)) (PP (IN of) (NP (NP (NN _PROT1_)) (CC and) (NP (NN c/EBPbeta))))) (VP (VBZ leads) (PP (TO to) (NP (NP (DT the) (JJ transcriptional) (NN activation)) (PP (IN of) (NP (DT the) (JJ human) (NP (JJ _PROT2_) (NN _PROT2_) (NN _PROT2_)) (NN _PROT2_) (NN gene))))))))
-1 #(S1 (S (NP (NP (NP (DT The) (JJ sterol-independent) (JJ regulatory) (NN element)) (PRN (-LRB- -LRB-) (NP (VB SIRE)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (NN _PROT1_) (NN _PROT1_) (-LRB- -LRB-) (NN _PROT2_) (-RRB- -RRB-) (NN promoter)))) (VP (VBZ mediates) (NP (NP (ADJP (NP (NN _PROT_) (NN _PROT_)) (-LRB- -LRB-) (NN OM) (-RRB- -RRB-) (JJ -induced)) (NN transcription)) (PP (IN of) (NP (DT the) (NN _PROT_) (NN gene)))) (PP (IN through) (NP (DT a) (JJ cholesterol-independent) (NN pathway))))))
+1 #(S1 (S (NP (NP (NP (DT The) (JJ sterol-independent) (JJ regulatory) (NN element)) (PRN (-LRB- -LRB-) (NP (VB SIRE)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (NN _PROT1_) (NN _PROT1_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-) (NN promoter)))) (VP (VBZ mediates) (NP (NP (ADJP (NP (NN _PROT2_) (NN _PROT2_)) (-LRB- -LRB-) (NN OM) (-RRB- -RRB-) (JJ -induced)) (NN transcription)) (PP (IN of) (NP (DT the) (NN _PROT_) (NN gene)))) (PP (IN through) (NP (DT a) (JJ cholesterol-independent) (NN pathway))))))
-1 #(S1 (S (NP (NP (NP (DT The) (JJ sterol-independent) (JJ regulatory) (NN element)) (PRN (-LRB- -LRB-) (NP (VB SIRE)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (NN _PROT1_) (NN _PROT1_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-) (NN promoter)))) (VP (VBZ mediates) (NP (NP (ADJP (NP (NN _PROT_) (NN _PROT_)) (-LRB- -LRB-) (NN OM) (-RRB- -RRB-) (JJ -induced)) (NN transcription)) (PP (IN of) (NP (DT the) (NN _PROT2_) (NN gene)))) (PP (IN through) (NP (DT a) (JJ cholesterol-independent) (NN pathway))))))
+1 #(S1 (S (NP (NP (NP (DT The) (JJ sterol-independent) (JJ regulatory) (NN element)) (PRN (-LRB- -LRB-) (NP (VB SIRE)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (NN _PROT_) (NN _PROT_) (-LRB- -LRB-) (NN _PROT1_) (-RRB- -RRB-) (NN promoter)))) (VP (VBZ mediates) (NP (NP (ADJP (NP (NN _PROT2_) (NN _PROT2_)) (-LRB- -LRB-) (NN OM) (-RRB- -RRB-) (JJ -induced)) (NN transcription)) (PP (IN of) (NP (DT the) (NN _PROT_) (NN gene)))) (PP (IN through) (NP (DT a) (JJ cholesterol-independent) (NN pathway))))))
-1 #(S1 (S (NP (NP (NP (DT The) (JJ sterol-independent) (JJ regulatory) (NN element)) (PRN (-LRB- -LRB-) (NP (VB SIRE)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (NN _PROT_) (NN _PROT_) (-LRB- -LRB-) (NN _PROT1_) (-RRB- -RRB-) (NN promoter)))) (VP (VBZ mediates) (NP (NP (ADJP (NP (NN _PROT_) (NN _PROT_)) (-LRB- -LRB-) (NN OM) (-RRB- -RRB-) (JJ -induced)) (NN transcription)) (PP (IN of) (NP (DT the) (NN _PROT2_) (NN gene)))) (PP (IN through) (NP (DT a) (JJ cholesterol-independent) (NN pathway))))))
+1 #(S1 (S (NP (NP (NP (DT The) (JJ sterol-independent) (JJ regulatory) (NN element)) (PRN (-LRB- -LRB-) (NP (VB SIRE)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (NN _PROT_) (NN _PROT_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-) (NN promoter)))) (VP (VBZ mediates) (NP (NP (ADJP (NP (NN _PROT1_) (NN _PROT1_)) (-LRB- -LRB-) (NN OM) (-RRB- -RRB-) (JJ -induced)) (NN transcription)) (PP (IN of) (NP (DT the) (NN _PROT2_) (NN gene)))) (PP (IN through) (NP (DT a) (JJ cholesterol-independent) (NN pathway))))))
-1 #(S1 (S (NP (NP (NN Regulation)) (PP (IN of) (NP (NN neutrophil) (NN adhesion))) (PP (IN by) (NP (JJ pituitary) (NN growth) (NN hormone)))) (VP (VBZ accompanies) (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NP (NN _PROT1_)) (, ,) (NP (NN p125FAK)) (, ,) (CC and) (NP (NN _PROT2_))))))))
-1 #(S1 (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (JJ pituitary) (NN GH)) (VP (VBZ modulates) (NP (NN neutrophil) (NN adhesion)) (PP (IN through) (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NP (NN _PROT1_)) (, ,) (NP (NN p125FAK)) (, ,) (CC and) (NP (NN _PROT2_)) (CC and) (NP (NN actin) (NN polymerization))))))))))))
-1 #(S1 (S (NP (JJ Pituitary) (NN GH)) (VP (VBD triggered) (NP (NP (NP (DT the) (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NP (NN _PROT1_) (NN _PROT1_) (CD _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))))) (CC and) (NP (NP (NN _PROT_)) (PP (IN in) (NP (NNS neutrophils))))))))
-1 #(S1 (S (NP (JJ Pituitary) (NN GH)) (VP (VBD triggered) (NP (NP (NP (DT the) (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NP (NN _PROT1_) (NN _PROT1_) (CD _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))) (CC and) (NP (NP (NN _PROT2_)) (PP (IN in) (NP (NNS neutrophils))))))))
-1 #(S1 (S (NP (JJ Pituitary) (NN GH)) (VP (VBD triggered) (NP (NP (NP (DT the) (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NP (NN _PROT_) (NN _PROT_) (CD _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))))) (CC and) (NP (NP (NN _PROT2_)) (PP (IN in) (NP (NNS neutrophils))))))))
-1 #(S1 (S (NP (NP (NN Preincubation)) (PP (IN with) (NP (NP (NN genistein)) (, ,) (NP (DT a) (NN tyrosine) (NN kinase) (NN inhibitor)) (, ,)))) (VP (VBD blocked) (NP (NP (DT the) (JJ GH-stimulated) (NN adhesion)) (CC and) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT2_)) (, ,) (NP (NN p125FAK)) (, ,) (CC and) (NP (NN _PROT_) (NN phosphorylation)))))))
-1 #(S1 (S (NP (NP (NN Preincubation)) (PP (IN with) (NP (NP (NN genistein)) (, ,) (NP (DT a) (NN tyrosine) (NN kinase) (NN inhibitor)) (, ,)))) (VP (VBD blocked) (NP (NP (DT the) (JJ GH-stimulated) (NN adhesion)) (CC and) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN p125FAK)) (, ,) (CC and) (NP (NN _PROT2_) (NN phosphorylation)))))))
-1 #(S1 (S (NP (NP (NN Preincubation)) (PP (IN with) (NP (NP (NN genistein)) (, ,) (NP (DT a) (NN tyrosine) (NN kinase) (NN inhibitor)) (, ,)))) (VP (VBD blocked) (NP (NP (DT the) (JJ GH-stimulated) (NN adhesion)) (CC and) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (NP (NN p125FAK)) (, ,) (CC and) (NP (NN _PROT2_) (NN phosphorylation)))))))
+1 #(S1 (S (NP (NN Immunoprecipitation) (NNS experiments)) (VP (VBD revealed) (NP (NP (DT a) (JJ physical) (NN association)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN with) (NP (NN p125FAK)))) (PP (IN via) (NP (NN _PROT2_))) (ADVP (FW in) (FW vivo)))))
+1 #(S1 (S (NP (NP (JJ Cutting) (NN edge)) (: :) (NP (NP (NP (NN _PROT1_)) (VP (VBZ functions) (PP (IN as) (NP (NP (DT a) (NN T) (NN cell) (NN counterreceptor)) (PP (IN for) (NP (DT the) (NN macrophage) (NN adhesion) (NN receptor) (NN _PROT2_))))))) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))))
+1 #(S1 (S (NP (NP (JJ Cutting) (NN edge)) (: :) (NP (NP (NP (NN _PROT1_)) (VP (VBZ functions) (PP (IN as) (NP (NP (DT a) (NN T) (NN cell) (NN counterreceptor)) (PP (IN for) (NP (DT the) (NN macrophage) (NN adhesion) (NN receptor) (NN _PROT_))))))) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))))))
-1 #(S1 (S (NP (NP (JJ Cutting) (NN edge)) (: :) (NP (NP (NP (NN _PROT_)) (VP (VBZ functions) (PP (IN as) (NP (NP (DT a) (NN T) (NN cell) (NN counterreceptor)) (PP (IN for) (NP (DT the) (NN macrophage) (NN adhesion) (NN receptor) (NN _PROT1_))))))) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))))))
-1 #(S1 (S (NP (NP (DT The) (NN 130-)) (CC and) (NP (JJ 240-kDa) (NN sialoadhesin-binding) (NNS glycoproteins))) (VP (VBD were) (VP (VBN identified) (PP (IN as) (NP (DT the) (NNS sialomucins) (NP (NP (NN _PROT1_)) (CC and) (NP (NP (NN _PROT2_) (NN _PROT2_) (NN _PROT2_) (CD _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))))) (, ,) (ADVP (RB respectively))))))
-1 #(S1 (S (NP (NP (DT The) (NN 130-)) (CC and) (NP (JJ 240-kDa) (NN sialoadhesin-binding) (NNS glycoproteins))) (VP (VBD were) (VP (VBN identified) (PP (IN as) (NP (DT the) (NNS sialomucins) (NP (NP (NN _PROT1_)) (CC and) (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_) (CD _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))))) (, ,) (ADVP (RB respectively))))))
-1 #(S1 (S (NP (NP (DT The) (NN 130-)) (CC and) (NP (JJ 240-kDa) (NN sialoadhesin-binding) (NNS glycoproteins))) (VP (VBD were) (VP (VBN identified) (PP (IN as) (NP (DT the) (NNS sialomucins) (NP (NP (NN _PROT_)) (CC and) (NP (NP (NN _PROT1_) (NN _PROT1_) (NN _PROT1_) (CD _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))))) (, ,) (ADVP (RB respectively))))))
+1 #(S1 (S (NP (NP (NN _PROT1_)) (VP (VBN expressed) (PP (IN in) (NP (NN COS) (NNS cells))))) (VP (VBD supported) (NP (NP (VBN increased) (NN binding)) (PP (TO to) (NP (JJ immobilized) (NN _PROT2_)))))))
+1 #(S1 (S (ADVP (RB Finally)) (, ,) (NP (NN _PROT1_)) (VP (VBD bound) (NP (NP (JJ different) (NNS glycoforms)) (PP (IN of) (NP (NP (NN _PROT2_)) (VP (VBN expressed) (PP (IN in) (NP (NP (JJ Chinese) (NN hamster) (NN ovary) (NNS cells)) (, ,) (PP (VBG including) (NP (NP (ADJP (ADJP (JJ unbranched)) (PRN (-LRB- -LRB-) (NP (NN core) (CD 1)) (-RRB- -RRB-)) (CC and) (ADJP (JJ branched)) (PRN (-LRB- -LRB-) (NP (NN core) (CD 2)) (-RRB- -RRB-))) (NN O) (: :) (JJ -linked) (NNS glycans)) (, ,) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB normally)) (VP (VBN found) (PP (IN on) (NP (NP (NN _PROT_)) (PP (IN in) (NP (ADJP (ADJP (VBG resting)) (CC and) (ADJP (VBN activated))) (NN T) (NNS cells))))))))))))))))) (, ,) (ADVP (RB respectively)))))
-1 #(S1 (S (ADVP (RB Finally)) (, ,) (NP (NN _PROT1_)) (VP (VBD bound) (NP (NP (JJ different) (NNS glycoforms)) (PP (IN of) (NP (NP (NN _PROT_)) (VP (VBN expressed) (PP (IN in) (NP (NP (JJ Chinese) (NN hamster) (NN ovary) (NNS cells)) (, ,) (PP (VBG including) (NP (NP (ADJP (ADJP (JJ unbranched)) (PRN (-LRB- -LRB-) (NP (NN core) (CD 1)) (-RRB- -RRB-)) (CC and) (ADJP (JJ branched)) (PRN (-LRB- -LRB-) (NP (NN core) (CD 2)) (-RRB- -RRB-))) (NN O) (: :) (JJ -linked) (NNS glycans)) (, ,) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB normally)) (VP (VBN found) (PP (IN on) (NP (NP (NN _PROT2_)) (PP (IN in) (NP (ADJP (ADJP (VBG resting)) (CC and) (ADJP (VBN activated))) (NN T) (NNS cells))))))))))))))))) (, ,) (ADVP (RB respectively)))))
-1 #(S1 (S (ADVP (RB Finally)) (, ,) (NP (NN _PROT_)) (VP (VBD bound) (NP (NP (JJ different) (NNS glycoforms)) (PP (IN of) (NP (NP (NN _PROT1_)) (VP (VBN expressed) (PP (IN in) (NP (NP (JJ Chinese) (NN hamster) (NN ovary) (NNS cells)) (, ,) (PP (VBG including) (NP (NP (ADJP (ADJP (JJ unbranched)) (PRN (-LRB- -LRB-) (NP (NN core) (CD 1)) (-RRB- -RRB-)) (CC and) (ADJP (JJ branched)) (PRN (-LRB- -LRB-) (NP (NN core) (CD 2)) (-RRB- -RRB-))) (NN O) (: :) (JJ -linked) (NNS glycans)) (, ,) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB normally)) (VP (VBN found) (PP (IN on) (NP (NP (NN _PROT2_)) (PP (IN in) (NP (ADJP (ADJP (VBG resting)) (CC and) (ADJP (VBN activated))) (NN T) (NNS cells))))))))))))))))) (, ,) (ADVP (RB respectively)))))
+1 #(S1 (S (NP (DT These) (NNS results)) (VP (VP (VBP identify) (NP (NN _PROT1_)) (PP (IN as) (NP (NP (DT a) (NN T) (NN cell) (NN counterreceptor)) (PP (IN for) (NP (NN _PROT2_)))))) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (PP (IN in) (NN addition) (TO to) (NP (PRP$ its) (JJ anti-adhesive) (NN role))) (NP (NN _PROT_)) (VP (MD may) (VP (VB promote) (NP (JJ cell-cell) (NNS interactions))))))))))
-1 #(S1 (S (NP (DT These) (NNS results)) (VP (VP (VBP identify) (NP (NN _PROT1_)) (PP (IN as) (NP (NP (DT a) (NN T) (NN cell) (NN counterreceptor)) (PP (IN for) (NP (NN _PROT_)))))) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (PP (IN in) (NN addition) (TO to) (NP (PRP$ its) (JJ anti-adhesive) (NN role))) (NP (NN _PROT2_)) (VP (MD may) (VP (VB promote) (NP (JJ cell-cell) (NNS interactions))))))))))
-1 #(S1 (S (NP (DT These) (NNS results)) (VP (VP (VBP identify) (NP (NN _PROT_)) (PP (IN as) (NP (NP (DT a) (NN T) (NN cell) (NN counterreceptor)) (PP (IN for) (NP (NN _PROT1_)))))) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (PP (IN in) (NN addition) (TO to) (NP (PRP$ its) (JJ anti-adhesive) (NN role))) (NP (NN _PROT2_)) (VP (MD may) (VP (VB promote) (NP (JJ cell-cell) (NNS interactions))))))))))
+1 #(S1 (S (NP (NP (DT A) (NN role)) (PP (IN for) (NP (NP (NN _PROT1_) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT2_))))) (PP (IN in) (NP (NN cytokinesis))))))
+1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VP (VBP characterize) (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_)))))) (, ,) (VP (VBP show) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ phosphorylates) (NP (NN _PROT_)) (PP (IN at) (NP (VBN conserved) (NP (NP (NN S274)) (CC and) (NP (NN S326))) (NNS residues))) (ADVP (FW in) (FW vitro)))))) (, ,) (CC and) (VP (VBP present) (NP (NN evidence) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ is) (ADVP (RB also)) (NP (NP (DT a) (NN substrate)) (PP (IN for) (NP (NN _PROT_)))) (ADVP (FW in) (FW vivo))))))))))
-1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VP (VBP characterize) (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_)))))) (, ,) (VP (VBP show) (SBAR (IN that) (S (NP (NN _PROT2_)) (VP (VBZ phosphorylates) (NP (NN _PROT_)) (PP (IN at) (NP (VBN conserved) (NP (NP (NN S274)) (CC and) (NP (NN S326))) (NNS residues))) (ADVP (FW in) (FW vitro)))))) (, ,) (CC and) (VP (VBP present) (NP (NN evidence) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ is) (ADVP (RB also)) (NP (NP (DT a) (NN substrate)) (PP (IN for) (NP (NN _PROT_)))) (ADVP (FW in) (FW vivo))))))))))
-1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VP (VBP characterize) (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_)))))) (, ,) (VP (VBP show) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ phosphorylates) (NP (NN _PROT2_)) (PP (IN at) (NP (VBN conserved) (NP (NP (NN S274)) (CC and) (NP (NN S326))) (NNS residues))) (ADVP (FW in) (FW vitro)))))) (, ,) (CC and) (VP (VBP present) (NP (NN evidence) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ is) (ADVP (RB also)) (NP (NP (DT a) (NN substrate)) (PP (IN for) (NP (NN _PROT_)))) (ADVP (FW in) (FW vivo))))))))))
-1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VP (VBP characterize) (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_)))))) (, ,) (VP (VBP show) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ phosphorylates) (NP (NN _PROT_)) (PP (IN at) (NP (VBN conserved) (NP (NP (NN S274)) (CC and) (NP (NN S326))) (NNS residues))) (ADVP (FW in) (FW vitro)))))) (, ,) (CC and) (VP (VBP present) (NP (NN evidence) (SBAR (IN that) (S (NP (NN _PROT2_)) (VP (VBZ is) (ADVP (RB also)) (NP (NP (DT a) (NN substrate)) (PP (IN for) (NP (NN _PROT_)))) (ADVP (FW in) (FW vivo))))))))))
-1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VP (VBP characterize) (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_)))))) (, ,) (VP (VBP show) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ phosphorylates) (NP (NN _PROT_)) (PP (IN at) (NP (VBN conserved) (NP (NP (NN S274)) (CC and) (NP (NN S326))) (NNS residues))) (ADVP (FW in) (FW vitro)))))) (, ,) (CC and) (VP (VBP present) (NP (NN evidence) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ is) (ADVP (RB also)) (NP (NP (DT a) (NN substrate)) (PP (IN for) (NP (NN _PROT2_)))) (ADVP (FW in) (FW vivo))))))))))
-1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VP (VBP characterize) (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_)))))) (, ,) (VP (VBP show) (SBAR (IN that) (S (NP (NN _PROT2_)) (VP (VBZ phosphorylates) (NP (NN _PROT_)) (PP (IN at) (NP (VBN conserved) (NP (NP (NN S274)) (CC and) (NP (NN S326))) (NNS residues))) (ADVP (FW in) (FW vitro)))))) (, ,) (CC and) (VP (VBP present) (NP (NN evidence) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ is) (ADVP (RB also)) (NP (NP (DT a) (NN substrate)) (PP (IN for) (NP (NN _PROT_)))) (ADVP (FW in) (FW vivo))))))))))
-1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VP (VBP characterize) (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_)))))) (, ,) (VP (VBP show) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ phosphorylates) (NP (NN _PROT2_)) (PP (IN at) (NP (VBN conserved) (NP (NP (NN S274)) (CC and) (NP (NN S326))) (NNS residues))) (ADVP (FW in) (FW vitro)))))) (, ,) (CC and) (VP (VBP present) (NP (NN evidence) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ is) (ADVP (RB also)) (NP (NP (DT a) (NN substrate)) (PP (IN for) (NP (NN _PROT_)))) (ADVP (FW in) (FW vivo))))))))))
-1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VP (VBP characterize) (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_)))))) (, ,) (VP (VBP show) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ phosphorylates) (NP (NN _PROT_)) (PP (IN at) (NP (VBN conserved) (NP (NP (NN S274)) (CC and) (NP (NN S326))) (NNS residues))) (ADVP (FW in) (FW vitro)))))) (, ,) (CC and) (VP (VBP present) (NP (NN evidence) (SBAR (IN that) (S (NP (NN _PROT2_)) (VP (VBZ is) (ADVP (RB also)) (NP (NP (DT a) (NN substrate)) (PP (IN for) (NP (NN _PROT_)))) (ADVP (FW in) (FW vivo))))))))))
-1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VP (VBP characterize) (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_)))))) (, ,) (VP (VBP show) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ phosphorylates) (NP (NN _PROT_)) (PP (IN at) (NP (VBN conserved) (NP (NP (NN S274)) (CC and) (NP (NN S326))) (NNS residues))) (ADVP (FW in) (FW vitro)))))) (, ,) (CC and) (VP (VBP present) (NP (NN evidence) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ is) (ADVP (RB also)) (NP (NP (DT a) (NN substrate)) (PP (IN for) (NP (NN _PROT2_)))) (ADVP (FW in) (FW vivo))))))))))
+1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VP (VBP characterize) (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_)))))) (, ,) (VP (VBP show) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ phosphorylates) (NP (NN _PROT2_)) (PP (IN at) (NP (VBN conserved) (NP (NP (NN S274)) (CC and) (NP (NN S326))) (NNS residues))) (ADVP (FW in) (FW vitro)))))) (, ,) (CC and) (VP (VBP present) (NP (NN evidence) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ is) (ADVP (RB also)) (NP (NP (DT a) (NN substrate)) (PP (IN for) (NP (NN _PROT_)))) (ADVP (FW in) (FW vivo))))))))))
-1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VP (VBP characterize) (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_)))))) (, ,) (VP (VBP show) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ phosphorylates) (NP (NN _PROT_)) (PP (IN at) (NP (VBN conserved) (NP (NP (NN S274)) (CC and) (NP (NN S326))) (NNS residues))) (ADVP (FW in) (FW vitro)))))) (, ,) (CC and) (VP (VBP present) (NP (NN evidence) (SBAR (IN that) (S (NP (NN _PROT2_)) (VP (VBZ is) (ADVP (RB also)) (NP (NP (DT a) (NN substrate)) (PP (IN for) (NP (NN _PROT_)))) (ADVP (FW in) (FW vivo))))))))))
-1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VP (VBP characterize) (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_)))))) (, ,) (VP (VBP show) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ phosphorylates) (NP (NN _PROT_)) (PP (IN at) (NP (VBN conserved) (NP (NP (NN S274)) (CC and) (NP (NN S326))) (NNS residues))) (ADVP (FW in) (FW vitro)))))) (, ,) (CC and) (VP (VBP present) (NP (NN evidence) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ is) (ADVP (RB also)) (NP (NP (DT a) (NN substrate)) (PP (IN for) (NP (NN _PROT2_)))) (ADVP (FW in) (FW vivo))))))))))
-1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VP (VBP characterize) (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_)))))) (, ,) (VP (VBP show) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ phosphorylates) (NP (NN _PROT1_)) (PP (IN at) (NP (VBN conserved) (NP (NP (NN S274)) (CC and) (NP (NN S326))) (NNS residues))) (ADVP (FW in) (FW vitro)))))) (, ,) (CC and) (VP (VBP present) (NP (NN evidence) (SBAR (IN that) (S (NP (NN _PROT2_)) (VP (VBZ is) (ADVP (RB also)) (NP (NP (DT a) (NN substrate)) (PP (IN for) (NP (NN _PROT_)))) (ADVP (FW in) (FW vivo))))))))))
-1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VP (VBP characterize) (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_)))))) (, ,) (VP (VBP show) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ phosphorylates) (NP (NN _PROT1_)) (PP (IN at) (NP (VBN conserved) (NP (NP (NN S274)) (CC and) (NP (NN S326))) (NNS residues))) (ADVP (FW in) (FW vitro)))))) (, ,) (CC and) (VP (VBP present) (NP (NN evidence) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ is) (ADVP (RB also)) (NP (NP (DT a) (NN substrate)) (PP (IN for) (NP (NN _PROT2_)))) (ADVP (FW in) (FW vivo))))))))))
+1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VP (VBP characterize) (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_)))))) (, ,) (VP (VBP show) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ phosphorylates) (NP (NN _PROT_)) (PP (IN at) (NP (VBN conserved) (NP (NP (NN S274)) (CC and) (NP (NN S326))) (NNS residues))) (ADVP (FW in) (FW vitro)))))) (, ,) (CC and) (VP (VBP present) (NP (NN evidence) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ is) (ADVP (RB also)) (NP (NP (DT a) (NN substrate)) (PP (IN for) (NP (NN _PROT2_)))) (ADVP (FW in) (FW vivo))))))))))
-1 #(S1 (S (NP (NP (NN Downregulation)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN by) (NP (NN RNA) (NN interference)))) (VP (VBZ results) (PP (IN in) (NP (NP (JJ multiple) (JJ mitotic) (NNS defects)) (, ,) (PP (VBG including) (NP (NP (NN multinucleation)) (CC and) (NP (NP (NNS cells)) (VP (VBN arrested) (PP (IN at) (NP (DT the) (NN midbody) (NN stage))))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBN rescued) (PP (PP (IN by) (NP (NP (JJ ectopic) (NN expression)) (PP (IN of) (NP (JJ wild-type) (NN _PROT2_))))) (, ,) (CC but) (PP (RB not) (IN by) (NP (NP (NN _PROT_)) (PP (IN with) (NP (NP (NNS mutations)) (PP (IN in) (NP (DT the) (NN _PROT_) (NN phosphorylation) (NNS sites)))))))))))))))))
-1 #(S1 (S (NP (NP (NN Downregulation)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN by) (NP (NN RNA) (NN interference)))) (VP (VBZ results) (PP (IN in) (NP (NP (JJ multiple) (JJ mitotic) (NNS defects)) (, ,) (PP (VBG including) (NP (NP (NN multinucleation)) (CC and) (NP (NP (NNS cells)) (VP (VBN arrested) (PP (IN at) (NP (DT the) (NN midbody) (NN stage))))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBN rescued) (PP (PP (IN by) (NP (NP (JJ ectopic) (NN expression)) (PP (IN of) (NP (JJ wild-type) (NN _PROT_))))) (, ,) (CC but) (PP (RB not) (IN by) (NP (NP (NN _PROT2_)) (PP (IN with) (NP (NP (NNS mutations)) (PP (IN in) (NP (DT the) (NN _PROT_) (NN phosphorylation) (NNS sites)))))))))))))))))
-1 #(S1 (S (NP (NP (NN Downregulation)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN by) (NP (NN RNA) (NN interference)))) (VP (VBZ results) (PP (IN in) (NP (NP (JJ multiple) (JJ mitotic) (NNS defects)) (, ,) (PP (VBG including) (NP (NP (NN multinucleation)) (CC and) (NP (NP (NNS cells)) (VP (VBN arrested) (PP (IN at) (NP (DT the) (NN midbody) (NN stage))))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBN rescued) (PP (PP (IN by) (NP (NP (JJ ectopic) (NN expression)) (PP (IN of) (NP (JJ wild-type) (NN _PROT_))))) (, ,) (CC but) (PP (RB not) (IN by) (NP (NP (NN _PROT_)) (PP (IN with) (NP (NP (NNS mutations)) (PP (IN in) (NP (DT the) (NN _PROT2_) (NN phosphorylation) (NNS sites)))))))))))))))))
-1 #(S1 (S (NP (NP (NN Downregulation)) (PP (IN of) (NP (NN _PROT_))) (PP (IN by) (NP (NN RNA) (NN interference)))) (VP (VBZ results) (PP (IN in) (NP (NP (JJ multiple) (JJ mitotic) (NNS defects)) (, ,) (PP (VBG including) (NP (NP (NN multinucleation)) (CC and) (NP (NP (NNS cells)) (VP (VBN arrested) (PP (IN at) (NP (DT the) (NN midbody) (NN stage))))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBN rescued) (PP (PP (IN by) (NP (NP (JJ ectopic) (NN expression)) (PP (IN of) (NP (JJ wild-type) (NN _PROT1_))))) (, ,) (CC but) (PP (RB not) (IN by) (NP (NP (NN _PROT2_)) (PP (IN with) (NP (NP (NNS mutations)) (PP (IN in) (NP (DT the) (NN _PROT_) (NN phosphorylation) (NNS sites)))))))))))))))))
-1 #(S1 (S (NP (NP (NN Downregulation)) (PP (IN of) (NP (NN _PROT_))) (PP (IN by) (NP (NN RNA) (NN interference)))) (VP (VBZ results) (PP (IN in) (NP (NP (JJ multiple) (JJ mitotic) (NNS defects)) (, ,) (PP (VBG including) (NP (NP (NN multinucleation)) (CC and) (NP (NP (NNS cells)) (VP (VBN arrested) (PP (IN at) (NP (DT the) (NN midbody) (NN stage))))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBN rescued) (PP (PP (IN by) (NP (NP (JJ ectopic) (NN expression)) (PP (IN of) (NP (JJ wild-type) (NN _PROT1_))))) (, ,) (CC but) (PP (RB not) (IN by) (NP (NP (NN _PROT_)) (PP (IN with) (NP (NP (NNS mutations)) (PP (IN in) (NP (DT the) (NN _PROT2_) (NN phosphorylation) (NNS sites)))))))))))))))))
-1 #(S1 (S (NP (NP (NN Downregulation)) (PP (IN of) (NP (NN _PROT_))) (PP (IN by) (NP (NN RNA) (NN interference)))) (VP (VBZ results) (PP (IN in) (NP (NP (JJ multiple) (JJ mitotic) (NNS defects)) (, ,) (PP (VBG including) (NP (NP (NN multinucleation)) (CC and) (NP (NP (NNS cells)) (VP (VBN arrested) (PP (IN at) (NP (DT the) (NN midbody) (NN stage))))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBN rescued) (PP (PP (IN by) (NP (NP (JJ ectopic) (NN expression)) (PP (IN of) (NP (JJ wild-type) (NN _PROT_))))) (, ,) (CC but) (PP (RB not) (IN by) (NP (NP (NN _PROT1_)) (PP (IN with) (NP (NP (NNS mutations)) (PP (IN in) (NP (DT the) (NN _PROT2_) (NN phosphorylation) (NNS sites)))))))))))))))))
+1 #(S1 (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NN _PROT1_) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT2_)))) (VP (MD may) (VP (VB influence) (NP (NN cytokinesis)))))))))
-1 #(S1 (S (NP (NP (DT A) (JJ prominent) (NN isolate)) (, ,) (VP (VBN designated) (S (NP (NN _PROT1_AND_PROT2_)))) (, ,)) (ADVP (RB specifically)) (VP (VBZ interacts) (PP (IN with) (NP (NP (DT the) (NN _PROT_)) (PP (CONJP (RB not) (RB only)) (PP (IN in) (NP (FW vivo))) (CONJP (CC but) (RB also))))) (ADVP (FW in) (FW vitro)))))
+1 #(S1 (S (NP (NP (DT A) (JJ prominent) (NN isolate)) (, ,) (VP (VBN designated) (S (NP (NN _PROT1_)))) (, ,)) (ADVP (RB specifically)) (VP (VBZ interacts) (PP (IN with) (NP (NP (DT the) (NN _PROT2_)) (PP (CONJP (RB not) (RB only)) (PP (IN in) (NP (FW vivo))) (CONJP (CC but) (RB also))))) (ADVP (FW in) (FW vitro)))))
+1 #(S1 (S (NP (NP (DT A) (JJ prominent) (NN isolate)) (, ,) (VP (VBN designated) (S (NP (NN _PROT1_)))) (, ,)) (ADVP (RB specifically)) (VP (VBZ interacts) (PP (IN with) (NP (NP (DT the) (NN _PROT2_)) (PP (CONJP (RB not) (RB only)) (PP (IN in) (NP (FW vivo))) (CONJP (CC but) (RB also))))) (ADVP (FW in) (FW vitro)))))
-1 #(S1 (S (NP (NN _PROT1_)) (VP (VP (VBZ is) (NP (NP (DT a) (JJ nuclear) (NN protein)) (PP (IN with) (NP (NP (DT a) (JJ characteristic) (NN distribution)) (PP (IN in) (NP (JJ large) (ADJP (RB irregularly) (VBN shaped)) (JJ nuclear) (NNS speckles))))))) (CC and) (VP (VBZ co-localizes) (ADVP (RB perfectly)) (PP (IN with) (NP (DT the) (JJ SR) (JJ domain-containing) (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)))))))
